Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
74265 206596 107 None -2 3 Human 6.0 pEC50 = 6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 206596 107 None -2 3 Human 6.0 pEC50 = 6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
14434082 83355 11 None -1 3 Human 5.0 pEC50 = 5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83355 11 None -1 3 Human 5.0 pEC50 = 5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
16726107 83062 2 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
CHEMBL220199 83062 2 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
14338 4287 115 None -3 3 Human 5.0 pEC50 = 5.0 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4287 115 None -3 3 Human 5.0 pEC50 = 5.0 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
14338 4287 115 None -3 3 Human 4.9 pEC50 = 4.9 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4287 115 None -3 3 Human 4.9 pEC50 = 4.9 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
16301115 83008 5 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 435 7 1 6 3.8 Cc1ccc(-n2c(C)nnc2SCC(=O)NC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm061389p
CHEMBL219769 83008 5 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 435 7 1 6 3.8 Cc1ccc(-n2c(C)nnc2SCC(=O)NC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm061389p
93149 106704 78 None -16 3 Human 5.8 pEC50 = 5.8 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106704 78 None -16 3 Human 5.8 pEC50 = 5.8 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
3258407 84466 19 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
CHEMBL223686 84466 19 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
12987698 83362 4 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83362 4 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
1474 153853 133 None -1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153853 133 None -1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
12987698 83362 4 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83362 4 None 2 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15783796 83364 1 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83364 1 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 106704 78 None -16 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106704 78 None -16 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
2733927 83361 90 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83361 90 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
1474 153853 133 None -1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153853 133 None -1 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
16728788 83009 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
CHEMBL219770 83009 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
15783796 83364 1 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83364 1 None -3 3 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
2733927 83361 90 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83361 90 None -4 3 Human 4.7 pEC50 = 4.7 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
15664 83360 93 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83360 93 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
137660245 158727 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 461 7 1 4 4.4 CC(C)CN1CC(C(=O)Nc2ccc(CN(C)C3CCOCC3)cc2)=Cc2ccccc2C1=O 10.1016/j.ejmech.2017.04.046
CHEMBL4099473 158727 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 461 7 1 4 4.4 CC(C)CN1CC(C(=O)Nc2ccc(CN(C)C3CCOCC3)cc2)=Cc2ccccc2C1=O 10.1016/j.ejmech.2017.04.046
15664 83360 93 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83360 93 None 2 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
72792 198031 76 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 198031 76 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
72792 198031 76 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 198031 76 None -5 3 Human 5.6 pEC50 = 5.6 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
70848 204935 105 None -5 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204935 105 None -5 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
1167892 83011 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
CHEMBL219781 83011 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
70848 204935 105 None -5 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204935 105 None -5 3 Human 4.5 pEC50 = 4.5 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
10585 1058 1 None -1 2 Human 8.4 pEC50 = 8.4 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None -1 2 Human 8.4 pEC50 = 8.4 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None -1 2 Human 8.4 pEC50 = 8.4 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
12425 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
10585 1058 1 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None -1 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 173501 1 None 2 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 173501 1 None 2 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
155491018 173501 1 None 2 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 173501 1 None 2 2 Human 8.3 pEC50 = 8.3 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
12425 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None -4 4 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
155491018 173501 1 None 2 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 173501 1 None 2 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
155491018 173501 1 None 2 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 173501 1 None 2 2 Human 8.2 pEC50 = 8.2 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
65237 137086 97 None -28 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137086 97 None -28 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
65237 137086 97 None -28 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137086 97 None -28 2 Human 4.2 pEC50 = 4.2 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
183790 3673 8 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 3673 8 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 3673 8 None -2 4 Human 8.2 pEC50 = 8.2 Functional
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
10585 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
10585 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
10585 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 173501 1 None 2 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 173501 1 None 2 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
10585 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None -1 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 173501 1 None 2 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 173501 1 None 2 2 Human 8.1 pEC50 = 8.1 Functional
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
11151928 188887 0 None -10 4 Human 9.1 pED50 = 9.1 Functional
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@H]1CCCCNC1=O 10.1021/jm900133w
CHEMBL513863 188887 0 None -10 4 Human 9.1 pED50 = 9.1 Functional
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@H]1CCCCNC1=O 10.1021/jm900133w
15941255 81347 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 527 9 2 6 4.5 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2Cl)CC1 10.1021/ml2002604
CHEMBL2164207 81347 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 527 9 2 6 4.5 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2Cl)CC1 10.1021/ml2002604
57402801 68866 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 600 12 2 7 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C(=O)NC(C)C)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926899 68866 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 600 12 2 7 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C(=O)NC(C)C)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50993591 56898 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3cccc(F)c3)c2C1 10.1021/jm100978n
CHEMBL1649924 56898 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3cccc(F)c3)c2C1 10.1021/jm100978n
15940800 81342 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 561 10 1 7 3.9 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CN2CCOC2=O)CC1 10.1021/ml2002604
CHEMBL2164202 81342 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 561 10 1 7 3.9 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CN2CCOC2=O)CC1 10.1021/ml2002604
15941086 81350 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 518 9 2 7 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2Cl)CC1 10.1021/ml2002604
CHEMBL2164210 81350 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 518 9 2 7 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2Cl)CC1 10.1021/ml2002604
11285792 864 30 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 864 30 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 864 30 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 864 30 None -3 6 Human 10.0 pIC50 = 10 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
62706107 81357 0 None - 1 Human 10.0 pIC50 = 10.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 554 9 2 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)Nc2cccnc2)CC1 10.1021/ml2002604
CHEMBL2164217 81357 0 None - 1 Human 10.0 pIC50 = 10.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 554 9 2 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)Nc2cccnc2)CC1 10.1021/ml2002604
11650548 103054 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085308 103054 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
15947119 68860 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926893 68860 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
3002977 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
803 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
806 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
CHEMBL1201187 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
CHEMBL256907 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
CHEMBL584744 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
DB04835 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
50993593 56900 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
CHEMBL1649926 56900 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
50992494 56901 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 6 1 7 4.1 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)OC)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
CHEMBL1649927 56901 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 6 1 7 4.1 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)OC)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
3002977 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
803 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
806 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
CHEMBL1201187 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
CHEMBL256907 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
CHEMBL584744 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
DB04835 2416 70 None 2 2 Human 9.7 pIC50 = 9.7 Functional
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
11285792 864 30 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 864 30 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 864 30 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 864 30 None -3 6 Human 9.7 pIC50 = 9.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
11513274 103055 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 103055 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
9810893 103053 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 103053 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
44511934 68863 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 10 1 6 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926896 68863 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 10 1 6 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512090 68865 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 7 5.0 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926898 68865 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 7 5.0 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512058 68874 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 10 1 8 4.5 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927008 68874 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 10 1 8 4.5 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44511938 68875 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 10 1 7 5.3 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927009 68875 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 10 1 7 5.3 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50992641 56897 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
CHEMBL1649922 56897 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
62706110 81343 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 491 8 2 5 4.2 CNC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164203 81343 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 491 8 2 5 4.2 CNC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
15940799 81345 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 493 8 3 6 4.0 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NO)CC1 10.1021/ml2002604
CHEMBL2164205 81345 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 493 8 3 6 4.0 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NO)CC1 10.1021/ml2002604
57384005 81346 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 9 2 6 4.2 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164206 81346 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 9 2 6 4.2 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
57384006 81351 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 12 2 7 4.2 COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164211 81351 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 12 2 7 4.2 COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
50915506 18840 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
CHEMBL1288663 18840 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
44455217 94962 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assayAntagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 608 7 1 5 6.4 CC(=O)N1CCc2c(nc(C)n2[C@H]2C[C@@H]3CC[C@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1 10.1016/j.bmcl.2007.12.058
CHEMBL257000 94962 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assayAntagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 608 7 1 5 6.4 CC(=O)N1CCc2c(nc(C)n2[C@H]2C[C@@H]3CC[C@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1 10.1016/j.bmcl.2007.12.058
50992577 56893 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 6 1 5 3.5 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649919 56893 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 6 1 5 3.5 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
50992639 56895 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 477 7 1 5 3.9 CCC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
CHEMBL1649920 56895 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 477 7 1 5 3.9 CCC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
50992640 56896 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 491 7 1 5 4.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649921 56896 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 491 7 1 5 4.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
59458228 81348 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 558 11 3 7 3.6 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C(=O)NC(C)C)nc2C)CC1 10.1021/ml2002604
CHEMBL2164208 81348 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 558 11 3 7 3.6 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C(=O)NC(C)C)nc2C)CC1 10.1021/ml2002604
59458061 81349 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 543 9 2 6 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)[n+]([O-])c2Cl)CC1 10.1021/ml2002604
CHEMBL2164209 81349 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 543 9 2 6 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)[n+]([O-])c2Cl)CC1 10.1021/ml2002604
15941083 81359 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 506 10 1 6 4.1 COCC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164219 81359 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 506 10 1 6 4.1 COCC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
15940801 81360 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 501 9 1 6 4.3 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC#N)CC1 10.1021/ml2002604
CHEMBL2164220 81360 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 501 9 1 6 4.3 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC#N)CC1 10.1021/ml2002604
5275766 3669 33 None - 1 Human 9.4 pIC50 = 9.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
800 3669 33 None - 1 Human 9.4 pIC50 = 9.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
CHEMBL207004 3669 33 None - 1 Human 9.4 pIC50 = 9.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
11700429 103057 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 103057 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
53325983 56887 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 416 6 1 4 4.8 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3ccccc31)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649913 56887 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 416 6 1 4 4.8 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3ccccc31)C2)c1ccccc1 10.1021/jm100978n
15940498 81352 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 611 11 3 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NCc2ccc(C(=O)O)cc2)CC1 10.1021/ml2002604
CHEMBL2164212 81352 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 611 11 3 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NCc2ccc(C(=O)O)cc2)CC1 10.1021/ml2002604
457871 100243 1 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 100243 1 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
44511935 68867 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 593 13 1 7 5.8 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926900 68867 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 593 13 1 7 5.8 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50993592 56899 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649925 56899 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
3008904 198273 1 None 1 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 198273 1 None 1 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11614352 544 1 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
7686 544 1 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
CHEMBL1951914 544 1 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
57392303 68858 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926891 68858 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512001 68876 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 544 10 1 7 4.8 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927010 68876 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 544 10 1 7 4.8 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
62706106 81355 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 560 10 1 6 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
CHEMBL2164215 81355 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 560 10 1 6 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
3008917 201087 4 None -6 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 201087 4 None -6 2 Human 9.2 pIC50 = 9.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3002977 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
803 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
806 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL1201187 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL256907 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL584744 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
DB04835 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
44511871 68868 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 13 1 8 5.0 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926901 68868 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 13 1 8 5.0 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72711958 92209 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 92209 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 92254 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 92254 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
62706109 81341 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 10 1 7 4.5 Cc1cc(C#N)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
CHEMBL2164201 81341 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 10 1 7 4.5 Cc1cc(C#N)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
3008909 197411 1 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 197411 1 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
3013701 76726 1 None - 1 Human 9.1 pIC50 = 9.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207487 76726 1 None - 1 Human 9.1 pIC50 = 9.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
3002977 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
803 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
806 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
CHEMBL1201187 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
CHEMBL256907 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
CHEMBL584744 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
DB04835 2416 70 None 2 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
72711739 92252 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435907 92252 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
62706108 81358 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 476 8 1 5 4.4 CC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164218 81358 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 476 8 1 5 4.4 CC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
11636141 103056 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085310 103056 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
57402802 68871 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 12 2 8 3.8 Cc1ccncc1CN(c1ccc(OCC(N)=O)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926904 68871 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 12 2 8 3.8 Cc1ccncc1CN(c1ccc(OCC(N)=O)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
46225532 197981 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593042 197981 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008928 200961 1 None -1 2 Human 9.0 pIC50 = 9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 200961 1 None -1 2 Human 9.0 pIC50 = 9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3013575 75403 1 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 75403 1 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
49798082 10704 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 579 9 1 5 5.5 C=CCN(C(=O)OCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172043 10704 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 579 9 1 5 5.5 C=CCN(C(=O)OCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
44194590 10709 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 612 9 2 4 5.4 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172048 10709 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 612 9 2 4 5.4 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11353001 58485 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 58485 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
11597 666 3 None -11 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
23725180 666 3 None -11 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
CHEMBL4781426 666 3 None -11 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
51039119 175633 29 None 1 3 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 175633 29 None 1 3 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
3008927 197170 1 None -2 2 Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 197170 1 None -2 2 Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008909 197411 1 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 197411 1 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
72711956 92207 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 92207 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
3009355 3914 21 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
807 3914 21 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
CHEMBL82301 3914 21 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
DB06652 3914 21 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
11605997 58487 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688240 58487 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
71458736 81353 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 10 1 7 4.8 COc1ccc(N(Cc2ccsc2)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
CHEMBL2164213 81353 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 10 1 7 4.8 COc1ccc(N(Cc2ccsc2)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
183790 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
783 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
CHEMBL1178786 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
44512349 68869 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 577 13 1 7 5.2 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926902 68869 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 577 13 1 7 5.2 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72711742 92205 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 92205 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49864971 15592 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222769 15592 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
49768863 56886 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1021/jm100978n
CHEMBL1649912 56886 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1021/jm100978n
3008913 101493 1 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101493 1 None -1 2 Human 8.9 pIC50 = 8.9 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
183790 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
783 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
CHEMBL1178786 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
183790 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
783 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
CHEMBL1178786 3673 8 None -2 4 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
5275759 76748 1 None - 1 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207630 76748 1 None - 1 Human 8.9 pIC50 = 8.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
9810893 103053 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 103053 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL5084989 213158 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL None None None CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1021/acs.jmedchem.1c00781
57395817 68861 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926894 68861 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72714078 92230 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 92230 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72714079 92231 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 92231 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49871007 58490 9 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 assessed as inhibition of receptor internalizationAntagonist activity at CCR5 assessed as inhibition of receptor internalization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58490 9 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 assessed as inhibition of receptor internalizationAntagonist activity at CCR5 assessed as inhibition of receptor internalization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
44194588 10771 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 622 11 2 6 3.2 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172625 10771 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 622 11 2 6 3.2 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
57394057 68864 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 519 10 1 6 4.9 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926897 68864 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 519 10 1 6 4.9 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
49798089 10711 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)cc1F)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172050 10711 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)cc1F)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798090 10712 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172051 10712 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
50915506 18840 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
CHEMBL1288663 18840 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
49798085 10706 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 562 9 2 4 4.5 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172045 10706 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 562 9 2 4 4.5 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72711741 92204 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 92204 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
11505350 168211 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL437494 168211 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
46225515 197964 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592940 197964 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008904 198273 1 None 1 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 198273 1 None 1 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
118727180 116868 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 592 8 0 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCN(S(=O)(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397991 116868 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 592 8 0 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCN(S(=O)(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
44511967 68855 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926888 68855 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44511967 68855 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
CHEMBL1926888 68855 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
3008907 200971 1 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 405 4 1 3 4.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61465 200971 1 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 405 4 1 3 4.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccccc3)CC2)CC1 10.1021/jm031046g
505868 27556 1 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137072 27556 1 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44357072 98027 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL275998 98027 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
505878 118670 1 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343160 118670 1 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44356944 118701 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343366 118701 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357078 118883 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344641 118883 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
46225346 198349 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595570 198349 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46837554 10553 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 516 9 1 4 5.6 COC(=O)C1(Cc2ccccc2)CCN(CC[C@H](NC(=O)C2CCC2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.ejmech.2010.03.003
CHEMBL1170529 10553 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 516 9 1 4 5.6 COC(=O)C1(Cc2ccccc2)CCN(CC[C@H](NC(=O)C2CCC2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.ejmech.2010.03.003
46837425 102918 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 547 7 1 5 6.8 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)c1ccc(F)cc1)c1cccc2ccccc12 10.1016/j.ejmech.2010.03.003
CHEMBL3084746 102918 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 547 7 1 5 6.8 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)c1ccc(F)cc1)c1cccc2ccccc12 10.1016/j.ejmech.2010.03.003
53389085 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817911 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852138 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057814 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
53389085 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817911 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852138 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057814 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
46226118 13992 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198032 13992 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593605 13992 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
44395365 123941 0 None - 1 Human 5.0 pIC50 = 5 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
CHEMBL363999 123941 0 None - 1 Human 5.0 pIC50 = 5 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
53389085 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817911 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852138 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057814 66118 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
54752873 76807 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057812 76807 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2078840 76807 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
54752873 76807 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057812 76807 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078840 76807 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
46225343 198447 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596299 198447 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008911 100499 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 100499 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
3008925 100434 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 100434 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
90656325 110565 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 431 7 1 6 3.8 CC(C)Oc1ccc(N2CCN(Cc3ccccc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263023 110565 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 431 7 1 6 3.8 CC(C)Oc1ccc(N2CCN(Cc3ccccc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
70690766 76802 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064266 76802 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078746 76802 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
57397596 68847 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 646 12 2 6 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Oc3ccc(C(=O)O)cc3)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926878 68847 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 646 12 2 6 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Oc3ccc(C(=O)O)cc3)cc2)CC1 10.1016/j.bmcl.2011.09.133
49798132 10616 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 547 9 1 4 4.4 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171029 10616 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 547 9 1 4 4.4 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52948296 18870 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288924 18870 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
44357379 27912 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL137327 27912 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
505869 28040 1 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137419 28040 1 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44357375 115490 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL335562 115490 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
9914742 166071 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL428104 166071 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
3008927 197170 1 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 197170 1 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
53325460 58171 0 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683190 58171 0 None -2 2 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
3008934 197006 1 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 197006 1 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49864972 15593 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222770 15593 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
49864975 15596 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 695 11 2 6 4.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222773 15596 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 695 11 2 6 4.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
52943424 18859 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288913 18859 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
73346388 92223 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 92223 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
118727176 116864 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3cccc(F)c3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397987 116864 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3cccc(F)c3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
168279183 190307 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 541 9 1 8 5.2 COC(=O)C1CCC(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 10.1021/acs.jmedchem.2c01383
CHEMBL5185201 190307 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 541 9 1 8 5.2 COC(=O)C1CCC(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 10.1021/acs.jmedchem.2c01383
145967391 163686 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 589 7 0 5 6.9 Cc1nc2cnccc2n1C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)Cc3ccccc3)C2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL4211358 163686 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 589 7 0 5 6.9 Cc1nc2cnccc2n1C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)Cc3ccccc3)C2)CC1 10.1021/acs.jmedchem.8b00180
76327885 102915 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 418 6 0 6 4.3 COC(=O)[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3cccnc31)C2)c1ccccc1 10.1016/j.bmcl.2010.02.023
CHEMBL3084729 102915 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 418 6 0 6 4.3 COC(=O)[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3cccnc31)C2)c1ccccc1 10.1016/j.bmcl.2010.02.023
44194496 10702 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 587 9 1 8 4.3 C=CCN(C(=O)OCc1ccc2nonc2c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172041 10702 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 587 9 1 8 4.3 C=CCN(C(=O)OCc1ccc2nonc2c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
57397595 68846 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 10 1 5 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(=O)N(C)C)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926877 68846 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 10 1 5 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(=O)N(C)C)cc2)CC1 10.1016/j.bmcl.2011.09.133
46225348 198478 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596519 198478 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008936 197009 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 197009 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
57401042 68854 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 9 1 6 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926887 68854 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 9 1 6 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
126567277 165078 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4243842 165078 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 10.1021/acs.jmedchem.8b01077
3008930 196993 1 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 196993 1 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11527582 76060 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205964 76060 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
505875 25755 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL135432 25755 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505873 27723 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137206 27723 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
3008913 101493 1 None -1 2 Human 7.9 pIC50 = 7.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101493 1 None -1 2 Human 7.9 pIC50 = 7.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
57395816 68859 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3cnc(Cl)cc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926892 68859 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3cnc(Cl)cc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72712159 92212 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 92212 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
73352463 92191 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
CHEMBL2435846 92191 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
491775 12753 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188807 12753 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL537424 12753 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10117348 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL1196455 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL557015 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
10117348 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196455 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL557015 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
10117348 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1196455 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL557015 13799 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
16728326 10699 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 9 1 7 4.5 C=CCN(C(=O)OCc1ccc2c(c1)OCO2)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172037 10699 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 9 1 7 4.5 C=CCN(C(=O)OCc1ccc2c(c1)OCO2)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
76317388 104100 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 614 11 0 4 5.8 CCN(CCc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104693 104100 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 614 11 0 4 5.8 CCN(CCc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL5071060 212470 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1021/acs.jmedchem.1c00408
89702731 108895 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
CHEMBL3219777 108895 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
162650661 179559 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4748891 179559 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
89702731 108895 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL3219777 108895 0 None -3 2 Human 6.9 pIC50 = 6.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL5074037 212528 0 None -1 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
3008936 197009 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 197009 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
122185609 122380 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604296 122380 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606029 122380 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
162677279 182886 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1cccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1016/j.bmc.2016.09.059
CHEMBL4799343 182886 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1cccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1016/j.bmc.2016.09.059
46225344 198376 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595760 198376 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122185613 122388 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604298 122388 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606076 122388 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
21064283 14202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1170878 14202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1200019 14202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
21064283 14202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170878 14202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200019 14202 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226132 13989 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198014 13989 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593205 13989 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
3002977 2416 70 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
803 2416 70 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
806 2416 70 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
CHEMBL1201187 2416 70 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
CHEMBL256907 2416 70 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
CHEMBL584744 2416 70 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
DB04835 2416 70 None 2 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
3008930 196993 1 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 196993 1 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
72713860 92258 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 92258 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
57395818 68870 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 548 10 1 7 4.2 Cc1ccncc1CN(c1ccc([S+](C)[O-])cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926903 68870 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 548 10 1 7 4.2 Cc1ccncc1CN(c1ccc([S+](C)[O-])cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1016/j.bmcl.2011.09.133
16728785 12706 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 12706 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536298 12706 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 12706 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188408 12706 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL536298 12706 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064293 14198 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170874 14198 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200015 14198 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226126 13986 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198011 13986 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593177 13986 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
23577409 66070 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813439 66070 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851891 66070 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
162660215 180620 0 None -79 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)c1 10.1016/j.bmc.2016.09.059
CHEMBL4761273 180620 0 None -79 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)c1 10.1016/j.bmc.2016.09.059
122185641 122394 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604312 122394 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606113 122394 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
46225350 199463 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL603325 199463 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
70694942 76832 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064263 76832 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079186 76832 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
168283795 190289 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 586 10 2 9 4.2 COc1ccc(S(N)(=O)=O)cc1C(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
CHEMBL5184978 190289 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 586 10 2 9 4.2 COc1ccc(S(N)(=O)=O)cc1C(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
90666578 108898 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
CHEMBL3219780 108898 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
112500049 131951 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
CHEMBL3697626 131951 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
71458737 81356 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 563 9 2 6 5.2 Cc1ccncc1CN(C(=O)Nc1cccnc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164216 81356 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 563 9 2 6 5.2 Cc1ccncc1CN(C(=O)Nc1cccnc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
49864974 15599 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222776 15599 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
76316949 102917 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 511 8 1 5 5.5 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](C(=O)NCc1ccc(F)cc1)c1ccccc1 10.1016/j.bmcl.2010.02.023
CHEMBL3084731 102917 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 511 8 1 5 5.5 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](C(=O)NCc1ccc(F)cc1)c1ccccc1 10.1016/j.bmcl.2010.02.023
3008913 101493 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101493 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008917 201087 4 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 201087 4 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798130 10752 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 559 10 1 5 4.3 C=CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172438 10752 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 559 10 1 5 4.3 C=CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008902 200984 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 200984 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008902 200984 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 200984 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008905 197031 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 197031 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577386 66025 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813435 66025 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851672 66025 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
52944616 18860 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288914 18860 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
72714077 92229 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435884 92229 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
3008911 100499 1 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 100499 1 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
49798157 10768 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 597 9 1 4 5.3 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172622 10768 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 597 9 1 4 5.3 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72711281 92246 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
CHEMBL2435901 92246 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
72711048 92238 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 92238 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
52944586 18847 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288873 18847 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225347 198351 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595584 198351 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225530 197976 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592997 197976 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122668134 189736 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 415 7 1 6 4.2 CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
CHEMBL5176665 189736 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 415 7 1 6 4.2 CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
118727172 116860 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 524 8 0 4 4.8 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397983 116860 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 524 8 0 4 4.8 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
72712373 92218 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
CHEMBL2435873 92218 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
3008917 201087 4 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 201087 4 None -6 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008935 201032 1 None - 1 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 201032 1 None - 1 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008914 199314 1 None - 1 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 199314 1 None - 1 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
126567253 164949 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4240763 164949 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 10.1021/acs.jmedchem.8b01077
72712597 92221 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 92221 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
122668182 189644 2 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 10.1021/acs.jmedchem.2c01383
CHEMBL5175220 189644 2 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 10.1021/acs.jmedchem.2c01383
52943426 18869 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 751 13 1 6 6.1 C=CCN(C(=O)CCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288923 18869 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 751 13 1 6 6.1 C=CCN(C(=O)CCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728786 13841 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 13841 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL558043 13841 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
76310165 104099 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 598 11 0 4 5.3 CCN(CCc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104692 104099 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 598 11 0 4 5.3 CCN(CCc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
56673134 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817913 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852005 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057818 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
56673134 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817913 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852005 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057818 66093 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
72714319 92234 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 92234 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
72711050 92240 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 92240 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
90666579 108899 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 628 9 2 7 7.3 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)OC(C)(C)C)cc1 10.1039/c3md00080j
CHEMBL3219781 108899 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 628 9 2 7 7.3 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)OC(C)(C)C)cc1 10.1039/c3md00080j
57397603 68873 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 10 1 7 5.6 Cc1ccncc1CN(c1ccc(N2CCOCC2)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1927007 68873 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 10 1 7 5.6 Cc1ccncc1CN(c1ccc(N2CCOCC2)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1016/j.bmcl.2011.09.133
72712375 92220 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 514 6 0 3 6.5 Cc1ccccc1N1CCC(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435875 92220 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 514 6 0 3 6.5 Cc1ccccc1N1CCC(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
49871007 58490 9 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilizationAntagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58490 9 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilizationAntagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3008929 193954 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 193954 1 None -1 2 Human 7.8 pIC50 = 7.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983513 164997 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 457 8 1 6 5.2 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C(C)C)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242034 164997 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 457 8 1 6 5.2 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C(C)C)s1 10.1021/acs.jmedchem.8b01077
10278617 94726 2 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 94726 2 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008931 200951 1 None - 1 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 200951 1 None - 1 Human 7.8 pIC50 = 7.8 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
464990 14255 1 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200254 14255 1 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3216057 14255 1 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
46225343 198447 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596299 198447 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
118727191 116879 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 535 7 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398002 116879 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 535 7 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
62707284 76821 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057807 76821 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2079027 76821 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
62707284 76821 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057807 76821 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079027 76821 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
70688700 76828 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064264 76828 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079127 76828 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
46225346 198349 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595570 198349 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225529 198003 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593195 198003 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008912 199377 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 199377 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
90656328 110566 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccccc3[N+](=O)[O-])CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263025 110566 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccccc3[N+](=O)[O-])CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
72712160 92214 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 92214 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
52943389 18850 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288876 18850 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46191233 197978 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 575 6 0 5 4.6 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593027 197978 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 575 6 0 5 4.6 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
118727184 116872 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 578 9 0 5 4.4 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(S(C)(=O)=O)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397995 116872 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 578 9 0 5 4.4 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(S(C)(=O)=O)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
15950679 92213 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 92213 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
49798156 10459 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 9 1 4 5.0 C=CCN(C(=O)Cc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1169819 10459 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 9 1 4 5.0 C=CCN(C(=O)Cc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72712161 92215 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 92215 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
10280945 12716 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188557 12716 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL536743 12716 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10277467 12958 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL1190217 12958 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL540366 12958 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
21064331 14247 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1172871 14247 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200224 14247 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226120 14016 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198114 14016 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL596165 14016 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
122185611 122382 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604297 122382 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606030 122382 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
52945865 18866 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288920 18866 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
168271219 189826 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 483 8 1 6 5.7 Cc1ccsc1[C@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCCC1 10.1021/acs.jmedchem.2c01383
CHEMBL5178121 189826 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 483 8 1 6 5.7 Cc1ccsc1[C@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCCC1 10.1021/acs.jmedchem.2c01383
11237537 191490 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5203084 191490 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 10.1021/acs.jmedchem.2c01383
10277467 12958 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1190217 12958 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL540366 12958 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
53324598 59781 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668020 59781 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 59781 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
46225512 199905 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL605727 199905 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122185639 122393 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604311 122393 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606112 122393 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
11466794 68844 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 9 1 5 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926875 68844 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 9 1 5 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
122185633 122390 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604308 122390 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606102 122390 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
46225428 198249 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594914 198249 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
76335572 104096 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 570 10 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104689 104096 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 570 10 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
90656340 110627 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 461 8 1 7 3.8 COc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263319 110627 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 461 8 1 7 3.8 COc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
57402800 68852 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 10 1 6 5.9 COc1ccc(N(Cc2cccc(C#N)c2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926885 68852 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 10 1 6 5.9 COc1ccc(N(Cc2cccc(C#N)c2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
53319405 56892 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 499 7 1 6 2.9 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(S(C)(=O)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649918 56892 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 499 7 1 6 2.9 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(S(C)(=O)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
46191232 197982 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593046 197982 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008902 200984 1 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 200984 1 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008908 200972 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 200972 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
11570778 140375 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL382252 140375 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
44194589 10770 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 608 10 2 6 2.9 C=CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172624 10770 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 608 10 2 6 2.9 C=CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3002977 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
803 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
806 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL1201187 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL256907 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL584744 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
DB04835 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
3013689 76673 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207190 76673 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
11700429 103057 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 103057 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
3002977 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
803 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
806 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL1201187 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL256907 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL584744 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
DB04835 2416 70 None 2 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
457871 100243 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 100243 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
3008928 200961 1 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 200961 1 None -1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
483407 165476 18 None - 1 Human 8.7 pIC50 = 8.7 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
CHEMBL425618 165476 18 None - 1 Human 8.7 pIC50 = 8.7 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
5275765 137693 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL377026 137693 1 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
145984727 165004 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4242114 165004 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
145986021 165233 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248009 165233 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
59458103 92251 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 92251 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3008927 197170 1 None -2 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 197170 1 None -2 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008914 199314 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 199314 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
11513274 103055 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 103055 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
57397598 68857 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926890 68857 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
59458247 92257 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435912 92257 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
3008923 197211 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 197211 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
3008908 200972 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 200972 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
168268916 189401 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 549 10 1 7 5.9 COCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.2c01383
CHEMBL5171331 189401 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 549 10 1 7 5.9 COCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.2c01383
122668213 165020 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242489 165020 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 10.1021/acs.jmedchem.8b01077
145984502 165040 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
CHEMBL4242913 165040 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
145984829 165254 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248472 165254 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
52948296 18870 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288924 18870 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008917 201087 4 None -6 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 201087 4 None -6 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798086 10707 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 578 9 2 4 5.0 C=CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172046 10707 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 578 9 2 4 5.0 C=CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11577846 76752 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207654 76752 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
145985461 164935 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.5 CCc1nnc(C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
CHEMBL4240475 164935 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.5 CCc1nnc(C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
126567264 165245 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4248282 165245 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
3008932 200950 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 200950 1 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008904 198273 1 None 1 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 198273 1 None 1 2 Human 8.6 pIC50 = 8.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983733 164909 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 571 8 1 6 6.5 O=C(N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C3CC3)nnc1C(F)(F)F)C2)c1ccsc1)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4239790 164909 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 571 8 1 6 6.5 O=C(N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C3CC3)nnc1C(F)(F)F)C2)c1ccsc1)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
145982775 164986 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 7 4.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(=O)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4241721 164986 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 7 4.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(=O)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
145985042 165104 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4244672 165104 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
72711955 92206 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435861 92206 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16663418 10697 15 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172035 10697 15 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008930 196993 1 None 1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 196993 1 None 1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
16663418 10697 15 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1172035 10697 15 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.046
44194676 10713 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 637 11 3 6 3.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172052 10713 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 637 11 3 6 3.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49864973 15594 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222771 15594 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
3500 1493 9 None 245 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
491774 1493 9 None 245 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
CHEMBL1196395 1493 9 None 245 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
49798083 10705 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 9 1 5 5.6 C=CCN(C(=O)OCc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172044 10705 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 9 1 5 5.6 C=CCN(C(=O)OCc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52948295 18857 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288911 18857 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
145983844 165238 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 484 8 2 7 3.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)[C@@H]1CCC(=O)N1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248119 165238 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 484 8 2 7 3.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)[C@@H]1CCC(=O)N1)c1cccs1 10.1021/acs.jmedchem.8b01077
72713859 92256 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 92256 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
3008919 100285 1 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 100285 1 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
10184169 12696 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188324 12696 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL536063 12696 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
56661526 66064 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813447 66064 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851866 66064 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
57331340 104086 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 10 0 4 5.4 CCN(Cc1ccc(C)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104677 104086 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 10 0 4 5.4 CCN(Cc1ccc(C)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
118727182 116870 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 511 8 0 3 6.2 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)c2ccc(F)cc2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397993 116870 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 511 8 0 3 6.2 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)c2ccc(F)cc2)cc1Cl 10.1016/j.bmc.2014.12.052
46191232 197982 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593046 197982 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927139 14249 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200232 14249 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3216934 14249 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
168293785 191568 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1csc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5204027 191568 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1csc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)c1 10.1021/acs.jmedchem.2c01383
52944618 18867 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 797 13 2 6 6.1 C=CCN(C(=O)Cc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288921 18867 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 797 13 2 6 6.1 C=CCN(C(=O)Cc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
10186729 13825 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 13825 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL557789 13825 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
56678576 66280 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813449 66280 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852754 66280 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
118727181 116869 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 431 7 0 3 4.7 CC(=O)N(CCCN1CCN(Cc2ccc(F)cc2)CC1C)c1ccc(C)c(Cl)c1 10.1016/j.bmc.2014.12.052
CHEMBL3397992 116869 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 431 7 0 3 4.7 CC(=O)N(CCCN1CCN(Cc2ccc(F)cc2)CC1C)c1ccc(C)c(Cl)c1 10.1016/j.bmc.2014.12.052
3008911 100499 1 None - 1 Human 5.7 pIC50 = 5.7 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 100499 1 None - 1 Human 5.7 pIC50 = 5.7 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
52947063 18848 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 788 12 1 6 7.7 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288874 18848 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 788 12 1 6 7.7 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225533 197985 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593080 197985 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
73355478 92222 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 92222 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
49798081 10703 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 5 5.0 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172042 10703 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 5 5.0 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
16659334 13876 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1197042 13876 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL559168 13876 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
3008931 200951 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 200951 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
90656333 110568 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 7 1 6 4.6 CC(C)Oc1ccc(N2CCN(Cc3ccc(Br)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263029 110568 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 7 1 6 4.6 CC(C)Oc1ccc(N2CCN(Cc3ccc(Br)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
56678574 66032 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813443 66032 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851694 66032 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56664937 66063 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813446 66063 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851865 66063 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
118727190 116878 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 521 7 0 5 4.3 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398001 116878 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 521 7 0 5 4.3 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
122185637 122392 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604310 122392 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606111 122392 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
52948264 18846 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288872 18846 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225532 197981 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593042 197981 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44404643 71863 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cellsInhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198114 71863 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cellsInhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
3008930 196993 1 None 1 2 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 196993 1 None 1 2 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983159 165365 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 497 8 1 7 4.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2=CCOCC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4250560 165365 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 497 8 1 7 4.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2=CCOCC2)s1 10.1021/acs.jmedchem.8b01077
3008932 200950 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 200950 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
72711506 92247 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435902 92247 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
162674876 182743 0 None -109 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1169 26 7 15 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4797451 182743 0 None -109 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1169 26 7 15 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
46225428 198249 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594914 198249 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
52948295 18857 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288911 18857 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
118727173 116861 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 538 8 0 4 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397984 116861 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 538 8 0 4 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
118727178 116866 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 528 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397989 116866 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 528 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
3002977 2416 70 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
803 2416 70 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
806 2416 70 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
CHEMBL1201187 2416 70 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
CHEMBL256907 2416 70 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
CHEMBL584744 2416 70 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
DB04835 2416 70 None 2 2 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
57331278 104093 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104684 104093 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008908 200972 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 200972 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
57331274 104091 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 538 9 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104682 104091 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 538 9 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
56661524 66083 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813438 66083 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851951 66083 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
16124598 10614 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 472 6 2 5 5.3 O=C(O)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
CHEMBL1171008 10614 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 472 6 2 5 5.3 O=C(O)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
145986205 165098 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 10.1021/acs.jmedchem.8b01077
CHEMBL4244470 165098 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 10.1021/acs.jmedchem.8b01077
76313867 104101 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104694 104101 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
46837553 102919 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 569 10 1 6 6.2 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)COc1ccccc1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2010.03.003
CHEMBL3084747 102919 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 569 10 1 6 6.2 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)COc1ccccc1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2010.03.003
90656342 110629 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 488 8 2 7 3.8 CC(=O)Nc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263321 110629 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 488 8 2 7 3.8 CC(=O)Nc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
118727183 116871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)C1 10.1016/j.bmc.2014.12.052
CHEMBL3397994 116871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)C1 10.1016/j.bmc.2014.12.052
11433338 68843 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 594 10 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926874 68843 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 594 10 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
52944616 18860 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288914 18860 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008934 197006 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 197006 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11693007 75893 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205851 75893 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57331307 104098 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 11 0 4 5.1 CCN(CCc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104691 104098 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 11 0 4 5.1 CCN(CCc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
23577386 66025 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813435 66025 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851672 66025 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
122185617 122384 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604300 122384 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606050 122384 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
52949523 18852 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 854 13 1 7 8.4 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288878 18852 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 854 13 1 7 8.4 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225514 198133 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594208 198133 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225512 199905 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL605727 199905 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
126567281 164947 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.8b01077
CHEMBL4240742 164947 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.8b01077
49864977 15600 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222777 15600 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
3008909 197411 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 197411 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
491773 12704 1 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188399 12704 1 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL536288 12704 1 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
11634966 12754 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 12754 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL537425 12754 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
491773 12704 1 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188399 12704 1 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL536288 12704 1 None 67 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
90656339 110626 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 446 7 2 7 3.4 CC(C)Oc1ccc(N2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263318 110626 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 446 7 2 7 3.4 CC(C)Oc1ccc(N2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
46225515 197964 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592940 197964 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225350 199463 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL603325 199463 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
10280945 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188557 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536743 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10280945 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188557 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL536743 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
10280945 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188557 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL536743 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064281 14201 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170877 14201 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200018 14201 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
10280945 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1188557 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL536743 12716 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
457871 100243 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 100243 1 None - 1 Human 7.6 pIC50 = 7.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
3008918 197693 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 197693 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577370 66017 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813270 66017 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851623 66017 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
73351059 92349 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 8 1 5 5.6 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436819 92349 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 8 1 5 5.6 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
56678576 66280 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813449 66280 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852754 66280 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
90656343 110630 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 474 8 1 7 3.9 CC(C)Oc1ccc(N2CCN(Cc3ccc(N(C)C)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263322 110630 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 474 8 1 7 3.9 CC(C)Oc1ccc(N2CCN(Cc3ccc(N(C)C)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
3008926 200151 1 None - 1 Human 6.6 pIC50 = 6.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
CHEMBL60711 200151 1 None - 1 Human 6.6 pIC50 = 6.6 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
73355550 92329 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 1 5 5.2 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436720 92329 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 1 5 5.2 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
50993435 56888 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 511 8 1 5 5.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(Cc1ccccc1)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649914 56888 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 511 8 1 5 5.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(Cc1ccccc1)CC3)C2)c1ccccc1 10.1021/jm100978n
10272003 58556 1 None -4 3 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 395 2 2 5 3.4 Cc1nn(C)c2ncc(C(=O)NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12 10.1021/jm1012903
CHEMBL1688888 58556 1 None -4 3 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 395 2 2 5 3.4 Cc1nn(C)c2ncc(C(=O)NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12 10.1021/jm1012903
145983098 165173 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 7 1 7 4.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)N2CCN(C)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4246290 165173 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 7 1 7 4.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)N2CCN(C)CC2)s1 10.1021/acs.jmedchem.8b01077
118727189 116877 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398000 116877 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
57402799 68851 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 603 9 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926884 68851 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 603 9 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
57397597 68853 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 619 10 1 6 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926886 68853 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 619 10 1 6 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
10106 858 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
91820689 858 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL4249798 858 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
145985672 164829 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 501 8 1 6 5.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4237964 164829 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 501 8 1 6 5.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
49871007 58490 9 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 assessed as inhibition of ERK phosphorylationAntagonist activity at CCR5 assessed as inhibition of ERK phosphorylation
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58490 9 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 assessed as inhibition of ERK phosphorylationAntagonist activity at CCR5 assessed as inhibition of ERK phosphorylation
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
49871007 58490 9 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58490 9 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
50992575 56891 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 7 1 5 4.4 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649917 56891 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 7 1 5 4.4 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
46225533 197985 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593080 197985 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008935 201032 1 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 201032 1 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008913 101493 1 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101493 1 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3013684 76670 1 None - 1 Human 8.5 pIC50 = 8.5 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207182 76670 1 None - 1 Human 8.5 pIC50 = 8.5 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
122668190 164835 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4238063 164835 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
49798087 10708 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 10 2 6 4.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172047 10708 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 10 2 6 4.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52941648 18863 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288917 18863 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008929 193954 1 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 193954 1 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
44194587 10772 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 636 11 1 6 3.5 C=CCN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172626 10772 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 636 11 1 6 3.5 C=CCN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
73347894 92208 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 92208 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3008929 193954 1 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 193954 1 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798129 10722 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 529 9 1 4 4.2 C=CCN(C(=O)Cc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172157 10722 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 529 9 1 4 4.2 C=CCN(C(=O)Cc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
16663418 10697 15 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevationAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevation
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172035 10697 15 None -1 2 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevationAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevation
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
53319838 58489 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688242 58489 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3008923 197211 1 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 197211 1 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
59458245 92211 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 92211 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711508 92250 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435905 92250 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49798133 10617 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 4 4.9 C=CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171030 10617 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 4 4.9 C=CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52947091 18858 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288912 18858 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008924 198011 1 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
CHEMBL59328 198011 1 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
3008905 197031 1 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 197031 1 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52947091 18858 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288912 18858 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
11585418 75643 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205539 75643 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
49864977 15598 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222775 15598 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
118727179 116867 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 556 7 0 4 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCN(C(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397990 116867 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 556 7 0 4 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCN(C(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
11399408 68848 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 622 9 1 4 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(Cl)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926880 68848 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 622 9 1 4 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(Cl)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
46225528 197975 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592993 197975 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225526 198041 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593520 198041 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
49864968 15589 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222766 15589 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
49864976 15597 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 606 9 2 4 5.2 C=CCN(C(=O)NCc1ccc(F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222774 15597 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 606 9 2 4 5.2 C=CCN(C(=O)NCc1ccc(F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
3008932 200950 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 200950 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
118727175 116863 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3F)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397986 116863 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3F)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
11598797 12802 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 12802 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL538084 12802 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10143882 14215 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1171289 14215 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1200078 14215 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
505866 28197 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137524 28197 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505865 29051 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138282 29051 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505867 29474 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138645 29474 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
72711280 92245 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
CHEMBL2435900 92245 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
10205915 12681 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188208 12681 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL535616 12681 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10116073 14274 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173708 14274 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200300 14274 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
23577448 66279 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813448 66279 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852753 66279 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3001322 439 19 None -75857 5 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 439 19 None -75857 5 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 439 19 None -75857 5 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 439 19 None -75857 5 Rabbit 4.5 pIC50 = 4.5 Functional
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 439 19 None -75857 5 Rat 4.5 pIC50 = 4.5 Functional
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 439 19 None -75857 5 Rat 4.5 pIC50 = 4.5 Functional
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 439 19 None -75857 5 Rat 4.5 pIC50 = 4.5 Functional
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 439 19 None -75857 5 Rat 4.5 pIC50 = 4.5 Functional
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
122185615 122383 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604299 122383 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606049 122383 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
3008925 100434 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 100434 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
3008931 200951 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 200951 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
71451541 81354 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 569 10 1 6 4.9 Cc1ccncc1CN(C(=O)CC1CCOCC1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164214 81354 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 569 10 1 6 4.9 Cc1ccncc1CN(C(=O)CC1CCOCC1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
168286382 191127 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 570 10 2 8 4.4 CNS(=O)(=O)c1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5197247 191127 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 570 10 2 8 4.4 CNS(=O)(=O)c1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
46225513 199714 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604680 199714 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
52943425 18861 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 812 13 3 6 6.2 C=CCN(C(=O)NCc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288915 18861 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 812 13 3 6 6.2 C=CCN(C(=O)NCc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
49864967 15588 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 620 11 1 8 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222765 15588 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 620 11 1 8 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2010.05.046
118727177 116865 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 494 8 0 4 4.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccccc2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397988 116865 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 494 8 0 4 4.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccccc2)CC1 10.1016/j.bmc.2014.12.052
72711049 92239 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 92239 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
49798920 14212 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1171103 14212 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1200062 14212 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
57331277 104087 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 584 10 0 4 5.2 CCN(Cc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104678 104087 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 584 10 0 4 5.2 CCN(Cc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
10204589 12918 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1189988 12918 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL539854 12918 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
56681915 66069 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813440 66069 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851889 66069 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
72714317 92232 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
CHEMBL2435887 92232 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
122668167 165310 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4249259 165310 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 10.1021/acs.jmedchem.8b01077
16659334 13876 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 13876 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL559168 13876 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
21064295 14199 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170875 14199 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200016 14199 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
505870 27405 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL136977 27405 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
505880 27499 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137038 27499 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505879 28420 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137728 28420 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505881 29223 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138437 29223 1 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357063 118626 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL342842 118626 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357079 118823 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344261 118823 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
118727185 116873 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 604 9 0 4 6.3 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397996 116873 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 604 9 0 4 6.3 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
10118535 14191 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1170471 14191 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1199972 14191 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
23577409 66070 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813439 66070 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851891 66070 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
23577328 66086 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813454 66086 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851967 66086 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
46225345 198346 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 549 6 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)CC(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595559 198346 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 549 6 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)CC(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
11192476 68841 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 578 9 1 4 7.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926872 68841 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 578 9 1 4 7.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
52947090 18855 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 773 11 2 5 7.6 C=CCN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288909 18855 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 773 11 2 5 7.6 C=CCN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3001322 439 19 None -363 5 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
805 439 19 None -363 5 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1255794 439 19 None -363 5 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
DB06497 439 19 None -363 5 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
11597 666 3 None -11 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
23725180 666 3 None -11 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
CHEMBL4781426 666 3 None -11 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
3001322 439 19 None -363 5 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 439 19 None -363 5 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 439 19 None -363 5 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 439 19 None -363 5 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
23577388 66031 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813434 66031 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851692 66031 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
52943424 18859 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288913 18859 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21926130 14254 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200253 14254 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3216711 14254 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
57331276 104092 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 556 9 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104683 104092 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 556 9 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008905 197031 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 197031 1 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577362 66029 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813433 66029 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851690 66029 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56678578 66055 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813451 66055 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851823 66055 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
46225429 198392 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595902 198392 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225348 198478 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596519 198478 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225347 198351 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595584 198351 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44356876 27818 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137272 27818 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44129650 10701 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 10 1 7 4.2 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172040 10701 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 10 1 7 4.2 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798084 10692 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 544 9 2 4 4.4 C=CCN(C(=O)NCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171966 10692 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 544 9 2 4 4.4 C=CCN(C(=O)NCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
56676455 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817916 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852060 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057819 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
56676455 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817916 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852060 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057819 66103 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
46225530 197976 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592997 197976 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225527 198002 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593184 198002 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
49864970 15591 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222768 15591 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
11947758 59789 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668021 59789 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739499 59789 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
23577382 66090 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813432 66090 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851977 66090 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
122185619 122385 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604301 122385 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606051 122385 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
57392302 68849 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 618 10 1 5 6.8 COc1cccc(CN(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.09.133
CHEMBL1926882 68849 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 618 10 1 5 6.8 COc1cccc(CN(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.09.133
73355553 92346 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 417 6 2 6 3.7 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436816 92346 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 417 6 2 6 3.7 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
56681917 66088 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813450 66088 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851972 66088 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
23577360 66026 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813271 66026 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851675 66026 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
162659856 180646 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 914 27 5 11 5.6 CNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4761614 180646 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 914 27 5 11 5.6 CNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
162658125 180504 0 None -100 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1 10.1021/acs.jmedchem.0c01137
CHEMBL4760108 180504 0 None -100 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1 10.1021/acs.jmedchem.0c01137
162666730 181682 0 None -562 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 589 9 2 6 6.5 N#CSCCNC(=O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.0c01137
CHEMBL4783861 181682 0 None -562 3 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 589 9 2 6 6.5 N#CSCCNC(=O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.0c01137
145984591 165357 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 587 8 1 6 7.0 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C(C)C)nnc2C(F)(F)F)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4250366 165357 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 587 8 1 6 7.0 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C(C)C)nnc2C(F)(F)F)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
49798158 10769 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 10 1 6 3.6 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172623 10769 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 10 1 6 3.6 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11585625 76716 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207447 76716 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
72712598 92193 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435848 92193 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
50992246 58148 2 None -1 5 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 58148 2 None -1 5 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
168276745 189994 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
CHEMBL5180628 189994 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
72714076 92228 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 92228 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
52943390 18851 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 795 12 1 7 7.4 C=CCN(C(=O)OCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288877 18851 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 795 12 1 7 7.4 C=CCN(C(=O)OCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
52943389 18850 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288876 18850 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
145986145 164926 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 573 8 1 6 6.7 CC(C)c1nnc(C(F)(F)F)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4240242 164926 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 573 8 1 6 6.7 CC(C)c1nnc(C(F)(F)F)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
72711277 92242 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 92242 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44511861 68862 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926895 68862 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
52944586 18847 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288873 18847 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21064299 14200 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170876 14200 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200017 14200 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
168275071 189846 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 534 9 2 7 5.5 CC(=O)Nc1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5178495 189846 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 534 9 2 7 5.5 CC(=O)Nc1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
70685193 72762 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL2011438 72762 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.8b00180
9956238 59867 1 None -3 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
CHEMBL1688889 59867 1 None -3 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
CHEMBL1739922 59867 1 None -3 4 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
10208679 12718 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 12718 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536751 12718 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
3008921 167658 1 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
CHEMBL433635 167658 1 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
52940989 18849 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 828 13 1 8 7.3 C=CCN(C(=O)OCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288875 18849 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 828 13 1 8 7.3 C=CCN(C(=O)OCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008933 199936 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 531 6 0 4 6.5 Cc1cc(C)c(S(=O)(=O)N2CCC(C)(N3CCC(N(c4ccccc4)c4ccccc4)CC3)CC2)c(C)c1 10.1021/jm031046g
CHEMBL60589 199936 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 531 6 0 4 6.5 Cc1cc(C)c(S(=O)(=O)N2CCC(C)(N3CCC(N(c4ccccc4)c4ccccc4)CC3)CC2)c(C)c1 10.1021/jm031046g
90656335 110570 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 475 8 2 7 3.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(C(=O)O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263031 110570 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 475 8 2 7 3.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(C(=O)O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
52944587 18854 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288880 18854 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
49799711 14277 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173712 14277 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200303 14277 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226128 13984 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198003 13984 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL592944 13984 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
3008922 197021 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 513 7 0 5 6.0 COc1cccc(OC)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58176 197021 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 513 7 0 5 6.0 COc1cccc(OC)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52942223 18868 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 14 1 6 7.1 C=CCN(C(=O)CCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288922 18868 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 14 1 6 7.1 C=CCN(C(=O)CCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008912 199377 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 199377 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
72712371 92216 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 92216 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
10278617 94726 2 None 1 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 94726 2 None 1 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
72712372 92217 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
CHEMBL2435872 92217 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
73355554 92353 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 431 7 2 6 4.1 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436824 92353 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 431 7 2 6 4.1 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
53324598 59781 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668020 59781 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 59781 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
5275761 76750 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207633 76750 1 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
53324598 59781 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1668020 59781 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739382 59781 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
6320546 59792 1 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668022 59792 1 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 59792 1 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
168295761 191853 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cn2cnnn2)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5208613 191853 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cn2cnnn2)s1 10.1021/acs.jmedchem.2c01383
21064338 14270 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173645 14270 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200293 14270 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
44356952 118758 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343745 118758 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
73349498 92321 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 1 5 6.0 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436712 92321 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 1 5 6.0 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
3008919 100285 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 100285 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
46225514 198133 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594208 198133 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
90656337 110571 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 8 1 8 3.2 CC(C)Oc1ccc(N2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263033 110571 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 8 1 8 3.2 CC(C)Oc1ccc(N2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
90656338 110572 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 445 7 1 6 4.1 Cc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263034 110572 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 445 7 1 6 4.1 Cc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
52944086 18856 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 787 12 2 5 7.3 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288910 18856 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 787 12 2 5 7.3 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225349 198357 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595610 198357 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3001322 439 19 None -363 5 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 439 19 None -363 5 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 439 19 None -363 5 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 439 19 None -363 5 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3008910 197941 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 1 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL59285 197941 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 1 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm031046g
53389083 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817912 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852020 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057816 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
53389083 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817912 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852020 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057816 66098 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
56661530 66089 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813457 66089 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851975 66089 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
122185621 122386 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604302 122386 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606052 122386 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
11947758 59789 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668021 59789 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739499 59789 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
73346462 92354 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 2 6 4.5 CCOc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436825 92354 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 2 6 4.5 CCOc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
57331308 104089 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 591 10 0 5 5.0 CCN(Cc1ccc(C#N)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104680 104089 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 591 10 0 5 5.0 CCN(Cc1ccc(C#N)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008926 200151 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
CHEMBL60711 200151 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
3008937 198406 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 198406 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
15942352 81344 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 505 8 1 5 4.6 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)N(C)C)CC1 10.1021/ml2002604
CHEMBL2164204 81344 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 505 8 1 5 4.6 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)N(C)C)CC1 10.1021/ml2002604
86294766 110179 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 502 10 1 7 4.7 CCN(CC)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3259855 110179 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 502 10 1 7 4.7 CCN(CC)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
23577362 66029 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813433 66029 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851690 66029 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
10230510 66068 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813436 66068 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851888 66068 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56659272 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817915 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852160 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057817 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
56659272 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817915 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852160 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057817 66123 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
54581479 60546 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1762313 60546 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
118727188 116876 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397999 116876 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
44194675 10714 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 651 11 2 6 3.6 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172053 10714 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 651 11 2 6 3.6 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
50992574 56890 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 435 6 1 5 3.6 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649916 56890 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 435 6 1 5 3.6 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C)CC3)C2)c1ccccc1 10.1021/jm100978n
46225528 197975 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592993 197975 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
72714321 92236 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 92236 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
3008902 200984 1 None -1 2 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 200984 1 None -1 2 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145985889 164830 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 498 8 1 7 3.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(=O)N(C)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4238007 164830 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 498 8 1 7 3.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(=O)N(C)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
59458213 92249 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435904 92249 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49798131 10753 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 574 10 1 6 4.2 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172439 10753 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 574 10 1 6 4.2 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3013575 75403 1 None - 1 Human 8.3 pIC50 = 8.3 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 75403 1 None - 1 Human 8.3 pIC50 = 8.3 Functional
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
168273684 189786 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
CHEMBL5177519 189786 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
145984717 164971 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 511 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C(C)(C)C(F)(F)F)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4241284 164971 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 511 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C(C)(C)C(F)(F)F)c1cccs1 10.1021/acs.jmedchem.8b01077
3001322 439 19 None -363 5 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
805 439 19 None -363 5 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1255794 439 19 None -363 5 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
DB06497 439 19 None -363 5 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
51039119 175633 29 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 175633 29 None 1 3 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
25024699 92192 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435847 92192 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
72711047 92237 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 92237 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
3001322 439 19 None -363 5 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 439 19 None -363 5 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 439 19 None -363 5 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 439 19 None -363 5 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
5275762 76725 1 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207485 76725 1 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57402798 68842 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 5 6.1 COc1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926873 68842 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 5 6.1 COc1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
10208080 12937 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL1190106 12937 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL540108 12937 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
10228759 14217 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171291 14217 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200080 14217 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
3500 1493 9 None 245 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
491774 1493 9 None 245 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
CHEMBL1196395 1493 9 None 245 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
10228761 13801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196469 13801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL557150 13801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10228761 13801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196469 13801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL557150 13801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56664935 66044 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813444 66044 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851773 66044 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
6320546 59792 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668022 59792 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 59792 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
122668161 165042 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242946 165042 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 10.1021/acs.jmedchem.8b01077
90656341 110628 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 477 8 1 7 4.6 CSc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263320 110628 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 477 8 1 7 4.6 CSc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
6320546 59792 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1668022 59792 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739500 59792 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3008919 100285 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 100285 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
73351060 92351 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 10 1 6 5.4 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436822 92351 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 10 1 6 5.4 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
52941008 18864 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 772 12 1 5 7.1 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288918 18864 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 772 12 1 5 7.1 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21926948 14193 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170694 14193 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1199991 14193 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56681915 66069 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813440 66069 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851889 66069 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
57331305 104102 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 5.1 CCN(Cc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104695 104102 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 5.1 CCN(Cc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
52941648 18863 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288917 18863 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728787 12719 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188566 12719 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536754 12719 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728787 12719 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188566 12719 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL536754 12719 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
46225531 198479 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596523 198479 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927225 14211 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171096 14211 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200061 14211 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
6479877 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1186558 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057533 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL469649 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
6479877 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1186558 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057533 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL469649 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
162660784 180676 0 None -25 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1225 30 7 15 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4761986 180676 0 None -25 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1225 30 7 15 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
6479877 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1186558 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057533 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL469649 12392 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
46225395 199598 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604070 199598 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL5078769 212802 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(C(C)=O)CC3)c3ccc(C)c(Cl)c3)CC2)cc1)C(N)=O 10.1021/acs.jmedchem.1c00781
9978318 121826 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL359986 121826 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
46225395 199598 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604070 199598 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225513 199714 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604680 199714 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3001322 439 19 None -363 5 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 439 19 None -363 5 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 439 19 None -363 5 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 439 19 None -363 5 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
73349506 92344 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 9 1 6 5.0 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436814 92344 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 9 1 6 5.0 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
49799707 14197 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170873 14197 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200014 14197 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL5074744 212548 0 None -1 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
21925890 14246 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1172870 14246 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200223 14246 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
3008921 167658 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
CHEMBL433635 167658 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
46225344 198376 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595760 198376 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927257 14192 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170660 14192 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1199989 14192 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
73352534 92347 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 7 2 6 4.1 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436817 92347 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 7 2 6 4.1 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
56657984 66041 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813445 66041 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851766 66041 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
72714320 92235 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 92235 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
49798080 10700 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 629 10 1 6 5.7 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172039 10700 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 629 10 1 6 5.7 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798088 10710 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 628 10 2 5 5.3 C=CCN(C(=O)NCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172049 10710 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 628 10 2 5 5.3 C=CCN(C(=O)NCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008914 199314 1 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 199314 1 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
16728325 10698 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 575 10 1 6 4.8 C=CCN(C(=O)OCc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172036 10698 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 575 10 1 6 4.8 C=CCN(C(=O)OCc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
59458159 92253 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435908 92253 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
56647076 92226 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 92226 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
11692945 76165 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL206088 76165 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
118727174 116862 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397985 116862 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
49864974 15595 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222772 15595 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
126567286 164814 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1021/acs.jmedchem.8b01077
CHEMBL4237581 164814 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1021/acs.jmedchem.8b01077
145986277 165335 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 549 9 1 7 6.0 COc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4249941 165335 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 549 9 1 7 6.0 COc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
56647023 92225 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 92225 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
52944587 18854 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288880 18854 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
52944617 18862 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 813 12 2 7 7.4 C=CCN(C(=O)Nc1ccc(OC(C)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288916 18862 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 813 12 2 7 7.4 C=CCN(C(=O)Nc1ccc(OC(C)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225531 198479 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596523 198479 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44395386 127003 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL366260 127003 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
3008934 197006 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 197006 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
73352529 92324 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 501 10 1 6 5.7 CCN(CC)c1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436715 92324 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 501 10 1 6 5.7 CCN(CC)c1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
73346461 92352 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 461 8 1 7 4.4 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436823 92352 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 461 8 1 7 4.4 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
3008937 198406 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 198406 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
90666577 108897 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219779 108897 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
101577042 182550 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4795179 182550 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
112500047 123938 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
CHEMBL3639964 123938 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
118727192 116880 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 430 7 1 4 4.5 N#Cc1ccc(N2CCN(CCC(NC(=O)C3CCCCC3)c3ccccc3)CC2)cc1 10.1016/j.bmc.2014.12.052
CHEMBL3398003 116880 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 430 7 1 4 4.5 N#Cc1ccc(N2CCN(CCC(NC(=O)C3CCCCC3)c3ccccc3)CC2)cc1 10.1016/j.bmc.2014.12.052
90656330 110567 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 465 7 1 6 4.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(Cl)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263026 110567 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 465 7 1 6 4.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(Cl)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
49798349 10676 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
CHEMBL1171786 10676 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
73347961 92350 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436820 92350 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
73347961 92350 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.bmcl.2014.03.073
CHEMBL2436820 92350 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.bmcl.2014.03.073
10416 1841 23 None -309 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
46861584 1841 23 None -309 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
CHEMBL2018969 1841 23 None -309 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
52947064 18853 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 823 11 2 5 8.5 C=CCN(C(=O)Nc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288879 18853 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 823 11 2 5 8.5 C=CCN(C(=O)Nc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
10278617 94726 2 None -1 2 Crab-eating macaque 7.2 pIC50 = 7.2 Functional
Antagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 94726 2 None -1 2 Crab-eating macaque 7.2 pIC50 = 7.2 Functional
Antagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
57331304 104090 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 9 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)N(C)Cc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104681 104090 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 9 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)N(C)Cc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
73357100 92348 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 10 1 4 6.6 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436818 92348 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 10 1 4 6.6 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
90656326 110564 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263022 110564 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
52949553 18865 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 832 13 1 7 6.4 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288919 18865 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 832 13 1 7 6.4 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225394 198416 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596081 198416 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
16658856 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817909 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852220 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057810 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
16658856 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817909 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852220 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057810 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
16658856 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817909 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852220 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057810 66129 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
73349499 92325 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 475 8 1 7 4.8 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436716 92325 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 475 8 1 7 4.8 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
46225529 198003 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593195 198003 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
145961982 160973 0 None -10 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assayAntagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assay
ChEMBL 553 8 1 6 4.3 CN(C1CCN(CCCN2CCCc3c(ccnc3Nc3ccc(Cl)c(Cl)c3)C2=O)CC1)S(C)(=O)=O 10.1016/j.bmc.2018.05.027
CHEMBL4128498 160973 0 None -10 2 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assayAntagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assay
ChEMBL 553 8 1 6 4.3 CN(C1CCN(CCCN2CCCc3c(ccnc3Nc3ccc(Cl)c(Cl)c3)C2=O)CC1)S(C)(=O)=O 10.1016/j.bmc.2018.05.027
56661524 66083 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813438 66083 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851951 66083 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
73354018 92322 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 443 7 2 4 5.7 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436713 92322 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 443 7 2 4 5.7 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
46225394 198416 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596081 198416 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008918 197693 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 197693 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
126567281 164947 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.2c01383
CHEMBL4240742 164947 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.2c01383
122185625 122379 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604304 122379 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606026 122379 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
168284187 190251 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 519 7 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C(F)(F)F)c1csc2ccccc12 10.1021/acs.jmedchem.2c01383
CHEMBL5184527 190251 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 519 7 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C(F)(F)F)c1csc2ccccc12 10.1021/acs.jmedchem.2c01383
23577370 66017 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813270 66017 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851623 66017 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56681917 66088 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813450 66088 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851972 66088 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
46225429 198392 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595902 198392 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21926618 14210 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171095 14210 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200060 14210 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
122185635 122391 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604309 122391 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606103 122391 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
44511966 68856 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cncc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926889 68856 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cncc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
57394058 68872 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 510 9 1 6 5.0 Cc1ccncc1CN(c1ccccc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926905 68872 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 510 9 1 6 5.0 Cc1ccncc1CN(c1ccccc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
21867666 161498 82 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) by HTS assayAntagonist activity at CCR5 (unknown origin) by HTS assay
ChEMBL 112 0 2 2 -0.6 C1NCC2CNCC12 10.1016/j.ejmech.2018.01.085
CHEMBL4160473 161498 82 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) by HTS assayAntagonist activity at CCR5 (unknown origin) by HTS assay
ChEMBL 112 0 2 2 -0.6 C1NCC2CNCC12 10.1016/j.ejmech.2018.01.085
76313867 104101 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysisAntagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysis
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104694 104101 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysisAntagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysis
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
5275760 76696 1 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207301 76696 1 None - 1 Human 8.2 pIC50 = 8.2 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
72711278 92243 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 92243 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
3008935 201032 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 201032 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
73346389 92224 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 92224 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
72711507 92248 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 92248 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
16728787 12719 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188566 12719 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL536754 12719 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
3008918 197693 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 197693 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
183790 3673 8 None -2 4 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
783 3673 8 None -2 4 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
CHEMBL1178786 3673 8 None -2 4 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
3008932 200950 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5Antagonistic activity against human C-C chemokine receptor type 5
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 200950 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5Antagonistic activity against human C-C chemokine receptor type 5
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008932 200950 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 200950 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008923 197211 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 197211 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
3008928 200961 1 None -1 2 Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 200961 1 None -1 2 Human 8.1 pIC50 = 8.1 Functional
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
168296928 191632 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5205216 191632 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 10.1021/acs.jmedchem.2c01383
72711051 92241 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
CHEMBL2435896 92241 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
73346454 92331 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 457 7 2 4 5.3 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436722 92331 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 457 7 2 4 5.3 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
49799680 14251 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200241 14251 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3217146 14251 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
23577378 66084 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813269 66084 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851957 66084 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3013673 76591 1 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
CHEMBL207085 76591 1 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
122668217 191658 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5205626 191658 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 10.1021/acs.jmedchem.2c01383
44395365 123941 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
CHEMBL363999 123941 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
73355552 92345 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 447 7 1 7 4.0 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436815 92345 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 447 7 1 7 4.0 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
23577382 66090 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813432 66090 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851977 66090 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3008916 161799 1 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 509 7 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)Cc3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL416512 161799 1 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 509 7 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)Cc3ccccc3)CC2)CC1 10.1021/jm031046g
57331339 104094 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 563 9 1 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(C#N)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104685 104094 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 563 9 1 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(C#N)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
57331275 104095 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 10 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104688 104095 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 10 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
10182763 13768 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1196226 13768 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL556188 13768 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
73347956 92330 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 415 6 2 4 4.9 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436721 92330 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 415 6 2 4 4.9 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
73355549 92326 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 2 6 4.5 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436717 92326 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 2 6 4.5 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
16728787 12719 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1188566 12719 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL536754 12719 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56669616 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817910 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852129 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057811 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
56669616 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817910 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852129 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057811 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
56669616 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817910 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852129 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057811 66116 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
16728784 12673 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188107 12673 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL535172 12673 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
21064126 14216 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171290 14216 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200079 14216 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064297 14275 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173710 14275 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200301 14275 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226124 13988 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198013 13988 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593204 13988 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
90666580 108900 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 657 13 3 8 4.7 CNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219782 108900 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 657 13 3 8 4.7 CNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
57390535 68850 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 613 9 1 5 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926883 68850 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 613 9 1 5 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
3002977 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
803 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
806 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL1201187 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL256907 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL584744 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
DB04835 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
3002977 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
803 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
806 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
CHEMBL1201187 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
CHEMBL256907 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
CHEMBL584744 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
DB04835 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
145985237 164961 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1cscc1[C@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4241066 164961 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1cscc1[C@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
3008937 198406 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 198406 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
5275764 75668 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205706 75668 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
118727171 116859 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 549 8 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397982 116859 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 549 8 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
122668179 191889 2 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1[C@@H]1C[C@H]3CC[C@@H](C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 10.1021/acs.jmedchem.2c01383
CHEMBL5209067 191889 2 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1[C@@H]1C[C@H]3CC[C@@H](C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 10.1021/acs.jmedchem.2c01383
3008931 200951 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 200951 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52948264 18846 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288872 18846 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728324 10691 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 545 9 1 5 4.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171965 10691 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 545 9 1 5 4.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
118727186 116874 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 540 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C[C@@H]3C[C@H]2CN3Cc2ccc(F)cc2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397997 116874 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 540 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C[C@@H]3C[C@H]2CN3Cc2ccc(F)cc2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
49864969 15590 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222767 15590 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
3008924 198011 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
CHEMBL59328 198011 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
3008903 162616 1 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3C#N)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL418120 162616 1 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3C#N)c3ccccc3)CC2)CC1 10.1021/jm031046g
72712158 92210 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435865 92210 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
122185627 122389 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604305 122389 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606099 122389 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
49799705 14271 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173646 14271 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200294 14271 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56661522 66303 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813437 66303 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852861 66303 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
126567273 165276 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 514 8 1 6 5.3 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccnc1 10.1021/acs.jmedchem.8b01077
CHEMBL4248733 165276 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 514 8 1 6 5.3 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccnc1 10.1021/acs.jmedchem.8b01077
72711279 92244 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
CHEMBL2435899 92244 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
11569805 13797 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 13797 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL556995 13797 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16659334 13876 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1197042 13876 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL559168 13876 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
11569805 13797 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196449 13797 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL556995 13797 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56683103 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817914 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852172 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057815 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
56683103 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817914 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852172 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057815 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
56683103 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817914 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852172 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057815 66126 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
72713858 92255 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 92255 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
46225349 198357 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595610 198357 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
491775 12753 1 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188807 12753 1 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL537424 12753 1 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
21064329 14209 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171069 14209 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200059 14209 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226122 13983 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198002 13983 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL592918 13983 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
76310164 104097 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 586 10 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104690 104097 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 586 10 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
52945865 18866 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288920 18866 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21064283 14202 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1170878 14202 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1200019 14202 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
145984103 165307 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 541 7 1 7 4.3 CC(=O)N1CCN(C(=O)N[C@@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)c2ccc(C)s2)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4249241 165307 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 541 7 1 7 4.3 CC(=O)N1CCN(C(=O)N[C@@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)c2ccc(C)s2)CC1 10.1021/acs.jmedchem.8b01077
9978318 121826 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Inhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL359986 121826 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Inhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
44395386 127003 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL366260 127003 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
73349500 92327 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 8 2 6 4.9 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436718 92327 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 8 2 6 4.9 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
50993436 56889 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 421 6 2 5 3.3 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CNCC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649915 56889 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 421 6 2 5 3.3 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CNCC3)C2)c1ccccc1 10.1021/jm100978n
3008936 197009 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 197009 1 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
126567306 165114 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4244935 165114 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
122668196 191354 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5200961 191354 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 10.1021/acs.jmedchem.2c01383
145985894 164844 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 10.1021/acs.jmedchem.8b01077
CHEMBL4238266 164844 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 10.1021/acs.jmedchem.8b01077
5275763 96330 1 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL264832 96330 1 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
3008925 100434 1 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 100434 1 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
57401041 68845 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 568 10 1 6 5.9 COC(=O)c1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926876 68845 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 568 10 1 6 5.9 COC(=O)c1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
10159218 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1196504 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL557199 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
10159218 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196504 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL557199 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
10159218 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1196504 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL557199 13807 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
73351055 92328 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 471 9 1 4 6.2 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436719 92328 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 471 9 1 4 6.2 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
118727187 116875 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397998 116875 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
72712374 92219 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 92219 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
72714318 92233 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 92233 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
3008912 199377 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 199377 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
23577378 66084 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813269 66084 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851957 66084 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
21064289 14272 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173647 14272 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200295 14272 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226130 13985 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198009 13985 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593111 13985 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
46225527 198002 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593184 198002 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
62707282 76808 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057534 76808 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2078850 76808 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
54752875 76822 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057813 76822 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2079028 76822 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
62707282 76808 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057534 76808 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078850 76808 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
54752875 76822 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057813 76822 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079028 76822 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
70692903 76839 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064265 76839 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079297 76839 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
73352528 92323 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 8 2 4 6.1 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436714 92323 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 8 2 4 6.1 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
46225526 198041 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593520 198041 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
57331306 104088 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 600 10 0 4 5.7 CCN(Cc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104679 104088 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 600 10 0 4 5.7 CCN(Cc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
491775 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL537424 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188807 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL537424 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
491775 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188807 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL537424 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
491775 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1188807 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL537424 12753 1 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
162677463 182984 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 857 23 5 11 4.1 CNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4800480 182984 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 857 23 5 11 4.1 CNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL5089300 213417 0 None -13 2 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
90656334 110569 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 489 8 1 8 3.6 COC(=O)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263030 110569 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 489 8 1 8 3.6 COC(=O)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
23577328 66086 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813454 66086 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851967 66086 0 None - 1 Human 4.0 pIC50 = 4.0 Functional
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
60196353 81197 2 None - 0 Human 8.8 pKd = 8.8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.6b01801
CHEMBL2163486 81197 2 None - 0 Human 8.8 pKd = 8.8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.6b01801
137643501 157836 0 None - 0 Human 8.0 pKd = 8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]1CC2 10.1021/acs.jmedchem.6b01801
CHEMBL4089991 157836 0 None - 0 Human 8.0 pKd = 8 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]1CC2 10.1021/acs.jmedchem.6b01801
137631641 156056 0 None - 0 Human 6.5 pKd = 6.5 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@H]1CC2 10.1021/acs.jmedchem.6b01801
CHEMBL4068906 156056 0 None - 0 Human 6.5 pKd = 6.5 Functional
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@H]1CC2 10.1021/acs.jmedchem.6b01801
3009353 167451 1 None - 0 Human 9.0 pKi = 9.0 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 531 6 0 5 5.7 CCC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
CHEMBL432170 167451 1 None - 0 Human 9.0 pKi = 9.0 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 531 6 0 5 5.7 CCC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
3009354 203555 1 None - 0 Human 8.9 pKi = 8.9 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 579 6 0 5 6.1 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](Cc3ccccc3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL79061 203555 1 None - 0 Human 8.9 pKi = 8.9 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 579 6 0 5 6.1 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](Cc3ccccc3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
3009356 105131 1 None - 0 Human 8.8 pKi = 8.8 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 543 6 0 5 5.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](CC3CC3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL312344 105131 1 None - 0 Human 8.8 pKi = 8.8 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 543 6 0 5 5.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](CC3CC3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
3009355 3914 21 None -1 2 Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
807 3914 21 None -1 2 Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
CHEMBL82301 3914 21 None -1 2 Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
DB06652 3914 21 None -1 2 Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
483747 104917 2 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL311795 104917 2 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
10436045 3447 3 None - 0 Human 5.4 pKi = 5.4 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
782 3447 3 None - 0 Human 5.4 pKi = 5.4 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
CHEMBL432713 3447 3 None - 0 Human 5.4 pKi = 5.4 Functional
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
3009352 96178 1 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 517 5 0 5 5.3 CC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
CHEMBL263555 96178 1 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 517 5 0 5 5.3 CC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
15664 83360 93 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
CHEMBL2205807 83360 93 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
10585 1058 1 None -1 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
145996522 1058 1 None -1 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
CHEMBL4531005 1058 1 None -1 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
10106 858 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
91820689 858 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
CHEMBL4249798 858 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
10750 2532 0 None -5011 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 5 2 5 6.3 Clc1ccc(cc1)C1(O)CCN(CC1(C)C)CC/C=C\1/c2cc(ccc2OCc2c1cccn2)C(O)(C)C 17715391
18437138 2532 0 None -5011 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 5 2 5 6.3 Clc1ccc(cc1)C1(O)CCN(CC1(C)C)CC/C=C\1/c2cc(ccc2OCc2c1cccn2)C(O)(C)C 17715391
11597 666 3 None -11 2 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
23725180 666 3 None -11 2 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
CHEMBL4781426 666 3 None -11 2 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
769 810 0 None -14 3 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10477718
3002977 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
803 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
806 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL1201187 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL256907 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL584744 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
DB04835 2416 70 None 2 2 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
486830 3927 0 None -6 5 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9287217
768 3927 0 None -6 5 Human 8.3 pIC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9287217
68764898 664 1 None -3 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
9430 664 1 None -3 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
CHEMBL3577945 664 1 None -3 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
3500 1493 9 None 245 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
491774 1493 9 None 245 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
CHEMBL1196395 1493 9 None 245 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
5275766 3669 33 None - 1 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
800 3669 33 None - 1 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
CHEMBL207004 3669 33 None - 1 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
11285792 864 30 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
801 864 30 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
CHEMBL2110727 864 30 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
DB11758 864 30 None -3 6 Human 8.6 pIC50 None 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
CHEMBL2372983 208576 0 None - 0 Human 9.7 pEC50 = 9.7 Binding
Effective concentration for antagonistic activity by inhibition of T-tropic strain of HIV-1 through its specific binding to a chemokine receptorEffective concentration for antagonistic activity by inhibition of T-tropic strain of HIV-1 through its specific binding to a chemokine receptor
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)c2ccc3ccccc3c2)CSSC[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C1=O 10.1016/s0960-894x(00)00664-8
483407 165476 18 None - 1 Human 9.0 pEC50 = 9 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/C6MD00311G
CHEMBL425618 165476 18 None - 1 Human 9.0 pEC50 = 9 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/C6MD00311G
129908110 155402 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 485 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4061273 155402 0 None - 0 Human 5.0 pEC50 = 5.0 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 485 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908195 158231 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 493 11 1 7 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)Cc3cccs3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4094196 158231 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 493 11 1 7 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)Cc3cccs3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908301 156145 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
132519568 156145 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4069939 156145 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908428 158395 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 417 8 3 5 4.6 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4095938 158395 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 417 8 3 5 4.6 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
129908452 155479 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 518 11 1 8 4.8 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4062349 155479 0 None - 0 Human 4.8 pEC50 = 4.8 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 518 11 1 8 4.8 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
3002977 2416 70 None -3 2 Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
803 2416 70 None -3 2 Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
806 2416 70 None -3 2 Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL1201187 2416 70 None -3 2 Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL256907 2416 70 None -3 2 Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL584744 2416 70 None -3 2 Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
DB04835 2416 70 None -3 2 Human 7.8 pEC50 = 7.8 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
129908456 157320 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 395 8 3 4 4.8 O=C(CCc1ccc(NC(=O)C2CCCCC2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4083941 157320 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 395 8 3 4 4.8 O=C(CCc1ccc(NC(=O)C2CCCCC2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908453 157332 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 479 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4084066 157332 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 479 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908111 157116 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 501 10 1 7 5.0 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4081563 157116 0 None - 0 Human 4.7 pEC50 = 4.7 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 501 10 1 7 5.0 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
129908196 156476 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 389 8 3 4 4.5 O=C(CCc1ccc(NC(=O)c2ccccc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4073567 156476 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 389 8 3 4 4.5 O=C(CCc1ccc(NC(=O)c2ccccc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908454 157529 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 487 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4086440 157529 0 None - 0 Human 4.6 pEC50 = 4.6 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 487 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908109 157785 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 477 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4089429 157785 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 477 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908455 155708 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 503 11 1 7 4.9 COc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4064975 155708 0 None - 0 Human 4.5 pEC50 = 4.5 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 503 11 1 7 4.9 COc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
129908558 155620 0 None - 0 Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 403 8 3 4 4.8 Cc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4063935 155620 0 None - 0 Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 403 8 3 4 4.8 Cc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
129907953 158944 0 None - 0 Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
132519569 158944 0 None - 0 Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4101931 158944 0 None - 0 Human 4.4 pEC50 = 4.4 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908281 158016 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 473 10 1 6 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccccc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4091826 158016 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 473 10 1 6 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccccc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908560 156377 0 None - 0 Human 4.3 pEC50 = 4.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 409 9 3 5 4.5 O=C(CCc1ccc(NC(=O)Cc2cccs2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4072528 156377 0 None - 0 Human 4.3 pEC50 = 4.3 Binding
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 409 9 3 5 4.5 O=C(CCc1ccc(NC(=O)Cc2cccs2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL5074744 212548 0 None - 2 Human 7.0 pEC50 = 7.0 Binding
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
483747 104917 2 None 177 4 Human 11.0 pIC50 = 11 Binding
Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL311795 104917 2 None 177 4 Human 11.0 pIC50 = 11 Binding
Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
44590586 176226 0 None - 0 Human 10.3 pIC50 = 10.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460845 176226 0 None - 0 Human 10.3 pIC50 = 10.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
10076141 77970 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21106 77970 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10076141 77970 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21106 77970 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
10076141 77970 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21106 77970 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44590681 174591 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 553 11 1 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457043 174591 0 None - 0 Human 10.2 pIC50 = 10.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 553 11 1 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44273531 74667 0 None - 0 Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20345 74667 0 None - 0 Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
501062 77366 1 None - 0 Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20896 77366 1 None - 0 Human 10.0 pIC50 = 10 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
501062 77366 1 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL20896 77366 1 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44273531 74667 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20345 74667 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44332684 106683 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL316475 106683 0 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501060 108086 1 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL320386 108086 1 None - 0 Human 10.0 pIC50 = 10 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501055 4530 1 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102826 4530 1 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501062 77366 1 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL20896 77366 1 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44332684 106683 0 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL316475 106683 0 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501060 108086 1 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL320386 108086 1 None - 0 Human 10.0 pIC50 = 10 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
490018 111120 1 None - 0 Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328445 111120 1 None - 0 Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
3002976 205536 1 None - 0 Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93139 205536 1 None - 0 Human 10.0 pIC50 = 10 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44373756 50333 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL157491 50333 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
11988311 178748 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 451 8 1 5 5.2 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473558 178748 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 451 8 1 5 5.2 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44590750 176312 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 10 2 3 5.1 CCN(C(=O)NCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461687 176312 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 10 2 3 5.1 CCN(C(=O)NCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
71451877 82145 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 638 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCC(S(C)(=O)=O)CC2)CC1 10.1021/jm300682j
CHEMBL2178577 82145 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 638 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCC(S(C)(=O)=O)CC2)CC1 10.1021/jm300682j
44274043 76186 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20622 76186 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
44273830 79185 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21147 79185 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
3002977 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
3002977 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
803 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
803 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
806 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
806 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
CHEMBL1201187 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
CHEMBL1201187 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
CHEMBL256907 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
CHEMBL256907 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
CHEMBL584744 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
CHEMBL584744 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
DB04835 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
DB04835 2416 70 None -3 2 Human 9.7 pIC50 = 9.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
10414981 107642 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL319593 107642 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
44332341 109151 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 10 1 7 5.3 Cn1nnnc1-c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL322422 109151 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 10 1 7 5.3 Cn1nnnc1-c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
44274043 76186 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20622 76186 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44273830 79185 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21147 79185 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10414981 107642 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL319593 107642 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
501063 206680 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99909 206680 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10414981 107642 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00606-6
CHEMBL319593 107642 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00606-6
501063 206680 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL99909 206680 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501055 4530 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL102826 4530 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516310 59283 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 642 12 1 6 7.1 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL171958 59283 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 642 12 1 6 7.1 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516257 59653 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL173400 59653 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516288 60064 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174927 60064 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516256 128112 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366770 128112 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516289 131011 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2ccc3ccccc3c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369235 131011 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2ccc3ccccc3c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
490023 112006 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 574 10 0 6 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329893 112006 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 574 10 0 6 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490019 167404 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 582 10 0 6 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL431852 167404 1 None - 0 Human 9.7 pIC50 = 9.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 582 10 0 6 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
9916998 79561 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212731 79561 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
3010274 188624 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511493 188624 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010273 191349 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520091 191349 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44342962 110716 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 529 10 1 5 5.9 O=C(O)C(CC1CC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL326487 110716 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 529 10 1 5 5.9 O=C(O)C(CC1CC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
44342961 114024 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 10 1 5 6.3 O=C(O)C(CC1CCC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL333619 114024 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 10 1 5 6.3 O=C(O)C(CC1CCC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
3010274 188624 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511493 188624 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010273 191349 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520091 191349 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
11285792 864 30 None - 0 Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
801 864 30 None - 0 Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
CHEMBL2110727 864 30 None - 0 Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
DB11758 864 30 None - 0 Mouse 9.6 pIC50 = 9.6 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
11614352 544 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
7686 544 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
CHEMBL1951914 544 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
3010264 183211 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480503 183211 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010264 183211 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480503 183211 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010264 183211 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480503 183211 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
10347790 78035 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21117 78035 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565720 173747 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL455073 173747 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
20672370 77664 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 531 11 1 4 6.1 N#Cc1ccc(CCCC2CCN(C[C@H]3CN([C@H](CC4CCC4)C(=O)O)C[C@@H]3c3cccc(F)c3)CC2)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL20988 77664 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 531 11 1 4 6.1 N#Cc1ccc(CCCC2CCN(C[C@H]3CN([C@H](CC4CCC4)C(=O)O)C[C@@H]3c3cccc(F)c3)CC2)cc1 10.1016/s0960-894x(02)00829-6
10347790 78035 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21117 78035 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
20672362 98964 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 10 1 3 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL282921 98964 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 10 1 3 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
10369469 69991 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 1 5 5.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL194497 69991 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 1 5 5.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
489315 106863 2 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL317710 106863 2 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
10347790 78035 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21117 78035 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565720 173747 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL455073 173747 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72712598 92193 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435848 92193 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
516231 59525 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172894 59525 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516245 59532 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172916 59532 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516235 59886 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL174004 59886 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516224 61311 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL177127 61311 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516234 98530 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL279992 98530 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516233 128144 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366868 128144 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516202 129746 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 5 7.3 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367987 129746 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 5 7.3 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516314 130148 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 662 11 1 5 8.2 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368329 130148 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 662 11 1 5 8.2 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516216 130902 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369059 130902 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516262 165800 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 9 1 5 7.0 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL427493 165800 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 9 1 5 7.0 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516232 167955 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 11 1 5 6.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435472 167955 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 11 1 5 6.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
16007088 79551 14 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1021/jm300682j
CHEMBL212689 79551 14 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1021/jm300682j
16007088 79551 14 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212689 79551 14 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
16007088 79551 14 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL212689 79551 14 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2011.12.117
3010271 183250 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480693 183250 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44590633 175620 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459384 175620 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3010271 183250 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480693 183250 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010271 183250 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480693 183250 1 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44401488 69719 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 9 1 5 5.6 CCc1ccn2c(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)cnc2c1 10.1016/j.bmcl.2005.02.030
CHEMBL193984 69719 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 9 1 5 5.6 CCc1ccn2c(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)cnc2c1 10.1016/j.bmcl.2005.02.030
53260398 62519 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 0 4 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784385 62519 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 0 4 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
3002977 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
44565038 186265 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489513 186265 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491679 186265 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010268 78295 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 10 2 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112559 78295 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 10 2 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44273996 75195 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20453 75195 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565673 177057 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL464132 177057 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
44273996 75195 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20453 75195 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273888 98300 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278117 98300 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44357079 118823 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344261 118823 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
3001322 439 19 None - 1 Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
805 439 19 None - 1 Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
CHEMBL1255794 439 19 None - 1 Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
DB06497 439 19 None - 1 Mouse 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
44332489 4671 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 557 10 2 5 4.7 C[n+]1n[nH]c(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/s0960-894x(02)00605-4
CHEMBL103790 4671 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 557 10 2 5 4.7 C[n+]1n[nH]c(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/s0960-894x(02)00605-4
44273996 75195 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20453 75195 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565673 177057 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL464132 177057 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
58834969 92202 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 586 8 1 6 5.9 Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435857 92202 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 586 8 1 6 5.9 Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516292 59947 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 9 1 5 7.3 CCn1nc(Cc2ccc(C(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174214 59947 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 9 1 5 7.3 CCn1nc(Cc2ccc(C(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516201 60126 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 608 12 1 6 6.2 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL175348 60126 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 608 12 1 6 6.2 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516246 60731 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176459 60731 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516255 60938 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL176669 60938 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516279 96019 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 11 1 6 7.8 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL262402 96019 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 11 1 6 7.8 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516230 127934 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366611 127934 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516274 128147 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366873 128147 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516221 132036 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369812 132036 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516271 167683 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL433793 167683 1 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
20664161 78583 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL2113086 78583 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
3002977 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2416 70 None -3 2 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
57391721 70704 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 11 0 6 4.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951913 70704 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 11 0 6 4.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
3009355 3914 21 None - 1 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
807 3914 21 None - 1 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
CHEMBL82301 3914 21 None - 1 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
DB06652 3914 21 None - 1 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
44590634 174223 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.0 CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL456226 174223 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.0 CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44565080 186491 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN([C@H](C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491319 186491 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN([C@H](C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
20672360 76950 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 3 6.4 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20831 76950 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 3 6.4 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
20672386 98289 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278085 98289 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273888 98300 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278117 98300 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44590440 178615 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)C(=O)C3CC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL472464 178615 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)C(=O)C3CC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
44357078 118883 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344641 118883 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44401956 133042 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4c(Cl)cc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL371177 133042 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4c(Cl)cc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
20672386 98289 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL278085 98289 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565742 178531 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 548 11 1 3 6.8 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471920 178531 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 548 11 1 3 6.8 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10163007 94642 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255429 94642 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501046 109174 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322603 109174 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72714079 92231 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 92231 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516311 59581 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.7 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173091 59581 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.7 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516312 59672 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 678 12 1 6 8.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173479 59672 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 678 12 1 6 8.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516192 59699 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL173583 59699 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516282 60070 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 11 1 6 6.6 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174996 60070 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 11 1 6 6.6 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516228 60084 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 12 1 7 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL175079 60084 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 12 1 7 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516227 60124 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 7 5.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5c(c4)OCO5)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL175341 60124 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 7 5.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5c(c4)OCO5)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516313 60791 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 2 6 6.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176528 60791 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 2 6 6.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44385583 61156 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 578 9 1 5 6.2 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177071 61156 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 578 9 1 5 6.2 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516251 96431 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL265723 96431 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516205 127933 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366610 127933 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516259 129195 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367416 129195 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
44384782 129659 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 6.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(NC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367897 129659 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 6.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(NC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516248 129750 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368000 129750 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516198 131289 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 612 12 1 6 6.2 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369398 131289 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 612 12 1 6 6.2 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516237 131366 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369478 131366 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516249 131573 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369593 131573 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
3010272 188852 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL513564 188852 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010272 188852 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL513564 188852 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
3010272 188852 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL513564 188852 1 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44564930 178774 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 5.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473759 178774 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 5.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
57391722 70706 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 637 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951917 70706 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 637 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44565761 187723 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL500631 187723 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010275 78294 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 572 11 2 4 6.2 CCc1[nH]c(Cc2ccccc2)nc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112558 78294 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 572 11 2 4 6.2 CCc1[nH]c(Cc2ccccc2)nc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
44565761 187723 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL500631 187723 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565762 178606 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472412 178606 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44401965 70959 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 549 9 1 7 4.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc([N+](=O)[O-])cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195753 70959 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 549 9 1 7 4.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc([N+](=O)[O-])cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565762 178606 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472412 178606 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008904 198273 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL59511 198273 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
58834906 92198 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 1 6 6.2 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435853 92198 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 1 6 6.2 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
3010276 78293 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 578 10 2 4 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112557 78293 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 578 10 2 4 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
516337 129644 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367837 129644 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516333 119821 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL352981 119821 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516293 59369 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 10 1 5 7.7 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172296 59369 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 10 1 5 7.7 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516194 59620 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 12 1 6 6.6 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173254 59620 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 12 1 6 6.6 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516280 60726 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 10 1 6 6.9 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176426 60726 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 10 1 6 6.9 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516223 61034 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176933 61034 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516199 96056 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 562 10 2 6 5.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL262663 96056 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 562 10 2 6 5.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516291 96176 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 1 5 7.2 CCn1nc(Cc2ccc(C(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL263529 96176 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 1 5 7.2 CCn1nc(Cc2ccc(C(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516252 129285 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367560 129285 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516212 129549 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367700 129549 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516209 130179 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368467 130179 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516290 131394 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 9 1 5 6.3 CCn1nc(Cc2ccc(C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369494 131394 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 9 1 5 6.3 CCn1nc(Cc2ccc(C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516250 131597 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369659 131597 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516253 157651 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL408800 157651 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516196 165518 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 12 1 6 7.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL425845 165518 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 12 1 6 7.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516281 165734 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.0 CCn1nc(Cc2ccc(OCC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL427122 165734 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.0 CCn1nc(Cc2ccc(OCC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3010261 191775 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520755 191775 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010261 191775 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520755 191775 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010261 191775 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL520755 191775 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
57403932 70703 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 6 3.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951912 70703 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 6 3.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
57396952 70705 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 655 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951915 70705 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 655 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
501056 106973 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318406 106973 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501056 106973 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318406 106973 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008917 201087 4 None - 0 Crab-eating macaque 9.2 pIC50 = 9.2 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL62152 201087 4 None - 0 Crab-eating macaque 9.2 pIC50 = 9.2 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501056 106973 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318406 106973 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
58835217 92201 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 9 1 6 5.8 CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435856 92201 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 9 1 6 5.8 CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44415755 138157 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 451 9 2 3 4.0 O=C(Cc1ccc(F)cc1)NC1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL377914 138157 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 451 9 2 3 4.0 O=C(Cc1ccc(F)cc1)NC1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
3010279 78288 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 564 10 2 4 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112552 78288 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 564 10 2 4 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
516285 59377 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 9 1 7 5.8 CCn1nc(Cc2ccc3c(c2)OCO3)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172322 59377 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 9 1 7 5.8 CCn1nc(Cc2ccc3c(c2)OCO3)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516229 59633 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL173308 59633 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516308 60131 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 13 1 6 7.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL175394 60131 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 13 1 6 7.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516275 61089 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 7.0 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177033 61089 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 7.0 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516220 61778 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL177648 61778 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516287 119474 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL349974 119474 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516276 130126 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368204 130126 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516269 167968 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2cccc(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL435554 167968 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2cccc(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3010267 78296 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 512 10 2 4 5.1 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112560 78296 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 512 10 2 4 5.1 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44461741 167479 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 619 14 1 6 5.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL432360 167479 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 619 14 1 6 5.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
76330829 85173 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 605 13 1 6 5.6 C=CCN(C(=O)Nc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282506 85173 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 605 13 1 6 5.6 C=CCN(C(=O)Nc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
16073660 79353 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211866 79353 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
44565853 178445 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL471251 178445 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010278 78289 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 589 11 1 5 7.0 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112553 78289 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 589 11 1 5 7.0 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
44565853 178445 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL471251 178445 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
76327166 85176 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282509 85176 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
501051 4405 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL101961 4405 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516260 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172854 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273960 98755 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL281607 98755 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565719 178529 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471909 178529 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516342 188641 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511634 188641 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274108 98684 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 516 10 1 4 6.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL281176 98684 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 516 10 1 4 6.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273960 98755 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL281607 98755 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
490022 111091 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL328260 111091 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
44357072 98027 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL275998 98027 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
490020 111100 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL328297 111100 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
20664149 69488 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 580 9 1 5 6.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(-c5ccccc5)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193822 69488 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 580 9 1 5 6.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(-c5ccccc5)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
516260 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172854 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516236 167967 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL435538 167967 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
490020 111100 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL328297 111100 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
501051 4405 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL101961 4405 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516260 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172854 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273960 98755 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL281607 98755 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565719 178529 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471909 178529 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516342 188641 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511634 188641 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447734 94683 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255644 94683 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
10413034 94724 0 None - 0 Crab-eating macaque 9.1 pIC50 = 9.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255856 94724 0 None - 0 Crab-eating macaque 9.1 pIC50 = 9.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501051 4405 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL101961 4405 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
486605 103872 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL310106 103872 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
44384927 167986 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3oncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL435709 167986 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3oncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516197 59296 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 6.5 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172013 59296 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 6.5 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516309 59379 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 14 1 6 7.7 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL172327 59379 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 14 1 6 7.7 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516260 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172854 59513 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516273 60134 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 13 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL175424 60134 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 13 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516218 60921 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 13 1 6 6.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176624 60921 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 13 1 6 6.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516244 61384 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL177168 61384 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516195 61423 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177204 61423 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516242 96199 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL263787 96199 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
516304 119977 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 726 12 1 7 7.4 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL354413 119977 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 726 12 1 7 7.4 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516272 120302 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 12 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL355809 120302 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 12 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516200 127520 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 601 11 1 7 5.5 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366492 127520 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 601 11 1 7 5.5 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516258 127987 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366742 127987 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516191 131081 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL369278 131081 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44325665 110901 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 632 10 0 6 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327241 110901 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 632 10 0 6 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490022 111091 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328260 111091 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490020 111100 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328297 111100 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44401760 168010 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(C(F)(F)F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL435886 168010 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(C(F)(F)F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565037 192372 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489324 192372 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL522259 192372 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
20672384 69226 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193440 69226 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44565852 172082 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL449758 172082 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401751 69720 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 538 8 1 5 5.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193988 69720 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 538 8 1 5 5.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565852 172082 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL449758 172082 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010277 78292 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 573 11 1 5 6.5 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112556 78292 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 573 11 1 5 6.5 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
516366 167989 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL435727 167989 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565718 178371 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470510 178371 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274106 76155 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 548 10 1 5 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20602 76155 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 548 10 1 5 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
516203 60003 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL174457 60003 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
516366 167989 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL435727 167989 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
44205000 169617 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 594 8 0 6 7.0 COC(=O)C(c1ccc(F)cc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL444497 169617 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 594 8 0 6 7.0 COC(=O)C(c1ccc(F)cc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
516366 167989 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL435727 167989 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565718 178371 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470510 178371 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10413034 94724 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255856 94724 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
16041411 92130 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 572 8 1 6 5.6 O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2434978 92130 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 572 8 1 6 5.6 O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
58835113 92189 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 607 8 1 7 5.6 O=C(O)c1ccc(Sc2ncc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435844 92189 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 607 8 1 7 5.6 O=C(O)c1ccc(Sc2ncc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
58834946 92190 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 2 7 5.5 Cc1nc(Nc2ccc(C(=O)O)cc2)ncc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435845 92190 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 2 7 5.5 Cc1nc(Nc2ccc(C(=O)O)cc2)ncc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
72711741 92204 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 92204 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711739 92252 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435907 92252 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
59458247 92257 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435912 92257 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
516208 59172 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL171468 59172 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516286 60061 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 10 1 7 5.9 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174904 60061 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 10 1 7 5.9 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516270 60881 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL176604 60881 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516300 127929 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 10 1 5 7.2 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366600 127929 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 10 1 5 7.2 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516213 128790 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL367102 128790 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
516298 130149 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368332 130149 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516236 167967 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435538 167967 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
3009355 3914 21 None - 1 Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
807 3914 21 None - 1 Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
CHEMBL82301 3914 21 None - 1 Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
DB06652 3914 21 None - 1 Mouse 9.0 pIC50 = 9.0 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
44590635 176315 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 493 10 1 3 5.1 CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461690 176315 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 493 10 1 3 5.1 CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
76335673 104296 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 652 18 1 6 8.8 Cc1nnc(CCCCCCCCCCN=[N+]=[N-])n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
CHEMBL3109175 104296 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 652 18 1 6 8.8 Cc1nnc(CCCCCCCCCCN=[N+]=[N-])n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
489315 106863 2 None - 0 Human 9.0 pIC50 = 9 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00652-7
CHEMBL317710 106863 2 None - 0 Human 9.0 pIC50 = 9 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00652-7
23650547 178491 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471623 178491 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
44590394 183290 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 485 6 0 3 5.0 Cc1cccc(C)c1C(=O)N1[C@H]2CC[C@@H]1C[C@@H](N1CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C1)C2 10.1016/j.bmcl.2009.01.012
CHEMBL481068 183290 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 485 6 0 3 5.0 Cc1cccc(C)c1C(=O)N1[C@H]2CC[C@@H]1C[C@@H](N1CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C1)C2 10.1016/j.bmcl.2009.01.012
59959034 78585 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cnccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL2113088 78585 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cnccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44332814 163108 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 11 2 6 5.2 OC1(CCCc2ccc(Cc3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL420465 163108 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 11 2 6 5.2 OC1(CCCc2ccc(Cc3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
16073662 138733 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 630 11 0 6 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL379082 138733 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 630 11 0 6 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
25132603 102803 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 5 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084499 102803 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 5 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
44565854 183271 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 559 11 1 5 6.7 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL480890 183271 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 559 11 1 5 6.7 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
501045 206662 1 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99788 206662 1 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10280445 94684 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255645 94684 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
3008928 200961 1 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61424 200961 1 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501043 4600 1 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103343 4600 1 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501047 4675 1 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103813 4675 1 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501045 206662 1 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL99788 206662 1 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72711958 92209 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 92209 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
59458245 92211 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 92211 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3010280 78291 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 563 10 1 5 6.4 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112555 78291 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 563 10 1 5 6.4 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
516336 130086 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368183 130086 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
3002976 205536 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL93139 205536 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
516307 59312 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 12 1 6 7.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL172079 59312 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 12 1 6 7.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44384584 59505 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172820 59505 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516193 60712 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 6 6.2 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176337 60712 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 6 6.2 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516296 61424 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177205 61424 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516190 129138 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367383 129138 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516215 130144 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL368309 130144 1 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44273816 98576 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 588 10 1 5 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL280344 98576 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 588 10 1 5 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44357379 27912 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL137327 27912 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
16073670 140513 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 648 11 0 6 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL382435 140513 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 648 11 0 6 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
57400374 70698 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 603 11 0 6 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951906 70698 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 603 11 0 6 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16728787 12719 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188566 12719 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536754 12719 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10163007 94642 0 None - 0 Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255429 94642 0 None - 0 Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008927 197170 1 None - 0 Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58387 197170 1 None - 0 Crab-eating macaque 9.0 pIC50 = 9.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
58835114 92199 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 8 1 6 5.8 Cc1cccc([C@@H]2CN(C3CCOCC3)C(=O)N2C2CCN(Cc3ccc(Oc4ccc(C(=O)O)cc4)nc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435854 92199 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 8 1 6 5.8 Cc1cccc([C@@H]2CN(C3CCOCC3)C(=O)N2C2CCN(Cc3ccc(Oc4ccc(C(=O)O)cc4)nc3C)CC2)c1 10.1021/jm401101p
58834953 92203 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 569 8 1 6 4.9 Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435858 92203 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 569 8 1 6 4.9 Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 92254 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 92254 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3010260 78290 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 8 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(-c4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112554 78290 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 8 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(-c4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516175 59046 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL170829 59046 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516283 59565 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 9 2 6 5.7 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173019 59565 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 9 2 6 5.7 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516261 59677 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 9 1 5 6.6 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173492 59677 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 9 1 5 6.6 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516178 60719 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)c(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176391 60719 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)c(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516295 129220 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367489 129220 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516267 129670 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 11 1 7 6.9 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367916 129670 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 11 1 7 6.9 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516278 129747 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 12 1 6 7.6 CCn1nc(Cc2ccc(OCc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367988 129747 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 12 1 6 7.6 CCn1nc(Cc2ccc(OCc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516240 130901 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369040 130901 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516214 131070 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL369277 131070 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516306 131591 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369632 131591 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516222 168598 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL440554 168598 1 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516361 59582 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL173095 59582 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516362 60122 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL175327 60122 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516172 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL353331 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516343 178479 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471542 178479 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44357063 118626 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL342842 118626 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44356952 118758 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343745 118758 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516361 59582 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL173095 59582 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516362 60122 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL175327 60122 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516172 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353331 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
11525100 83098 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 444 7 1 4 5.2 Cc1nc2ccccc2n1C1(C)CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203619 83098 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 444 7 1 4 5.2 Cc1nc2ccccc2n1C1(C)CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
516361 59582 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL173095 59582 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516362 60122 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL175327 60122 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516172 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL353331 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516343 178479 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471542 178479 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711742 92205 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 92205 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72714078 92230 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 92230 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
52946954 18178 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 549 7 0 6 3.4 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271208 18178 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 549 7 0 6 3.4 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
3013684 76670 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207182 76670 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
44384875 59576 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL173064 59576 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516335 129577 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 10 2 4 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3CCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL367787 129577 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 10 2 4 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3CCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516204 58866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 11 1 5 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(CC4CCCCC4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL170118 58866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 11 1 5 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(CC4CCCCC4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516284 59501 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 11 1 7 6.0 CCn1nc(Cc2ccc(OC)c(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172806 59501 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 11 1 7 6.0 CCn1nc(Cc2ccc(OC)c(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516243 129547 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367697 129547 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516211 167930 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435347 167930 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516172 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cell
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL353331 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cell
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516172 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL353331 119866 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.006
145967247 163850 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting methodDisplacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting method
ChEMBL 574 11 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@@H]2C[C@@H](N(C)[C@H](C(=O)O)C(C)C)C[C@H]2c2cccc(F)c2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL4213499 163850 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting methodDisplacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting method
ChEMBL 574 11 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@@H]2C[C@@H](N(C)[C@H](C(=O)O)C(C)C)C[C@H]2c2cccc(F)c2)CC1 10.1021/acs.jmedchem.8b00180
3002977 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
44565038 186265 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489513 186265 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491679 186265 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010262 183291 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL481080 183291 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447732 154550 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL401929 154550 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
58835000 92188 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 8 1 6 5.2 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)c(C)n2)cc1 10.1021/jm401101p
CHEMBL2435843 92188 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 8 1 6 5.2 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)c(C)n2)cc1 10.1021/jm401101p
58835027 92196 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 8 1 6 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435851 92196 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 8 1 6 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
3010262 183291 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL481080 183291 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516207 59673 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL173482 59673 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516217 60857 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176571 60857 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516176 61022 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176850 61022 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516219 61039 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176980 61039 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516187 61342 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 686 12 1 7 6.5 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177156 61342 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 686 12 1 7 6.5 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516189 119755 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 1 6 5.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL352511 119755 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 1 6 5.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516264 128927 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367169 128927 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516239 128943 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367246 128943 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516181 132039 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 580 10 1 5 6.3 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369822 132039 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 580 10 1 5 6.3 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
49768863 103017 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1016/j.bmcl.2009.01.008
CHEMBL3085107 103017 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1016/j.bmcl.2009.01.008
183790 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
783 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
CHEMBL1178786 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
183790 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
783 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
CHEMBL1178786 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
3008913 101493 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL301454 101493 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
3002977 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
803 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
806 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
CHEMBL1201187 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
CHEMBL256907 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
CHEMBL584744 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
DB04835 2416 70 None -3 2 Human 8.9 pIC50 = 8.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
183790 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
783 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
CHEMBL1178786 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
183790 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
783 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
CHEMBL1178786 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
58835024 92197 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 570 8 1 6 5.5 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435852 92197 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 570 8 1 6 5.5 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516225 130159 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368375 130159 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
183790 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
783 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
CHEMBL1178786 3673 8 None 3 2 Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
474160 11907 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183361 11907 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL292548 11907 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
44273872 99101 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL283788 99101 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
44356944 118701 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343366 118701 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516173 59962 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL174304 59962 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516173 59962 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL174304 59962 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273872 99101 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL283788 99101 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
3010265 183318 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL481274 183318 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
58835155 92200 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 8 1 6 5.6 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435855 92200 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 8 1 6 5.6 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(F)c2)CC1 10.1021/jm401101p
486632 79129 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL2114183 79129 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
483369 163845 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL421342 163845 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486604 203952 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82168 203952 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
3010265 183318 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL481274 183318 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516226 59315 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172090 59315 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516299 59607 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173202 59607 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516173 59962 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174304 59962 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516301 127521 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 654 10 1 5 7.6 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366494 127521 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 654 10 1 5 7.6 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516268 130823 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368823 130823 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474168 11140 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179044 11140 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL56565 11140 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
483369 163845 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL421342 163845 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461689 203930 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL81926 203930 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44590682 174593 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1cccc(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457044 174593 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1cccc(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44274090 76096 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL20598 76096 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
21341080 79311 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 4 6.3 O=C(CCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL21167 79311 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 4 6.3 O=C(CCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
3002977 2416 70 None -3 2 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2416 70 None -3 2 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2416 70 None -3 2 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2416 70 None -3 2 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2416 70 None -3 2 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2416 70 None -3 2 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2416 70 None -3 2 Human 8.8 pIC50 = 8.8 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
505881 29223 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138437 29223 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516367 59392 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172371 59392 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516365 119756 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL352514 119756 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
516294 119865 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353330 119865 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
57402175 70690 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 658 11 0 7 3.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951898 70690 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 658 11 0 7 3.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
44274090 76096 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL20598 76096 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
516365 119756 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL352514 119756 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010270 183212 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480504 183212 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010270 183212 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480504 183212 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516294 119865 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL353330 119865 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516247 127021 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366328 127021 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516266 129211 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 10 1 7 5.4 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367461 129211 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 10 1 7 5.4 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516238 130085 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368182 130085 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
44357375 115490 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL335562 115490 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
11635721 71874 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198150 71874 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
11635721 71874 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL198150 71874 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
9810893 103053 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 103053 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
11513274 103055 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 103055 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
10186910 94725 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
CHEMBL255857 94725 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
25024699 92192 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435847 92192 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
72711956 92207 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 92207 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
59458103 92251 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 92251 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5275759 76748 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207630 76748 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
11505350 168211 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL437494 168211 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516185 127278 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366400 127278 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516302 130176 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 611 10 1 6 6.4 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368459 130176 1 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 611 10 1 6 6.4 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
9914742 166071 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL428104 166071 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
9914742 166071 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL428104 166071 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
9914742 166071 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL428104 166071 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44447735 94685 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255646 94685 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 3673 8 None 3 2 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
783 3673 8 None 3 2 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
CHEMBL1178786 3673 8 None 3 2 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
474167 11909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183370 11909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL293393 11909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
3013575 75403 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 75403 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
76316241 85170 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 6 5.2 C=CCN(C(=O)c1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282503 85170 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 6 5.2 C=CCN(C(=O)c1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
486604 203952 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL82168 203952 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
11467704 204098 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83335 204098 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5275829 204299 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL85086 204299 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461628 104769 0 None - 0 Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL311532 104769 0 None - 0 Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461714 203627 0 None - 0 Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79667 203627 0 None - 0 Human 8.0 pIC50 = 8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
483344 5014 1 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 581 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105570 5014 1 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 581 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44335765 5350 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107380 5350 0 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
5481702 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL83338 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
505867 29474 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138645 29474 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
54582105 62528 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2cc(F)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784400 62528 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2cc(F)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
44401731 170619 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 499 7 2 3 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3c[nH]c4ccccc34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL445925 170619 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 499 7 2 3 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3c[nH]c4ccccc34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496972 107726 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL319689 107726 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
505867 29474 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL138645 29474 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496972 107726 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL319689 107726 1 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
46882916 5552 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.7 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077779 5552 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.7 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46883031 5635 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.4 CCCC[C@H]1CN(CC2CCCCO2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078335 5635 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.4 CCCC[C@H]1CN(CC2CCCCO2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
11786927 60628 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 624 10 1 7 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762463 60628 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 624 10 1 7 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2011.02.058
44461628 104769 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311532 104769 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461714 203627 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79667 203627 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481702 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481702 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL83338 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83338 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
16064151 120713 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 6 1 5 5.2 CC(C)[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577948 120713 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 6 1 5 5.2 CC(C)[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
5481702 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83338 204099 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5275841 122788 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 5.2 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL361585 122788 1 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 5.2 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
72714321 92236 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 92236 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
76316185 85157 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 10 3 3 8.1 CCc1cccc(CC)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281968 85157 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 10 3 3 8.1 CCc1cccc(CC)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
76327120 85155 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 598 8 3 3 7.9 Cc1cc(C)c(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1007/s00044-012-0118-7
CHEMBL2281966 85155 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 598 8 3 3 7.9 Cc1cc(C)c(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1007/s00044-012-0118-7
478449 85171 1 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282504 85171 1 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
76309037 85174 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.2 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282507 85174 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.2 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461560 203588 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79315 203588 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5481754 204732 1 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1007/s00044-011-9863-2
CHEMBL88159 204732 1 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1007/s00044-011-9863-2
489337 5529 2 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 9 2 3 6.5 CC(CCN1CCC(c2ccccc2)CC1)(CN1C(=O)N[C@H](Cc2c[nH]c3ccccc23)C1=O)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL107749 5529 2 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 9 2 3 6.5 CC(CCN1CCC(c2ccccc2)CC1)(CN1C(=O)N[C@H](Cc2c[nH]c3ccccc23)C1=O)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
5481704 163856 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL421356 163856 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
478496 204579 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1016/s0960-894x(00)00637-5
CHEMBL87167 204579 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1016/s0960-894x(00)00637-5
5481744 204812 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1016/s0960-894x(00)00637-5
CHEMBL88644 204812 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1016/s0960-894x(00)00637-5
5481750 204893 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1016/s0960-894x(00)00637-5
CHEMBL89167 204893 1 None - 0 Human 7.0 pIC50 = 7 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1016/s0960-894x(00)00637-5
44392229 65280 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 8 1 2 5.5 CN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183406 65280 0 None - 0 Human 7.0 pIC50 = 7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 8 1 2 5.5 CN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54584053 62526 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 586 6 0 4 7.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2c(C(F)(F)F)nc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784398 62526 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 586 6 0 4 7.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2c(C(F)(F)F)nc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
44401734 68806 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc(=O)c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL192456 68806 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc(=O)c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496970 4590 1 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL103268 4590 1 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
496970 4590 1 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL103268 4590 1 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44431977 87535 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 599 8 3 4 6.8 Cc1cc(C)c(NC(=O)NCC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1016/j.bmcl.2007.01.050
CHEMBL234208 87535 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 599 8 3 4 6.8 Cc1cc(C)c(NC(=O)NCC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1016/j.bmcl.2007.01.050
44455001 97182 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL271076 97182 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
46882871 5597 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 6.0 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3ccccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077988 5597 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 6.0 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3ccccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882985 5619 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078141 5619 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
54586339 60550 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2C#N)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762317 60550 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2C#N)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478440 103771 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL309922 103771 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461560 203588 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79315 203588 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481714 203615 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79566 203615 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461831 204045 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82879 204045 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481716 204135 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1016/s0960-894x(01)00491-7
CHEMBL83745 204135 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1016/s0960-894x(01)00491-7
5481704 163856 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL421356 163856 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479858 204967 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 480 9 0 3 5.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89715 204967 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 480 9 0 3 5.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
482147 205147 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90747 205147 1 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479877 205282 2 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91522 205282 2 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44273846 77831 0 None - 0 Human 6.0 pIC50 = 6 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 2 4 4.8 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCP(=O)(O)c3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21058 77831 0 None - 0 Human 6.0 pIC50 = 6 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 2 4 4.8 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCP(=O)(O)c3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
76315543 84825 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cncc2ccccc12 10.1007/s00044-011-9863-2
CHEMBL2259881 84825 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cncc2ccccc12 10.1007/s00044-011-9863-2
76322864 84826 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 504 8 0 6 3.2 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1cn(C)cn1 10.1007/s00044-011-9863-2
CHEMBL2259882 84826 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 504 8 0 6 3.2 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1cn(C)cn1 10.1007/s00044-011-9863-2
76334365 85144 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 425 4 0 3 4.6 Brc1ccc(COc2ccc(Br)cc2N2CCOCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL2281892 85144 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 425 4 0 3 4.6 Brc1ccc(COc2ccc(Br)cc2N2CCOCC2)cc1 10.1007/s00044-012-0118-7
76319944 85175 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 11 1 4 4.0 CCCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282508 85175 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 11 1 4 4.0 CCCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461785 103962 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 459 9 1 5 3.3 COC(=O)NC1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL310369 103962 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 459 9 1 5 3.3 COC(=O)NC1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5481746 112272 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1007/s00044-011-9863-2
CHEMBL330570 112272 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1007/s00044-011-9863-2
11188669 144836 3 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL391379 144836 3 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1007/s00044-012-0118-7
44461790 164001 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL421527 164001 0 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
478412 167396 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL431795 167396 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
5481703 204067 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83107 204067 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478499 204766 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL88344 204766 1 None - 0 Human 6.0 pIC50 = 6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1007/s00044-011-9863-2
5481741 110979 1 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 556 8 0 4 6.4 CN(Cc1ccccc1)C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL327703 110979 1 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 556 8 0 4 6.4 CN(Cc1ccccc1)C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
5481705 162917 1 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL420057 162917 1 None - 0 Human 6.0 pIC50 = 6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
11502371 152582 1 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of MIP1-alpha from CCR5 receptorDisplacement of MIP1-alpha from CCR5 receptor
ChEMBL 407 5 1 2 5.0 C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1 10.1016/j.bmcl.2007.01.115
CHEMBL397647 152582 1 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of MIP1-alpha from CCR5 receptorDisplacement of MIP1-alpha from CCR5 receptor
ChEMBL 407 5 1 2 5.0 C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1 10.1016/j.bmcl.2007.01.115
57403173 67513 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 409 9 1 4 3.7 N#Cc1cccc(C(=O)NCCCN2CCC(COCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910166 67513 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 409 9 1 4 3.7 N#Cc1cccc(C(=O)NCCCN2CCC(COCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2011.09.013
6479877 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1186558 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057533 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL469649 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
15485365 188065 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 8 1 4 6.3 O=C1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL503631 188065 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 8 1 4 6.3 O=C1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
11188669 144836 3 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL391379 144836 3 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2006.09.052
11188669 144836 3 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL391379 144836 3 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2007.01.050
6479877 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
CHEMBL1186558 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
CHEMBL2057533 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
CHEMBL469649 12392 2 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
53326700 58140 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683066 58140 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
11329244 70757 10 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70757 10 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11272103 123843 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123843 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
21148035 79131 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 9 0 5 3.4 CN(C[C@@H](CCN1CCC(N2CCOC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL2114185 79131 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 9 0 5 3.4 CN(C[C@@H](CCN1CCC(N2CCOC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461790 164001 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL421527 164001 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
478439 204142 1 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83773 204142 1 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481705 162917 1 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL420057 162917 1 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478307 105326 1 None - 0 Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL312701 105326 1 None - 0 Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5482809 163706 1 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 588 9 0 4 7.3 CCN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL421168 163706 1 None - 0 Human 5.0 pIC50 = 5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 588 9 0 4 7.3 CCN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
11224188 87217 0 None - 0 Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233635 87217 0 None - 0 Human 5.0 pIC50 = 5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11224188 87217 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233635 87217 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
44590849 176126 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CC(N(C)C2CCN(C(c3ccccc3)c3ccccc3)CC2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL459985 176126 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CC(N(C)C2CCN(C(c3ccccc3)c3ccccc3)CC2)C1 10.1016/j.bmcl.2009.01.012
10393635 172031 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 5.9 O=C1CC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL449125 172031 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 5.9 O=C1CC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
44570307 177728 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 4 0 6 3.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC3(CC2)CCN(S(C)(=O)=O)CC3c2ccccc2)CC1 10.1016/j.bmcl.2008.10.115
CHEMBL465106 177728 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 4 0 6 3.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC3(CC2)CCN(S(C)(=O)=O)CC3c2ccccc2)CC1 10.1016/j.bmcl.2008.10.115
483362 14342 1 None - 0 Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120204 14342 1 None - 0 Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44404656 134740 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 551 10 1 5 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(N)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372640 134740 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 551 10 1 5 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(N)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
3007227 59269 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8gInhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8g
ChEMBL 582 11 1 5 6.6 CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL171911 59269 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8gInhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8g
ChEMBL 582 11 1 5 6.6 CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
11204472 60632 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 638 10 1 7 6.6 COC(=O)c1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762468 60632 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 638 10 1 7 6.6 COC(=O)c1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
10186910 94725 0 None - 0 Crab-eating macaque 7.0 pIC50 = 7.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
CHEMBL255857 94725 0 None - 0 Crab-eating macaque 7.0 pIC50 = 7.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
53322809 58134 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683060 58134 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
4716524 87029 4 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233385 87029 4 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44431965 89452 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
CHEMBL237896 89452 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
44374088 119560 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL350763 119560 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
25230970 188026 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 590 7 0 7 3.3 CCCCC1CN(S(=O)(=O)N2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL502927 188026 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 590 7 0 7 3.3 CCCCC1CN(S(=O)(=O)N2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888455 8664 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 447 7 1 3 4.2 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C(C)C)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096447 8664 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 447 7 1 3 4.2 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C(C)C)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404644 134757 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 687 14 1 6 6.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372733 134757 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 687 14 1 6 6.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
44573335 186708 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 5 1 5 5.0 CN/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492960 186708 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 5 1 5 5.0 CN/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11569805 13797 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 13797 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL556995 13797 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16730521 87391 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 613 10 3 4 7.0 CCc1cccc(CC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL233847 87391 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 613 10 3 4 7.0 CCc1cccc(CC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
52944537 18113 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 8 0 5 4.4 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270693 18113 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 8 0 5 4.4 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
11527582 76060 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205964 76060 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
10208080 12937 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL1190106 12937 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL540108 12937 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
44384969 167707 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 594 10 1 5 6.9 CCn1ncc(C2(c3ccccc3)CC2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL433980 167707 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 594 10 1 5 6.9 CCn1ncc(C2(c3ccccc3)CC2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
5275835 122406 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL360667 122406 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
59458213 92249 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435904 92249 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516357 187665 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
CHEMBL499793 187665 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
44384011 59624 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL173262 59624 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516357 187665 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
CHEMBL499793 187665 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
72714320 92235 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 92235 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
505875 25755 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL135432 25755 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
505868 27556 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137072 27556 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
20664115 179517 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL474838 179517 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44392220 64344 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 1 3 6.1 C=CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181858 64344 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 1 3 6.1 C=CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392111 121986 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 0 4 5.7 CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360106 121986 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 0 4 5.7 CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073672 140515 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 638 12 0 6 5.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL382436 140515 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 638 12 0 6 5.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
479853 111508 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328908 111508 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479873 204734 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1F 10.1016/s0960-894x(00)00639-9
CHEMBL88164 204734 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1F 10.1016/s0960-894x(00)00639-9
479859 205032 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 10 0 3 5.9 CCc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL90141 205032 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 10 0 3 5.9 CCc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
479847 205249 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91374 205249 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
474165 11167 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179191 11167 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL64163 11167 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
44392147 165738 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 516 11 0 5 5.4 COc1cc(OC)c(OC)cc1CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL427144 165738 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 516 11 0 5 5.4 COc1cc(OC)c(OC)cc1CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728626 90763 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 396 5 3 3 4.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc2ccccc12 10.1016/j.bmcl.2006.09.052
CHEMBL239998 90763 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 396 5 3 3 4.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc2ccccc12 10.1016/j.bmcl.2006.09.052
4716524 87029 4 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233385 87029 4 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
44431965 89452 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL237896 89452 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
474154 11163 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL1179158 11163 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL62611 11163 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
483356 12235 1 None - 0 Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 647 14 0 7 7.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118544 12235 1 None - 0 Human 5.0 pIC50 = 5.0 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 647 14 0 7 7.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
2600 3708 73 None -5 13 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
2608 3708 73 None -5 13 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
5405 3708 73 None -5 13 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
CHEMBL17157 3708 73 None -5 13 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
DB00342 3708 73 None -5 13 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
483332 4801 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnc(-c3ccccc3)n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104464 4801 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnc(-c3ccccc3)n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483343 5034 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 536 11 0 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105659 5034 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 536 11 0 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
516346 130808 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368757 130808 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
155491018 173501 1 None - 1 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 173501 1 None - 1 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
72711281 92246 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
CHEMBL2435901 92246 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
5481712 105411 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL312808 105411 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
16728630 150463 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL395843 150463 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
486595 204198 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL84120 204198 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
5481707 204863 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
CHEMBL88976 204863 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
25205767 7022 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 598 6 0 6 4.9 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085225 7022 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 598 6 0 6 4.9 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46890428 7133 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 599 6 0 7 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@@H]3c3ccccn3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085721 7133 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 599 6 0 7 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@@H]3c3ccccn3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888565 8611 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 499 7 1 5 4.0 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095827 8611 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 499 7 1 5 4.0 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888583 8888 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 557 8 1 5 4.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098357 8888 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 557 8 1 5 4.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
505875 25755 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL135432 25755 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505868 27556 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137072 27556 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44404724 134666 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 564 11 0 5 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(SC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372134 134666 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 564 11 0 5 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(SC)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401763 68275 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL191803 68275 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44401863 69850 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc4c3=O)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL194078 69850 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc4c3=O)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496985 106895 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccncc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL317908 106895 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccncc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
505875 25755 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL135432 25755 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
505868 27556 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137072 27556 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
20664115 179517 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL474838 179517 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
46883029 5695 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 571 7 0 7 4.8 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(=O)oc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078712 5695 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 571 7 0 7 4.8 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(=O)oc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44447735 94685 0 None - 0 Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255646 94685 0 None - 0 Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008930 196993 1 None - 0 Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58004 196993 1 None - 0 Crab-eating macaque 7.9 pIC50 = 7.9 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11692945 76165 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL206088 76165 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516352 167964 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 574 9 2 5 6.2 COc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)[nH]n2)cc1 10.1016/j.bmcl.2003.12.004
CHEMBL435526 167964 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 574 9 2 5 6.2 COc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)[nH]n2)cc1 10.1016/j.bmcl.2003.12.004
490008 205669 2 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 537 7 0 4 5.9 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93961 205669 2 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 537 7 0 4 5.9 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
489594 112246 2 None - 0 Human 6.9 pIC50 = 6.9 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
CHEMBL330528 112246 2 None - 0 Human 6.9 pIC50 = 6.9 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
5481752 106398 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cnc2ccccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL314551 106398 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cnc2ccccc2c1 10.1016/s0960-894x(00)00637-5
5481707 204863 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
CHEMBL88976 204863 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
54580468 60552 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762319 60552 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
44461623 167261 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL430818 167261 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481726 204037 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL82838 204037 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
486608 204212 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 486 10 1 4 3.6 CCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84268 204212 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 486 10 1 4 3.6 CCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478308 110934 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 462 9 0 3 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL327484 110934 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 462 9 0 3 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478418 85172 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282505 85172 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478439 204142 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83773 204142 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
16728630 150463 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL395843 150463 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
77281925 187164 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@](C)(O)C(=O)O)C1=O 10.1021/np060121y
CHEMBL495654 187164 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@](C)(O)C(=O)O)C1=O 10.1021/np060121y
474151 11174 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
CHEMBL1179234 11174 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
CHEMBL65649 11174 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
516346 130808 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368757 130808 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516346 130808 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368757 130808 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
54581478 60543 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 538 6 1 5 5.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2=NOCc3cc(Br)ccc32)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762309 60543 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 538 6 1 5 5.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2=NOCc3cc(Br)ccc32)CC1 10.1016/j.bmcl.2011.02.058
155554273 173631 0 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4548396 173631 0 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.9b00742
44590395 178375 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL470578 178375 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
66768640 120700 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 515 13 6 5 2.6 CCC[C@H](O)[C@H](CNCC1CC1)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577934 120700 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 515 13 6 5 2.6 CCC[C@H](O)[C@H](CNCC1CC1)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
25131901 102794 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 7 0 4 7.2 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084490 102794 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 7 0 4 7.2 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
3011725 70695 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951903 70695 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
44573098 186768 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 496 6 1 7 4.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2nnn[nH]2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL493312 186768 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 496 6 1 7 4.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2nnn[nH]2)CC1 10.1016/j.bmcl.2009.02.014
483347 106888 2 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 621 12 2 5 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL317860 106888 2 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 621 12 2 5 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
46888582 8608 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 507 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095816 8608 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 507 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
11421221 63417 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL180155 63417 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
44565874 178373 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL470512 178373 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44573301 169072 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 554 6 0 6 6.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443730 169072 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 554 6 0 6 6.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC(C)C)CC1 10.1016/j.bmcl.2009.02.014
44573341 187739 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 604 8 0 6 7.5 COC(=O)C(c1cccc(C)c1C)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL500824 187739 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 604 8 0 6 7.5 COC(=O)C(c1cccc(C)c1C)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573252 192490 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 7 0 6 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncco2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL522659 192490 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 7 0 6 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncco2)CC1 10.1016/j.bmcl.2009.02.014
44565874 178373 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470512 178373 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
46880850 7383 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.9 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOCC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087028 7383 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.9 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOCC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
56647076 92226 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 92226 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
516188 60934 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 547 10 1 6 5.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176655 60934 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 547 10 1 6 5.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
73355478 92222 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 92222 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
44590717 188956 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 475 10 1 3 5.0 CCN(C(=O)Cc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL514410 188956 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 475 10 1 3 5.0 CCN(C(=O)Cc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72714078 92230 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 92230 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5482810 106506 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.3 CCN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL315293 106506 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.3 CCN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
44404641 72176 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 637 12 1 5 6.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199119 72176 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 637 12 1 5 6.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
54585384 60541 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 554 9 1 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762307 60541 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 554 9 1 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
11410758 60545 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 589 9 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762312 60545 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 589 9 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
11193076 60630 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 648 9 1 5 7.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C(F)(F)F)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762466 60630 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 648 9 1 5 7.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C(F)(F)F)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
57398009 67515 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 460 6 0 4 4.4 COc1ccc(C)cc1S(=O)(=O)N1CCC(CN2CCC(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.09.013
CHEMBL1910168 67515 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 460 6 0 4 4.4 COc1ccc(C)cc1S(=O)(=O)N1CCC(CN2CCC(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.09.013
16728618 91360 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241251 91360 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
11408704 86560 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL232412 86560 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431953 87850 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234844 87850 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431926 144834 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL391378 144834 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1016/j.bmcl.2007.01.050
479838 111117 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328438 111117 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
11408704 86560 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL232412 86560 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44431953 87850 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234844 87850 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
16728618 91360 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL241251 91360 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
44431926 144834 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL391378 144834 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1007/s00044-012-0118-7
16073664 138207 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(OC)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL378035 138207 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(OC)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
73355478 92222 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 92222 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
52942058 18099 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 511 8 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270594 18099 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 511 8 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
66768099 120698 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 517 13 6 5 2.9 CCC[C@H](O)[C@H](CNCC(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577932 120698 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 517 13 6 5 2.9 CCC[C@H](O)[C@H](CNCC(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
16728643 147256 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL393274 147256 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
76323541 85161 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 367 6 0 2 5.5 CCN(CC)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281971 85161 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 367 6 0 2 5.5 CCN(CC)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11350639 87625 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL234634 87625 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
5481751 106477 1 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1007/s00044-011-9863-2
CHEMBL315084 106477 1 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1007/s00044-011-9863-2
44373973 50880 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL157983 50880 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
44590583 174145 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 517 11 1 4 5.1 CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
CHEMBL456019 174145 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 517 11 1 4 5.1 CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
3002977 2416 70 None -3 2 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
803 2416 70 None -3 2 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
806 2416 70 None -3 2 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
CHEMBL1201187 2416 70 None -3 2 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
CHEMBL256907 2416 70 None -3 2 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
CHEMBL584744 2416 70 None -3 2 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
DB04835 2416 70 None -3 2 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
46888563 8564 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095517 8564 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888524 8788 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 7 1 3 5.4 O=C(N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(Cl)cccc3Cl)C[C@H]2C1)c1ccccc1)C1CCCC1 10.1016/j.bmcl.2010.03.095
CHEMBL1097515 8788 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 7 1 3 5.4 O=C(N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(Cl)cccc3Cl)C[C@H]2C1)c1ccccc1)C1CCCC1 10.1016/j.bmcl.2010.03.095
505865 29051 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138282 29051 1 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44373973 50880 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL157983 50880 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
46882076 5519 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 567 7 0 7 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077358 5519 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 567 7 0 7 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
72714076 92228 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 92228 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 92254 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 92254 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16728643 147256 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL393274 147256 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11444710 60555 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762326 60555 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
54581480 60558 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccnc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
CHEMBL1762330 60558 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccnc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
11490468 60564 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ncccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762336 60564 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ncccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
489811 111002 2 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327800 111002 2 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489812 205329 2 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1cccc(C(=O)N2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL91793 205329 2 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1cccc(C(=O)N2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)c1 10.1016/s0960-894x(01)00545-5
478495 205191 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL91045 205191 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
44392155 65495 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1cccc(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183514 65495 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1cccc(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11350639 87625 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL234634 87625 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11350639 87625 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL234634 87625 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
16728648 90776 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1016/j.bmcl.2006.09.052
CHEMBL240037 90776 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1016/j.bmcl.2006.09.052
10483364 192464 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 7 1 5 5.6 O=C(c1ccco1)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL522493 192464 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 7 1 5 5.6 O=C(c1ccco1)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728788 83009 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
CHEMBL219770 83009 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
16728648 90776 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1007/s00044-012-0118-7
CHEMBL240037 90776 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1007/s00044-012-0118-7
25057602 5685 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 517 7 0 4 6.0 CCCCC1N(Cc2ccccc2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078647 5685 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 517 7 0 4 6.0 CCCCC1N(Cc2ccccc2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44590332 178462 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 7 1 3 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(CNC(=O)C3CC3)(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471403 178462 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 7 1 3 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(CNC(=O)C3CC3)(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2009.01.012
91884571 180868 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 471 5 3 5 2.5 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(C)(C)C)n2)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4764460 180868 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 471 5 3 5 2.5 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(C)(C)C)n2)C1=O 10.1021/acsmedchemlett.1c00082
10053691 192024 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 1 5 5.2 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL521699 192024 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 1 5 5.2 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
11246827 87533 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234206 87533 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
11177360 146720 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
CHEMBL392868 146720 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
478494 204903 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1007/s00044-011-9863-2
CHEMBL89221 204903 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1007/s00044-011-9863-2
76308985 85147 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 570 8 3 3 7.3 Cc1ccc(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)cc1 10.1007/s00044-012-0118-7
CHEMBL2281958 85147 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 570 8 3 3 7.3 Cc1ccc(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)cc1 10.1007/s00044-012-0118-7
5481716 204135 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1007/s00044-011-9863-2
CHEMBL83745 204135 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1007/s00044-011-9863-2
483335 5530 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 13 0 8 5.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(CC#N)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107750 5530 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 13 0 8 5.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(CC#N)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483336 109153 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 562 13 0 9 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc([N+](=O)[O-])c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL322439 109153 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 562 13 0 9 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc([N+](=O)[O-])c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483330 110071 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2ncc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL325357 110071 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2ncc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
46888454 8663 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 419 6 1 3 3.6 CC(=O)N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(C)cccc3C)C[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.03.095
CHEMBL1096446 8663 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 419 6 1 3 3.6 CC(=O)N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(C)cccc3C)C[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.03.095
46888497 8863 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 4 3.6 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098151 8863 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 4 3.6 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
57403931 70689 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 618 12 0 7 3.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951897 70689 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 618 12 0 7 3.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
44454999 97181 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL271075 97181 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1)c1ccccc1 10.1016/j.bmcl.2007.12.058
46882077 5520 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 591 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077359 5520 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 591 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
44461559 103680 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309657 103680 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461521 167286 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL431009 167286 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481703 204067 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83107 204067 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481703 204067 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83107 204067 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
490011 110892 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 495 7 0 4 5.1 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327186 110892 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 495 7 0 4 5.1 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44461559 103680 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309657 103680 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461521 167286 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL431009 167286 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
73346389 92224 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 92224 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
16041594 92194 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 555 8 1 5 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435849 92194 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 555 8 1 5 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
25132254 62518 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784384 62518 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54582110 62537 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm200279v
CHEMBL1784479 62537 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm200279v
25133962 102799 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084495 102799 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
478501 105486 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(00)00637-5
CHEMBL313072 105486 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(00)00637-5
44392130 121849 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 471 9 0 4 5.3 CN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360044 121849 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 471 9 0 4 5.3 CN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11246827 87533 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234206 87533 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
11177360 146720 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
CHEMBL392868 146720 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
44461774 168536 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL440137 168536 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
489835 206060 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 428 6 0 2 5.9 Fc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL96217 206060 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 428 6 0 2 5.9 Fc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
44431969 89517 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 575 8 3 4 6.0 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1ccc(F)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL238118 89517 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 575 8 3 4 6.0 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1ccc(F)cc1 10.1016/j.bmcl.2007.01.050
483360 12191 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 569 14 0 6 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CCC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118501 12191 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 569 14 0 6 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CCC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
3010252 113293 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 585 14 0 7 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL332458 113293 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 585 14 0 7 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44461774 168536 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL440137 168536 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
473305 111797 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 460 6 0 3 5.0 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329131 111797 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 460 6 0 3 5.0 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72714318 92233 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 92233 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
489807 205553 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 438 6 0 2 5.4 O=C(Cc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93229 205553 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 438 6 0 2 5.4 O=C(Cc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
155531379 171029 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 532 7 1 5 2.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](N(C)S(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4465351 171029 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 532 7 1 5 2.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](N(C)S(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
54581070 62527 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 610 7 0 6 6.2 Cc1nc2cc(S(C)(=O)=O)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784399 62527 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 610 7 0 6 6.2 Cc1nc2cc(S(C)(=O)=O)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
23294214 168583 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 7 1 4 6.9 O=C(c1ccccc1)N1CCCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL440465 168583 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 7 1 4 6.9 O=C(c1ccccc1)N1CCCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728619 90196 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL238949 90196 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
483337 5015 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 585 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(Cl)c2Cl)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105572 5015 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 585 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(Cl)c2Cl)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
516345 59491 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172761 59491 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3013673 76591 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
CHEMBL207085 76591 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
516349 59539 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 622 9 1 5 7.8 CCn1nc(-c2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL172944 59539 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 622 9 1 5 7.8 CCn1nc(-c2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
516345 59491 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL172761 59491 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
6320581 122259 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 527 8 0 5 4.8 CN(C[C@@H](CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL360522 122259 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 527 8 0 5 4.8 CN(C[C@@H](CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
72714076 92228 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 92228 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5482811 112315 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 CCN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL330734 112315 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 CCN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
479868 205346 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1cc(C)cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL91892 205346 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1cc(C)cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
5482807 106362 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 560 8 1 4 6.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314486 106362 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 560 8 1 4 6.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
16728619 90196 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL238949 90196 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
11534473 90254 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 14 1 5 8.0 CCN(CC)CCCC(NC(=O)CCOc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1)C(C)C 10.1016/j.bmcl.2006.10.060
CHEMBL239144 90254 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 14 1 5 8.0 CCN(CC)CCCC(NC(=O)CCOc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1)C(C)C 10.1016/j.bmcl.2006.10.060
57400373 70693 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951901 70693 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
42606792 109307 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 517 7 1 5 3.0 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL3233178 109307 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 517 7 1 5 3.0 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
44564931 188909 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 467 8 1 6 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL514000 188909 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 467 8 1 6 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
76319890 85154 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 662 8 3 3 8.3 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281965 85154 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 662 8 3 3 8.3 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
11267381 87389 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233845 87389 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
16728622 90636 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL239783 90636 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728616 91125 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-012-0118-7
CHEMBL240638 91125 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-012-0118-7
16728625 146983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1007/s00044-012-0118-7
CHEMBL393068 146983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1007/s00044-012-0118-7
11690481 83097 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 428 7 1 4 4.5 Cc1nc2ccccc2n1C1[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@H]12 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203618 83097 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 428 7 1 4 4.5 Cc1nc2ccccc2n1C1[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@H]12 10.1111/j.1747-0285.2006.00376.x
10228761 13801 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196469 13801 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL557150 13801 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
490010 206064 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 509 7 0 4 5.5 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL96242 206064 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 509 7 0 4 5.5 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
54581076 62540 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 7 0 5 6.8 COc1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1 10.1021/jm200279v
CHEMBL1784483 62540 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 7 0 5 6.8 COc1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1 10.1021/jm200279v
44590718 174219 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccccc1OC)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL456224 174219 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccccc1OC)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489595 167306 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
CHEMBL431111 167306 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
44431976 146889 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 663 8 3 4 7.2 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL393002 146889 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 663 8 3 4 7.2 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
16728622 90636 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL239783 90636 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
16728616 91125 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2006.09.052
CHEMBL240638 91125 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2006.09.052
16728625 146983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL393068 146983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
11267381 87389 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233845 87389 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
1167892 83011 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
CHEMBL219781 83011 1 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
54587374 60538 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 8 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762303 60538 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 8 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
72714317 92232 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
CHEMBL2435887 92232 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
72711050 92240 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 92240 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44565035 186228 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 7 1 6 3.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489323 186228 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 7 1 6 3.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
54585369 60237 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 568 9 1 5 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1760024 60237 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 568 9 1 5 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
54580093 62536 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1 10.1021/jm200279v
CHEMBL1784478 62536 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1 10.1021/jm200279v
54583049 62521 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 526 5 0 5 5.7 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC(=O)C1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784388 62521 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 526 5 0 5 5.7 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC(=O)C1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
478495 205191 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL91045 205191 1 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
162668957 182168 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 495 5 3 7 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(C)(C)C)nc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4790208 182168 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 495 5 3 7 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(C)(C)C)nc23)C1=O 10.1021/acsmedchemlett.1c00082
25230826 169444 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 582 7 0 7 4.5 CCCCC1CN(S(=O)(=O)c2ccccn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL444255 169444 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 582 7 0 7 4.5 CCCCC1CN(S(=O)(=O)c2ccccn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483345 4889 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104867 4889 1 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
44335765 5350 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107380 5350 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
46888496 8862 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 471 7 1 4 4.5 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccoc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098150 8862 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 471 7 1 4 4.5 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccoc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404643 71863 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198114 71863 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
44392096 131250 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL369311 131250 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
56647023 92225 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 92225 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
44573299 188253 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 555 7 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C(C)C)C(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506788 188253 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 555 7 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C(C)C)C(C)C)CC1 10.1016/j.bmcl.2009.02.014
46882872 5598 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 5.9 CCCCC1N(CC2CCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077989 5598 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 5.9 CCCCC1N(CC2CCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46864993 6144 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081486 6144 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
53321616 58137 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683063 58137 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
68769802 120714 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 493 7 1 6 4.2 COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577949 120714 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 493 7 1 6 4.2 COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
3010256 188663 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511806 188663 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010256 188663 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligandInhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511806 188663 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligandInhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
3010256 188663 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511806 188663 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711278 92243 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 92243 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
15950679 92213 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 92213 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
44392094 165710 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 0 4 5.8 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL426960 165710 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 0 4 5.8 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54586286 60481 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 9 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(CCCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762143 60481 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 9 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(CCCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
5481711 204227 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL84374 204227 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
479872 204746 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)ccc1F 10.1016/s0960-894x(00)00639-9
CHEMBL88219 204746 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)ccc1F 10.1016/s0960-894x(00)00639-9
479852 205059 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90291 205059 1 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392211 122762 4 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 433 7 1 2 5.6 CN(C(=O)NC1CCCCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL361444 122762 4 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 433 7 1 2 5.6 CN(C(=O)NC1CCCCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
72714077 92229 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435884 92229 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
44590944 189280 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1nnc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)o1 10.1016/j.bmcl.2009.01.009
CHEMBL516939 189280 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1nnc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)o1 10.1016/j.bmcl.2009.01.009
44565036 186264 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 481 7 1 6 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCN(C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489512 186264 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 481 7 1 6 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCN(C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
24794656 180284 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 450 4 3 6 2.0 CC(=O)N[C@@H]1C[C@H](N)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4757452 180284 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 450 4 3 6 2.0 CC(=O)N[C@@H]1C[C@H](N)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
9915724 76924 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 12 1 5 5.4 COP(=O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccccc1 10.1016/s0960-894x(02)00829-6
CHEMBL20818 76924 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 12 1 5 5.4 COP(=O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccccc1 10.1016/s0960-894x(02)00829-6
25230771 171985 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 7 0 6 5.1 CCCCC1CN(S(=O)(=O)c2ccccc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL448610 171985 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 7 0 6 5.1 CCCCC1CN(S(=O)(=O)c2ccccc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230773 172240 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 563 7 0 5 5.5 CCCCC1C(=O)N(Cc2ccc(F)cc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL451400 172240 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 563 7 0 5 5.5 CCCCC1C(=O)N(Cc2ccc(F)cc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44570267 176856 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 587 7 0 6 4.6 CCCC[C@H]1CN(S(=O)(=O)CC(F)(F)F)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL463874 176856 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 587 7 0 6 4.6 CCCC[C@H]1CN(S(=O)(=O)CC(F)(F)F)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888544 8673 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 464 7 1 5 3.7 Cc1noc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096486 8673 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 464 7 1 5 3.7 Cc1noc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404650 133017 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 570 10 0 4 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370998 133017 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 570 10 0 4 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
52942071 18130 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 547 8 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270798 18130 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 547 8 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
5275764 75668 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205706 75668 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
44325489 106486 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 474 5 0 2 6.6 O=C(c1cccc2ccccc12)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL315159 106486 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 474 5 0 2 6.6 O=C(c1cccc2ccccc12)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489825 205706 2 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 416 5 0 2 5.3 O=C(C1CCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL94179 205706 2 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 416 5 0 2 5.3 O=C(C1CCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72711507 92248 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 92248 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
72711047 92237 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 92237 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
59458103 92251 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 92251 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72713860 92258 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 92258 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
478452 85169 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282502 85169 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478448 103649 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309447 103649 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461522 203653 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79907 203653 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
54580081 62529 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 0 5 6.2 Cc1nc2cccnc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784401 62529 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 0 5 6.2 Cc1nc2cccnc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
25132255 102798 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 524 6 0 4 6.7 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C2CCCC2)CC1 10.1021/jm800598a
CHEMBL3084494 102798 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 524 6 0 4 6.7 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C2CCCC2)CC1 10.1021/jm800598a
68772423 171388 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 541 7 1 7 3.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4470701 171388 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 541 7 1 7 3.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
44392159 62572 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 445 7 1 2 6.0 CN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL178477 62572 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 445 7 1 2 6.0 CN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11353001 58485 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 58485 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
11753754 60557 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccnc1OC(c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762329 60557 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccnc1OC(c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
44392144 64863 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccccc1F)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182557 64863 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccccc1F)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728610 152157 6 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1016/j.bmcl.2006.09.052
CHEMBL397295 152157 6 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1016/j.bmcl.2006.09.052
16728610 152157 6 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1007/s00044-012-0118-7
CHEMBL397295 152157 6 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1007/s00044-012-0118-7
72714319 92234 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 92234 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
72712374 92219 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 92219 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
9869601 91332 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL241097 91332 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44565559 189166 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL516027 189166 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
54581071 62531 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 8 0 5 6.9 CCOc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784403 62531 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 8 0 5 6.9 CCOc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
23294208 96687 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 6.8 O=C1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL26790 96687 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 6.8 O=C1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
25131900 102792 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 610 6 0 5 8.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084488 102792 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 610 6 0 5 8.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
16728614 91124 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL240637 91124 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728649 168424 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1007/s00044-012-0118-7
CHEMBL439223 168424 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1007/s00044-012-0118-7
5481726 204037 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL82838 204037 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489308 5202 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 587 13 0 5 7.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
CHEMBL106569 5202 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 587 13 0 5 7.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
42623163 178284 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 8 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL469724 178284 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 8 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489338 5089 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 655 12 2 5 6.6 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL105975 5089 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 655 12 2 5 6.6 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
496975 108045 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 546 12 2 4 6.1 O=C(O)CCc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL320149 108045 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 546 12 2 4 6.1 O=C(O)CCc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
25256856 192672 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 510 5 0 6 5.4 CO/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL524001 192672 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 510 5 0 6 5.4 CO/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11503459 83095 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203615 83095 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
501052 106938 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318210 106938 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010263 188625 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511494 188625 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447731 94643 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255430 94643 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008902 200984 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61536 200984 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 3673 8 None 3 2 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 3673 8 None 3 2 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 3673 8 None 3 2 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
501052 106938 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318210 106938 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
483382 79130 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL2114184 79130 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461684 104407 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 604 14 0 6 5.1 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311248 104407 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 604 14 0 6 5.1 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
21147749 104804 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311549 104804 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
486606 203622 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79622 203622 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486601 203844 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81252 203844 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
44461707 203941 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82048 203941 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
11467704 204098 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83335 204098 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5275829 204299 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL85086 204299 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415800 80096 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL214818 80096 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
3010263 188625 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511494 188625 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
6320582 62916 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179141 62916 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
6320585 62928 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179209 62928 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
5275829 204299 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL85086 204299 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
516182 59297 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 614 10 1 5 6.7 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172019 59297 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 614 10 1 5 6.7 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516277 130848 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 10 1 6 7.2 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368979 130848 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 10 1 6 7.2 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516172 119866 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353331 119866 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
490017 167268 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 517 8 0 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL430867 167268 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 517 8 0 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490014 205647 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 559 8 0 4 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93851 205647 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 559 8 0 4 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
516354 187643 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL499483 187643 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516354 187643 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL499483 187643 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44383787 58976 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C(F)(F)c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL170543 58976 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C(F)(F)c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516206 59406 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172436 59406 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516172 119866 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL353331 119866 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516325 59465 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL172659 59465 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516325 59465 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL172659 59465 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
11636141 103056 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085310 103056 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
3008928 200961 1 None - 0 Crab-eating macaque 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61424 200961 1 None - 0 Crab-eating macaque 8.7 pIC50 = 8.7 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3013701 76726 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207487 76726 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
516353 129645 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 600 11 1 5 6.8 CCn1nc(CCc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367838 129645 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 600 11 1 5 6.8 CCn1nc(CCc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
516325 59465 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL172659 59465 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516177 129250 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367529 129250 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474170 11159 2 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179149 11159 2 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL62339 11159 2 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
44404705 71692 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197641 71692 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2005.08.014
516339 127935 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL366626 127935 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
3008927 197170 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58387 197170 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
516339 127935 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL366626 127935 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
516263 61025 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 9 1 5 8.1 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176859 61025 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 9 1 5 8.1 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516303 61343 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 664 11 1 7 6.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177157 61343 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 664 11 1 7 6.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516174 130918 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 552 10 1 5 6.2 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369151 130918 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 552 10 1 5 6.2 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516339 127935 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL366626 127935 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
44590683 174999 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457960 174999 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
68764898 664 1 None - 3 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
9430 664 1 None - 3 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL3577945 664 1 None - 3 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
3011734 70699 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 12 0 6 4.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951907 70699 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 12 0 6 4.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
11650548 103054 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085308 103054 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
68764898 664 1 None - 3 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
9430 664 1 None - 3 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
CHEMBL3577945 664 1 None - 3 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
486601 203844 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL81252 203844 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2003.12.004
10008665 167912 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3O[C@H](c4ccccc4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL435259 167912 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3O[C@H](c4ccccc4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
20664156 124082 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL364070 124082 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
20664156 124082 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL364070 124082 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711047 92237 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 92237 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
478445 203610 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 576 13 1 4 5.6 CCCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79530 203610 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 576 13 1 4 5.6 CCCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
3500 1493 9 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
491774 1493 9 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
CHEMBL1196395 1493 9 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
478440 103771 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL309922 103771 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL3109173 209331 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL None None None Cc1nnc(CCCCCCCCCCn2cc(COCCOCCOCCOCCOCc3ccc(C(=O)N4CCC4=O)cc3)nn2)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
44401686 69676 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 9 1 5 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193972 69676 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 9 1 5 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
3008917 201087 4 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL62152 201087 4 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
516254 128145 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366871 128145 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516179 130150 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368333 130150 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516241 78487 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 5.5 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(CN)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL2112951 78487 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 5.5 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(CN)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
20664163 168073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL436290 168073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
20664163 168073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL436290 168073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
20664163 168073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL436290 168073 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008904 198273 1 None - 0 Crab-eating macaque 8.6 pIC50 = 8.6 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL59511 198273 1 None - 0 Crab-eating macaque 8.6 pIC50 = 8.6 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11570778 140375 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL382252 140375 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516364 59437 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 528 10 1 5 5.5 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172551 59437 1 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 528 10 1 5 5.5 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
16663418 10697 15 None - 0 Mouse 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.ejmech.2018.01.085
CHEMBL1172035 10697 15 None - 0 Mouse 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.ejmech.2018.01.085
3008930 196993 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58004 196993 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11585418 75643 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205539 75643 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516363 59059 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 542 11 1 5 5.9 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL170892 59059 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 542 11 1 5 5.9 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
501053 4508 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102675 4508 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501059 107020 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318681 107020 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496971 107064 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL318909 107064 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
516328 127579 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366536 127579 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516332 130138 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368265 130138 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565791 180158 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475606 180158 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44336415 167425 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 524 9 1 5 5.0 O=S(=O)(c1cccs1)N1CC(CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL432010 167425 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 524 9 1 5 5.0 O=S(=O)(c1cccs1)N1CC(CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
46890342 7021 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 6 1 6 4.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085224 7021 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 6 1 6 4.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
25205766 7025 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085229 7025 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888581 8607 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 511 8 1 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095815 8607 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 511 8 1 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
16073667 96362 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL265131 96362 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2F)CC1 10.1016/j.bmcl.2006.03.089
16073665 138040 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 664 11 0 6 5.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(F)(F)F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL377551 138040 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 664 11 0 6 5.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(F)(F)F)c2)CC1 10.1016/j.bmcl.2006.03.089
15958353 83094 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203614 83094 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
516338 59077 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL170987 59077 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
44455144 97449 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272490 97449 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
52918140 60566 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762338 60566 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478448 103649 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309447 103649 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461522 203653 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79907 203653 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461835 204031 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82786 204031 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415740 79757 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 458 9 1 5 4.9 O=C(N[C@@H](CCN1CCC(c2noc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
CHEMBL213541 79757 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 458 9 1 5 4.9 O=C(N[C@@H](CCN1CCC(c2noc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
11693007 75893 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205851 75893 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
10277467 12958 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL1190217 12958 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL540366 12958 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
516338 59077 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL170987 59077 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
489324 107736 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 555 8 1 4 5.6 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](Cc4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
CHEMBL319697 107736 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 555 8 1 4 5.6 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](Cc4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
44404638 132208 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 533 10 1 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(N)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL369947 132208 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 533 10 1 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(N)cc2)CC1 10.1016/j.bmcl.2005.08.014
44404730 140348 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 605 12 1 6 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NOC(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL382079 140348 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 605 12 1 6 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NOC(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401608 123792 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL363564 123792 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
9869601 91332 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241097 91332 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44565559 189166 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL516027 189166 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
478409 204178 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83963 204178 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481866 111102 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 566 8 0 6 4.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328339 111102 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 566 8 0 6 4.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479865 205372 2 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1 10.1016/s0960-894x(00)00639-9
CHEMBL92094 205372 2 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1 10.1016/s0960-894x(00)00639-9
457679 168738 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 7 0 2 5.8 c1ccc(CCN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL441635 168738 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 7 0 2 5.8 c1ccc(CCN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
16728614 91124 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL240637 91124 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
16728649 168424 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL439223 168424 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1016/j.bmcl.2006.09.052
479837 204997 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89929 204997 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
10445499 178300 1 None - 0 Human 4.7 pIC50 = 4.7 Binding
Inhibition of MIP1alpha binding to human CCR5 receptorInhibition of MIP1alpha binding to human CCR5 receptor
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np049974l
CHEMBL469856 178300 1 None - 0 Human 4.7 pIC50 = 4.7 Binding
Inhibition of MIP1alpha binding to human CCR5 receptorInhibition of MIP1alpha binding to human CCR5 receptor
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np049974l
53326702 58145 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683071 58145 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
53326701 58142 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683068 58142 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
72712160 92214 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 92214 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
10416552 187855 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 628 8 1 6 4.7 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
CHEMBL502593 187855 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 628 8 1 6 4.7 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
53324141 58144 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683070 58144 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
76312665 85145 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 520 7 1 4 5.7 CC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281956 85145 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 520 7 1 4 5.7 CC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
25206070 7026 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 584 5 0 6 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085231 7026 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 584 5 0 6 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44356876 27818 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137272 27818 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
16073663 77429 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2ccc(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL209251 77429 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2ccc(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
44573297 186634 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 499 5 0 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492544 186634 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 499 5 0 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C)C)CC1 10.1016/j.bmcl.2009.02.014
6320585 62928 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179209 62928 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44590945 175818 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
CHEMBL459599 175818 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
11656080 83099 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 488 7 1 5 5.5 Cc1nc2ccccc2n1[C@@H]1C[C@H]2CSC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203620 83099 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 488 7 1 5 5.5 Cc1nc2ccccc2n1[C@@H]1C[C@H]2CSC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
516344 127287 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366450 127287 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44431967 145502 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 521 7 1 5 4.3 CN1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL391886 145502 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 521 7 1 5 4.3 CN1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
44392131 65476 3 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 453 9 1 2 6.4 C=CCN(C(=O)Nc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183492 65476 3 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 453 9 1 2 6.4 C=CCN(C(=O)Nc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54682467 188684 24 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 276 0 1 5 2.1 CC1OC(=O)C=C2C3=C(OC(C)(C)CC3)C(=O)C(O)=C21 10.1021/np030146m
CHEMBL512035 188684 24 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 276 0 1 5 2.1 CC1OC(=O)C=C2C3=C(OC(C)(C)CC3)C(=O)C(O)=C21 10.1021/np030146m
53325088 58488 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 531 3 1 6 3.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H]3c4ccc(C(F)(F)F)cc4C[C@H]3O)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688241 58488 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 531 3 1 6 3.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H]3c4ccc(C(F)(F)F)cc4C[C@H]3O)[C@@H](C)C2)CC1 10.1021/ml1001536
53389902 171922 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 349 3 2 5 2.8 Nc1nc2[nH]c(C3CC3)c(Cc3ccc(Cl)c(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4483373 171922 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 349 3 2 5 2.8 Nc1nc2[nH]c(C3CC3)c(Cc3ccc(Cl)c(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
54583459 60542 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 566 9 1 5 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(CCNC(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762308 60542 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 566 9 1 5 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(CCNC(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/j.bmcl.2011.02.058
72712161 92215 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 92215 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
25230770 188176 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 577 6 0 6 5.1 CCCCC1CN(C(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL505595 188176 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 577 6 0 6 5.1 CCCCC1CN(C(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
52949128 17944 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 607 7 0 6 4.3 Cc1cccc(Cl)c1S(=O)(=O)C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1269386 17944 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 607 7 0 6 4.3 Cc1cccc(Cl)c1S(=O)(=O)C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25230898 173419 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 589 7 0 7 4.2 CCCCC1CN(S(=O)(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL454253 173419 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 589 7 0 7 4.2 CCCCC1CN(S(=O)(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230827 183417 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 7 0 6 4.2 CCCCC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL481980 183417 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 7 0 6 4.2 CCCCC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44404642 132893 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 617 11 1 5 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)C(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370552 132893 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 617 11 1 5 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)C(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
72714321 92236 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 92236 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
516344 127287 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366450 127287 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
46883028 5722 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 495 5 0 6 4.3 CCCC[C@H]1CN(C)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078937 5722 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 495 5 0 6 4.3 CCCC[C@H]1CN(C)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
68767078 120710 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 457 7 1 5 5.0 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(Cl)cc23)C1=O 10.1021/ml500505q
CHEMBL3577944 120710 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 457 7 1 5 5.0 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(Cl)cc23)C1=O 10.1021/ml500505q
57656833 74864 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human CCR5 by FLIPR analysisInhibition of human CCR5 by FLIPR analysis
ChEMBL 427 3 2 4 2.4 CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.04.118
CHEMBL2036782 74864 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human CCR5 by FLIPR analysisInhibition of human CCR5 by FLIPR analysis
ChEMBL 427 3 2 4 2.4 CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.04.118
516344 127287 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL366450 127287 1 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
44325917 155760 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 553 7 0 4 6.4 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL406552 155760 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 553 7 0 4 6.4 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44325710 205363 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 541 11 0 5 5.2 COC(=O)N(CC1CCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL92013 205363 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 541 11 0 5 5.2 COC(=O)N(CC1CCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
53321427 58143 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683069 58143 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
54580469 60560 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762332 60560 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
11570431 91536 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 564 13 1 4 7.9 CCN(CC)CCCC(C)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
CHEMBL241502 91536 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 564 13 1 4 7.9 CCN(CC)CCCC(C)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
44325511 112062 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 7 0 3 7.5 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3cccc(-c4ccsc4)c3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL330065 112062 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 7 0 3 7.5 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3cccc(-c4ccsc4)c3)C2)cc1 10.1016/s0960-894x(01)00545-5
44392092 63297 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1cccc(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180095 63297 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1cccc(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54580080 62520 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 1 4 6.3 Cc1nc2ccccc2n1C1CC2CCC(C1)C2NCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784386 62520 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 1 4 6.3 Cc1nc2ccccc2n1C1CC2CCC(C1)C2NCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
3258407 84466 19 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
CHEMBL223686 84466 19 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
57396949 70687 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 568 10 0 6 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951895 70687 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 568 10 0 6 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
483334 108083 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 593 13 0 7 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(-c3ccccc3)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL320365 108083 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 593 13 0 7 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(-c3ccccc3)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
505873 27723 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137206 27723 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44401985 71057 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195930 71057 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44573339 172862 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 602 8 1 6 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc(Cl)s2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL452913 172862 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 602 8 1 6 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc(Cl)s2)CC1 10.1016/j.bmcl.2009.02.014
44573300 192600 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 526 5 0 6 6.1 CS/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL523512 192600 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 526 5 0 6 6.1 CS/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
505873 27723 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137206 27723 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401985 71057 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195930 71057 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010258 178511 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471722 178511 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
46882082 5525 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 623 9 0 7 6.0 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC(C)C)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077364 5525 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 623 9 0 7 6.0 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC(C)C)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
53324304 58141 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683067 58141 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
3010258 178511 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471722 178511 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516340 59478 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL172721 59478 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
44384012 161100 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 10 1 6 6.1 CCn1ncc(C(=O)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL413058 161100 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 10 1 6 6.1 CCn1ncc(C(=O)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
505873 27723 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137206 27723 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401985 71057 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195930 71057 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010258 178511 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471722 178511 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
5482808 204911 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 576 8 1 4 5.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL89251 204911 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 576 8 1 4 5.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
44392093 63147 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 502 9 0 2 7.0 CN(C(=O)Cc1ccc(-c2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179950 63147 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 502 9 0 2 7.0 CN(C(=O)Cc1ccc(-c2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483361 95952 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL261935 95952 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44590864 176135 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 472 8 2 4 4.9 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(n2cc(-c3ccccc3)[nH]c2=O)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460009 176135 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 472 8 2 4 4.9 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(n2cc(-c3ccccc3)[nH]c2=O)CC1 10.1016/j.bmcl.2009.01.009
3117 206096 100 None -8 16 Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 206096 100 None -8 16 Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
25132945 171891 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 642 8 1 6 5.1 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)CC1)CC2 10.1021/jm800598a
CHEMBL448199 171891 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 642 8 1 6 5.1 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)CC1)CC2 10.1021/jm800598a
5481714 203615 1 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79566 203615 1 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44590704 189877 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CCC(N(C)C2CN(C(c3ccccc3)c3ccccc3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL517893 189877 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CCC(N(C)C2CN(C(c3ccccc3)c3ccccc3)C2)CC1 10.1016/j.bmcl.2009.01.012
46890427 6506 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 514 4 0 5 4.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1083126 6506 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 514 4 0 5 4.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44573298 188429 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 7 0 4 6.4 CCN(CC)C(=O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL509179 188429 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 7 0 4 6.4 CCN(CC)C(=O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
10186729 13825 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 13825 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL557789 13825 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
46882873 5610 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 525 7 0 5 5.2 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078072 5610 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 525 7 0 5 5.2 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46883027 5694 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 579 7 0 7 5.1 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078711 5694 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 579 7 0 7 5.1 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
501048 109122 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322232 109122 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44392196 65248 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 481 10 1 2 6.4 C=CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183261 65248 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 481 10 1 2 6.4 C=CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
474155 11935 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
CHEMBL1183547 11935 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
CHEMBL303964 11935 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
5482456 203593 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL79369 203593 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
483352 112374 2 None - 0 Human 4.6 pIC50 = 4.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL331007 112374 2 None - 0 Human 4.6 pIC50 = 4.6 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
483341 108694 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 550 12 0 5 7.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL321539 108694 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 550 12 0 5 7.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44590222 178521 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 419 5 1 3 3.7 CC(=O)NC(c1ccccc1)C1CN(C2CCN(C(=O)c3c(C)cccc3C)CC2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL471844 178521 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 419 5 1 3 3.7 CC(=O)NC(c1ccccc1)C1CN(C2CCN(C(=O)c3c(C)cccc3C)CC2)C1 10.1016/j.bmcl.2009.01.012
489312 4834 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 508 9 0 4 5.9 O=S(=O)(c1cccs1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL104628 4834 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 508 9 0 4 5.9 O=S(=O)(c1cccs1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
25230829 182643 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 519 6 0 6 3.6 CCCCC1CN(S(C)(=O)=O)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL479627 182643 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 519 6 0 6 3.6 CCCCC1CN(S(C)(=O)=O)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483339 4802 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 522 11 0 5 6.5 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104474 4802 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 522 11 0 5 6.5 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
489331 5171 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL106381 5171 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
46890429 7134 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 641 8 0 7 5.5 CCO[C@H]1CC[C@H](CN2C[C@H](c3ccccn3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085722 7134 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 641 8 0 7 5.5 CCO[C@H]1CC[C@H](CN2C[C@H](c3ccccn3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888604 8463 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 8 1 5 4.4 Cc1nc(Cl)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1094518 8463 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 8 1 5 4.4 Cc1nc(Cl)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
16073666 78040 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 650 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)c(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211175 78040 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 650 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)c(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
16073674 79474 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212408 79474 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2006.03.089
11520480 103058 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.3 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085312 103058 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.3 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CCC)cc1 10.1021/jm0509703
44555481 5625 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078231 5625 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
11342841 5698 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078723 5698 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882078 5521 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 581 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077360 5521 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 581 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
44461561 203656 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79930 203656 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478410 204176 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83957 204176 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
474157 11161 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
CHEMBL1179155 11161 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
CHEMBL62549 11161 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
44590800 176208 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 3 5.7 CCN(C(=O)c1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460629 176208 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 3 5.7 CCN(C(=O)c1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72711048 92238 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 92238 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
489328 4935 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 515 9 1 3 5.9 O=C1N[C@H](Cc2ccccc2)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL105109 4935 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 515 9 1 3 5.9 O=C1N[C@H](Cc2ccccc2)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
478413 203661 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79958 203661 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44415756 79378 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 471 9 1 5 4.9 Cc1nnc(Cc2ccccc2)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL212017 79378 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 471 9 1 5 4.9 Cc1nnc(Cc2ccccc2)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
478409 204178 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83963 204178 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478410 204176 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83957 204176 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
70848 204935 105 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204935 105 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
54585963 62525 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 7 1 5 6.5 CNc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784397 62525 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 7 1 5 6.5 CNc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54580082 62530 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 548 7 0 5 6.5 COc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784402 62530 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 548 7 0 5 6.5 COc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54581068 62522 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 6 0 4 5.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(N2C(=O)c4ccccc4C2=O)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784391 62522 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 6 0 4 5.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(N2C(=O)c4ccccc4C2=O)C3)(c2ccccc2)CC1 10.1021/jm200279v
70848 204935 105 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204935 105 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
456374 205013 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 410 6 0 2 5.8 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL90015 205013 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 410 6 0 2 5.8 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
54582104 62524 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 1 5 6.1 Nc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784396 62524 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 1 5 6.1 Nc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
489594 112246 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
CHEMBL330528 112246 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
46890340 7014 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 654 6 1 6 4.6 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085217 7014 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 654 6 1 6 4.6 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
25206071 7016 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 631 6 0 7 4.5 COC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085219 7016 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 631 6 0 7 4.5 COC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888526 8828 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 503 8 1 4 4.8 COc1cc(C)c(C(=O)N2C[C@@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@@H]3C2)c(C)c1 10.1016/j.bmcl.2010.03.095
CHEMBL1097816 8828 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 503 8 1 4 4.8 COc1cc(C)c(C(=O)N2C[C@@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@@H]3C2)c(C)c1 10.1016/j.bmcl.2010.03.095
44404639 71993 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 575 11 1 5 5.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(C)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198497 71993 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 575 11 1 5 5.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(C)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
489594 112246 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL330528 112246 2 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
53325639 58147 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683073 58147 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
3010257 178370 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470507 178370 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44404710 72068 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 561 11 1 5 4.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198777 72068 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 561 11 1 5 4.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
478399 204151 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83818 204151 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
489820 110920 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 425 5 0 3 4.8 O=C(c1cccnc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327354 110920 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 425 5 0 3 4.8 O=C(c1cccnc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392132 65748 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183875 65748 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
5481747 111050 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1007/s00044-011-9863-2
CHEMBL328025 111050 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1007/s00044-011-9863-2
44532866 188202 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 615 6 1 4 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)Nc2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL505908 188202 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 615 6 1 4 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)Nc2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2009.02.014
478493 205056 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL90272 205056 1 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
44373672 52166 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL159097 52166 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
76317476 104295 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 996 35 1 15 8.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCn1cc(COCCOCCOCCOCCOCc2ccc(C(=O)N3CCC3=O)cc2)nn1)c1ccccc1 10.1021/ml400370w
CHEMBL3109174 104295 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 996 35 1 15 8.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCn1cc(COCCOCCOCCOCCOCc2ccc(C(=O)N3CCC3=O)cc2)nn1)c1ccccc1 10.1021/ml400370w
25230899 172148 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 585 7 0 8 3.8 CCCCC1CN(S(=O)(=O)c2cn(C)cn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL450639 172148 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 585 7 0 8 3.8 CCCCC1CN(S(=O)(=O)c2cn(C)cn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483331 5140 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cc3ccccc3n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL106231 5140 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cc3ccccc3n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
25205921 7024 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)CC3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085228 7024 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)CC3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888566 8844 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 8 1 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098014 8844 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 8 1 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
3010257 178370 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470507 178370 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44431986 166774 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 617 10 3 6 5.8 COc1cccc(OC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL429442 166774 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 617 10 3 6 5.8 COc1cccc(OC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44455031 154612 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
CHEMBL402242 154612 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
44555482 5697 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 589 7 0 6 6.0 CCCC[C@H]1CN(CC2CCC(F)(F)CC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078714 5697 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 589 7 0 6 6.0 CCCC[C@H]1CN(CC2CCC(F)(F)CC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882083 5526 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 621 9 0 7 5.8 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC3CC3)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077365 5526 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 621 9 0 7 5.8 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC3CC3)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
3010257 178370 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL470507 178370 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
72713860 92258 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 92258 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5481859 203637 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79716 203637 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481861 167430 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL432040 167430 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5481859 203637 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL79716 203637 1 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392136 64493 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1cc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1 10.1016/j.bmcl.2004.10.044
CHEMBL182010 64493 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1cc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1 10.1016/j.bmcl.2004.10.044
44455103 155192 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL405634 155192 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
44455177 160470 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 9 1 5 4.9 CCCNC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL411640 160470 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 9 1 5 4.9 CCCNC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
53389637 169990 0 None - 1 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 317 3 2 5 2.4 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4450273 169990 0 None - 1 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 317 3 2 5 2.4 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
72712372 92217 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
CHEMBL2435872 92217 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
44431944 87650 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234672 87650 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
483338 5024 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 518 12 0 8 4.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cncn2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105606 5024 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 518 12 0 8 4.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cncn2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44404702 71716 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 532 10 0 4 5.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197714 71716 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 532 10 0 4 5.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C)cc2)CC1 10.1016/j.bmcl.2005.08.014
16728784 12673 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188107 12673 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL535172 12673 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
5275840 64538 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 483 8 0 4 3.6 CN1C(=O)CCC2CN(CC[C@](C)(CN(C)S(=O)(=O)c3ccccc3)c3ccccc3)CCC21 10.1016/j.bmcl.2004.12.044
CHEMBL182188 64538 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 483 8 0 4 3.6 CN1C(=O)CCC2CN(CC[C@](C)(CN(C)S(=O)(=O)c3ccccc3)c3ccccc3)CCC21 10.1016/j.bmcl.2004.12.044
44564984 186466 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 508 8 1 6 4.2 CC(=O)N1CCC(C(=O)N[C@@H](CC(C)N2CCC(n3c(C)nnc3C(C)C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491154 186466 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 508 8 1 6 4.2 CC(=O)N1CCC(C(=O)N[C@@H](CC(C)N2CCC(n3c(C)nnc3C(C)C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
56647023 92225 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 92225 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
44565558 178654 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472799 178654 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44431944 87650 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234672 87650 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
52948162 18187 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 531 8 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(C(=O)CC(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271310 18187 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 531 8 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(C(=O)CC(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
11669935 58131 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 467 5 1 4 4.3 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](NC2CCOCC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683055 58131 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 467 5 1 4 4.3 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](NC2CCOCC2)C1 10.1016/j.bmcl.2011.01.015
52949601 17989 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 515 7 0 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1269884 17989 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 515 7 0 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
57392726 67514 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910167 67514 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
154572822 170525 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 542 7 2 7 2.8 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4457723 170525 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 542 7 2 7 2.8 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
16728624 89859 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1007/s00044-012-0118-7
CHEMBL238546 89859 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1007/s00044-012-0118-7
44565558 178654 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL472799 178654 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
16728785 12706 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 12706 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536298 12706 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44565558 178654 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472799 178654 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44455072 95128 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
CHEMBL257728 95128 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
25133964 102802 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 5 0 5 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084498 102802 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 5 0 5 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
44374086 54681 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL161594 54681 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
44392117 64891 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 510 9 0 3 6.3 CN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182684 64891 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 510 9 0 3 6.3 CN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54583458 60539 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 530 9 1 5 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762304 60539 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 530 9 1 5 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
16728624 89859 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL238546 89859 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
162657824 180534 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 482 5 3 4 2.9 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(F)(F)F)c2)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4760566 180534 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 482 5 3 4 2.9 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(F)(F)F)c2)C1=O 10.1021/acsmedchemlett.1c00082
72711279 92244 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
CHEMBL2435899 92244 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
5481715 103916 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL310305 103916 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489306 5092 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 510 12 0 4 6.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL105987 5092 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 510 12 0 4 6.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL3109172 209330 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL None None None Cc1nnc(CCCCCCCCCCn2cc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCNC(=O)OC(C)(C)C)cc3)nn2)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
11285792 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
801 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
CHEMBL2110727 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
DB11758 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
44590439 178582 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(Cc3ccccc3)C(=O)C3CCC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL472260 178582 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(Cc3ccccc3)C(=O)C3CCC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
489342 5309 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 667 13 2 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL107128 5309 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 667 13 2 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
46888478 8707 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 487 7 1 3 5.1 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096764 8707 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 487 7 1 3 5.1 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
3002977 2416 70 None -3 2 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
803 2416 70 None -3 2 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
806 2416 70 None -3 2 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
CHEMBL1201187 2416 70 None -3 2 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
CHEMBL256907 2416 70 None -3 2 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
CHEMBL584744 2416 70 None -3 2 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
DB04835 2416 70 None -3 2 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
44565791 180158 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL475606 180158 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
496971 107064 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
CHEMBL318909 107064 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
44573253 186671 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 0 5 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ccco2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492728 186671 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 0 5 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ccco2)CC1 10.1016/j.bmcl.2009.02.014
10438399 188353 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1C 10.1016/j.bmcl.2009.02.014
CHEMBL508114 188353 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1C 10.1016/j.bmcl.2009.02.014
10030170 188469 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 538 6 0 6 6.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL509665 188469 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 538 6 0 6 6.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC(C)C)CC1 10.1016/j.bmcl.2009.02.014
3009355 3914 21 None - 1 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
807 3914 21 None - 1 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
CHEMBL82301 3914 21 None - 1 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
DB06652 3914 21 None - 1 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
501053 4508 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102675 4508 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501059 107020 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318681 107020 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496971 107064 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL318909 107064 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
516328 127579 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366536 127579 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516332 130138 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368265 130138 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565791 180158 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475606 180158 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
3008913 101493 1 None - 0 Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL301454 101493 1 None - 0 Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501053 4508 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102675 4508 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501059 107020 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318681 107020 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461275 104414 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311261 104414 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486607 203843 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81245 203843 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
44461817 204059 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83057 204059 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461699 204153 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83823 204153 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
68764925 120711 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 477 6 1 5 4.9 CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577946 120711 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 477 6 1 5 4.9 CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
516328 127579 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL366536 127579 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516332 130138 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368265 130138 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
478450 85167 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282500 85167 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461275 104414 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL311261 104414 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
486606 203622 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79622 203622 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461699 204153 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83823 204153 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
49871007 58490 9 None - 1 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm300682j
CHEMBL1688243 58490 9 None - 1 Human 8.5 pIC50 = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm300682j
57395178 70686 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 620 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951894 70686 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 620 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2011.12.117
11285792 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 864 30 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
516184 59292 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172004 59292 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474161 11153 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179115 11153 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL61208 11153 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
44564887 178949 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 425 8 1 5 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL474154 178949 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 425 8 1 5 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44590752 176314 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461689 176314 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44564886 189070 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 9 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL515261 189070 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 9 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44447734 94683 0 None - 0 Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255644 94683 0 None - 0 Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
11577846 76752 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207654 76752 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516183 129669 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 682 10 1 5 7.7 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367901 129669 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 682 10 1 5 7.7 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3008929 193954 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL556314 193954 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3013689 76673 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207190 76673 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
474163 11917 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
CHEMBL1183396 11917 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
CHEMBL294788 11917 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
44590753 175770 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 511 9 1 4 6.1 CCN(C(=O)Oc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459567 175770 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 511 9 1 4 6.1 CCN(C(=O)Oc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3008929 193954 1 None - 0 Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL556314 193954 1 None - 0 Crab-eating macaque 8.5 pIC50 = 8.5 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
68767049 120708 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 553 9 3 4 4.9 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NCC)C1=O 10.1021/ml500505q
CHEMBL3577942 120708 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 553 9 3 4 4.9 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NCC)C1=O 10.1021/ml500505q
44565557 178653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472798 178653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565557 178653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL472798 178653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
57393451 70707 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C(F)(F)F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951918 70707 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C(F)(F)F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16659334 13876 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 13876 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL559168 13876 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44565557 178653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472798 178653 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
5275766 3669 33 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
800 3669 33 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
CHEMBL207004 3669 33 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
516186 59712 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 624 11 1 7 5.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173630 59712 1 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 624 11 1 7 5.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44565674 178106 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL468150 178106 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
51039119 175633 29 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in human peripheral T cellsDisplacement of [125I]MIP-1beta from CCR5 in human peripheral T cells
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 175633 29 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in human peripheral T cellsDisplacement of [125I]MIP-1beta from CCR5 in human peripheral T cells
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
44565674 178106 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL468150 178106 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447732 154550 0 None - 0 Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL401929 154550 0 None - 0 Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
501044 4308 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL101333 4308 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44389412 62167 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(C[C@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL178189 62167 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(C[C@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44590798 190389 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 4 5.5 CCN(C(=O)Oc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518640 190389 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 4 5.5 CCN(C(=O)Oc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44565721 188103 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL504250 188103 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274022 98326 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 11 1 5 5.6 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC3(c4ccc(F)cc4)OCCO3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278383 98326 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 11 1 5 5.6 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC3(c4ccc(F)cc4)OCCO3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44565721 188103 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL504250 188103 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44590684 175084 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 489 10 1 3 5.3 CCN(C(=O)Cc1ccc(C)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL458157 175084 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 489 10 1 3 5.3 CCN(C(=O)Cc1ccc(C)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3010269 178515 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471766 178515 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711508 92250 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435905 92250 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5275765 137693 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL377026 137693 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
3010269 178515 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471766 178515 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
474169 11156 2 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179143 11156 2 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL62180 11156 2 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
3010269 178515 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471766 178515 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
505878 118670 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343160 118670 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
11353001 58485 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 58485 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
516305 78488 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 587 10 1 6 6.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL2112952 78488 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 587 10 1 6 6.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44564929 178674 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 423 8 1 5 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL472953 178674 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 423 8 1 5 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
478451 85168 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282501 85168 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478444 170557 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL445836 170557 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461707 203941 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL82048 203941 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
501049 4253 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100958 4253 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501057 4667 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL103782 4667 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44374086 54681 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL161594 54681 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
478307 105326 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00652-7
CHEMBL312701 105326 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00652-7
25230828 172064 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 595 9 0 6 5.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL449621 172064 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 595 9 0 6 5.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44570269 176990 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 552 7 0 6 5.8 CCCCC1C(=O)C(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL464054 176990 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 552 7 0 6 5.8 CCCCC1C(=O)C(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888564 8565 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 2 4 3.4 Cc1cc(=O)[nH]c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095518 8565 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 2 4 3.4 Cc1cc(=O)[nH]c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888605 8938 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cc(F)cc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098664 8938 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cc(F)cc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44374086 54681 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL161594 54681 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
11433740 5706 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.6 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078753 5706 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.6 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
54581479 60546 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762313 60546 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
54583460 60548 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 593 7 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Oc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762315 60548 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 593 7 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Oc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
11422270 60567 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 630 10 1 6 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762339 60567 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 630 10 1 6 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11180743 60629 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 580 9 1 5 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762464 60629 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 580 9 1 5 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
46880775 6290 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082201 6290 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
11844212 98183 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 590 7 1 2 7.7 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC2(C=Cc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm060439n
CHEMBL277279 98183 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 590 7 1 2 7.7 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC2(C=Cc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm060439n
52947038 18056 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 8 0 6 2.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270303 18056 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 8 0 6 2.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
478307 105326 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL312701 105326 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461561 203656 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79930 203656 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478307 105326 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL312701 105326 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478302 205003 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 538 8 0 5 4.3 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89958 205003 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 538 8 0 5 4.3 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44461561 203656 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79930 203656 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
25057877 5686 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 6 0 4 5.9 CCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078648 5686 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 6 0 4 5.9 CCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
482150 112227 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 9 0 5 5.1 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL330486 112227 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 9 0 5 5.1 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479867 205134 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.7 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90691 205134 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.7 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479857 162944 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL420242 162944 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
65237 137086 97 None - 0 Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137086 97 None - 0 Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
72711051 92241 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
CHEMBL2435896 92241 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
44431946 87670 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234674 87670 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
49768639 89135 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 591 7 1 6 5.2 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL2374447 89135 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 591 7 1 6 5.2 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
72714320 92235 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 92235 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44455223 94876 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 492 8 1 5 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL256584 94876 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 492 8 1 5 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
490007 167271 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 503 7 0 4 5.3 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL430905 167271 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 503 7 0 4 5.3 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
54584058 62538 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 568 6 0 4 7.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)c(F)c2)CC1 10.1021/jm200279v
CHEMBL1784480 62538 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 568 6 0 4 7.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)c(F)c2)CC1 10.1021/jm200279v
6320579 121653 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 547 10 0 5 5.1 CN(C[C@@H](CCN1CCC(N2C[C@@H](c3ccccc3)OC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL359752 121653 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 547 10 0 5 5.1 CN(C[C@@H](CCN1CCC(N2C[C@@H](c3ccccc3)OC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44392142 64921 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 524 10 0 3 6.7 CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182817 64921 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 524 10 0 3 6.7 CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392149 65012 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 10 0 4 5.8 O=C(Cc1ccc([N+](=O)[O-])cc1)N(C1CC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182929 65012 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 10 0 4 5.8 O=C(Cc1ccc([N+](=O)[O-])cc1)N(C1CC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44404605 72219 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 536 10 0 4 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199258 72219 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 536 10 0 4 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
44455225 94920 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 477 8 0 5 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL256792 94920 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 477 8 0 5 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
16728632 91128 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 370 5 3 3 4.0 N=C(N)N/N=C/c1cc(Cl)cc(Cl)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240641 91128 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 370 5 3 3 4.0 N=C(N)N/N=C/c1cc(Cl)cc(Cl)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44431946 87670 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234674 87670 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
53321482 58138 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683064 58138 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
44590738 175174 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2CC3CCC(C2)N3C(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL458351 175174 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2CC3CCC(C2)N3C(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.012
52944644 18042 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 523 8 0 6 2.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270209 18042 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 523 8 0 6 2.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
72714319 92234 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 92234 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
44564985 186494 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 413 7 1 6 4.2 COC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
CHEMBL491328 186494 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 413 7 1 6 4.2 COC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
65237 137086 97 None - 0 Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137086 97 None - 0 Human 4.5 pIC50 = 4.5 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
76330769 85152 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 592 8 3 3 7.2 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1007/s00044-012-0118-7
CHEMBL2281963 85152 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 592 8 3 3 7.2 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1007/s00044-012-0118-7
489344 5363 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 681 13 2 5 6.9 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL107439 5363 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 681 13 2 5 6.9 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
25206397 7018 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 6 1 6 4.1 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085221 7018 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 6 1 6 4.1 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
44392137 64504 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2005.08.014
CHEMBL182074 64504 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2005.08.014
72711278 92243 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 92243 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
16073669 79437 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)ccc2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212243 79437 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)ccc2F)CC1 10.1016/j.bmcl.2006.03.089
489818 110928 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 482 6 0 4 5.2 COC(=O)c1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327392 110928 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 482 6 0 4 5.2 COC(=O)c1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392213 165589 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 8 1 2 6.5 CCN(C(=O)Nc1ccc(C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL426250 165589 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 8 1 2 6.5 CCN(C(=O)Nc1ccc(C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44573097 192492 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 506 6 0 6 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2ncccn2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL522669 192492 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 506 6 0 6 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2ncccn2)CC1 10.1016/j.bmcl.2009.02.014
44431971 88356 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 593 8 3 4 6.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1016/j.bmcl.2007.01.050
CHEMBL236421 88356 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 593 8 3 4 6.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1016/j.bmcl.2007.01.050
474153 11173 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL1179232 11173 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL65605 11173 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
6480206 183768 1 None - 0 Human 4.5 pIC50 = 4.5 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 370 1 1 2 5.7 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)C[C@@]5(O)OC/C(=C/C[C@H]3[C@H]12)[C@@H]45 10.1021/np049844c
CHEMBL484427 183768 1 None - 0 Human 4.5 pIC50 = 4.5 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 370 1 1 2 5.7 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)C[C@@]5(O)OC/C(=C/C[C@H]3[C@H]12)[C@@H]45 10.1021/np049844c
66767933 120699 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 531 12 6 5 3.2 CCC[C@H](O)[C@H](CNCC(C)(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577933 120699 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 531 12 6 5 3.2 CCC[C@H](O)[C@H](CNCC(C)(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
44455106 97478 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 9 1 5 5.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NCc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272581 97478 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 9 1 5 5.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NCc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
155540798 172356 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cc(Cl)cc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4516788 172356 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cc(Cl)cc(Cl)c1 10.1021/acs.jmedchem.9b00742
44373768 193180 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL539943 193180 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
46890346 7027 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 612 6 1 6 5.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085232 7027 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 612 6 1 6 5.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44392125 131262 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 531 10 1 4 4.6 NS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL369352 131262 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 531 10 1 4 4.6 NS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44373768 193180 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL539943 193180 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
516331 59958 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 598 11 2 6 5.5 O=C(O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL174283 59958 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 598 11 2 6 5.5 O=C(O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
489823 111870 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccoc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329555 111870 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccoc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44373768 193180 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL539943 193180 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
44590801 175619 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 529 9 1 3 6.4 CCN(C(=O)c1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459378 175619 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 529 9 1 3 6.4 CCN(C(=O)c1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72712160 92214 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 92214 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
483333 4993 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnnc2-c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105460 4993 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnnc2-c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
72712373 92218 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
CHEMBL2435873 92218 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
3011722 70692 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951900 70692 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
54585385 60544 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 513 7 2 4 5.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(O)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762311 60544 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 513 7 2 4 5.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(O)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
5481748 111049 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1007/s00044-011-9863-2
CHEMBL328024 111049 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1007/s00044-011-9863-2
5481713 204046 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL82880 204046 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
162648673 179360 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 522 6 3 7 3.4 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(OC(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4746510 179360 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 522 6 3 7 3.4 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(OC(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
25206227 7017 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 651 7 0 7 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCN(S(C)(=O)=O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085220 7017 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 651 7 0 7 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCN(S(C)(=O)=O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888606 8939 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 536 8 1 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(C#N)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098665 8939 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 536 8 1 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(C#N)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46882081 5524 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 608 9 0 6 6.2 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077363 5524 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 608 9 0 6 6.2 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
52945332 18087 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 7 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270493 18087 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 7 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
489824 205499 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 2 5.7 O=C(C1CCCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL92861 205499 2 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 2 5.7 O=C(C1CCCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72711049 92239 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 92239 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
53322810 58149 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 499 6 1 7 2.7 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683075 58149 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 499 6 1 7 2.7 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
76308986 85158 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 10 3 3 9.2 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281969 85158 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 10 3 3 9.2 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
478512 106042 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 594 8 0 6 4.7 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cn(C)cn1 10.1016/s0960-894x(00)00637-5
CHEMBL314077 106042 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 594 8 0 6 4.7 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cn(C)cn1 10.1016/s0960-894x(00)00637-5
478493 205056 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL90272 205056 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
44392219 64554 4 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 392 8 0 2 5.2 CC(C)CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182234 64554 4 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 392 8 0 2 5.2 CC(C)CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728631 91127 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240640 91127 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728631 91127 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL240640 91127 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
72714318 92233 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 92233 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
72711050 92240 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 92240 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
25130569 187716 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 7 1 6 5.2 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
CHEMBL500523 187716 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 7 1 6 5.2 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
155529593 170879 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 518 7 2 5 2.2 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4463290 170879 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 518 7 2 5 2.2 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
25230896 187663 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 569 6 0 7 5.0 CCCCC1CN(C(=O)OC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL499729 187663 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 569 6 0 7 5.0 CCCCC1CN(C(=O)OC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44431954 86557 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1007/s00044-012-0118-7
CHEMBL232409 86557 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1007/s00044-012-0118-7
11326950 87220 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
CHEMBL233638 87220 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
5482456 203593 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL79369 203593 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
478503 204456 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1007/s00044-011-9863-2
CHEMBL86419 204456 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1007/s00044-011-9863-2
478500 205117 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1007/s00044-011-9863-2
CHEMBL90620 205117 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1007/s00044-011-9863-2
44570177 190815 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 498 5 1 5 4.0 CCCC[C@H]1CN(C(=O)NC)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL519278 190815 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 498 5 1 5 4.0 CCCC[C@H]1CN(C(=O)NC)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
471179 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL79504 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
5481702 204099 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00655-2
CHEMBL83338 204099 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00655-2
471179 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL79504 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
44392235 65042 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.2 CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182940 65042 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.2 CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431984 146334 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 641 10 3 4 8.1 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL392536 146334 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 641 10 3 4 8.1 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
46864993 6169 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081625 6169 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
44461603 105462 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCOC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL312945 105462 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCOC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
471179 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
471179 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL79504 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79504 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461494 203904 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 4 4.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL81719 203904 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 4 4.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
5482453 204096 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83311 204096 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5482454 204129 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 5.5 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83683 204129 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 5.5 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
478296 157366 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL408438 157366 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
471179 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL79504 203605 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
25132254 102796 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084492 102796 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
501058 109181 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL322693 109181 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44392162 64507 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 536 11 0 3 6.8 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182083 64507 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 536 11 0 3 6.8 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431954 86557 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL232409 86557 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1016/j.bmcl.2007.01.050
11326950 87220 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
CHEMBL233638 87220 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
5275833 121620 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL359687 121620 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
489597 99186 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](c2ccccc2)[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)C1 10.1016/s0960-894x(01)00232-3
CHEMBL284380 99186 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](c2ccccc2)[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)C1 10.1016/s0960-894x(01)00232-3
44392083 65518 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 532 11 0 3 7.0 CN(C(=O)Cc1ccc(OCc2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183554 65518 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 532 11 0 3 7.0 CN(C(=O)Cc1ccc(OCc2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483363 14495 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120569 14495 1 None - 0 Human 5.5 pIC50 = 5.5 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
478387 204916 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
CHEMBL89279 204916 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
501058 109181 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL322693 109181 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501058 109181 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322693 109181 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72711277 92242 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 92242 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
5275832 62273 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL178337 62273 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
76324826 104297 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 576 18 1 6 7.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCN=[N+]=[N-])c1ccccc1 10.1021/ml400370w
CHEMBL3109177 104297 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 576 18 1 6 7.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCN=[N+]=[N-])c1ccccc1 10.1021/ml400370w
5481747 111050 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00637-5
CHEMBL328025 111050 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00637-5
44392082 65517 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccccc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183553 65517 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccccc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
56750906 122468 6 None - 0 Human 4.4 pIC50 = 4.4 Binding
Inhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readoutInhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readout
ChEMBL 332 5 1 3 3.8 c1ccc(Cc2cn[nH]c2C2CCN(Cc3ccncc3)CC2)cc1 10.1021/acsmedchemlett.5b00036
CHEMBL3608763 122468 6 None - 0 Human 4.4 pIC50 = 4.4 Binding
Inhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readoutInhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readout
ChEMBL 332 5 1 3 3.8 c1ccc(Cc2cn[nH]c2C2CCN(Cc3ccncc3)CC2)cc1 10.1021/acsmedchemlett.5b00036
3011719 70684 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 540 10 0 6 3.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951892 70684 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 540 10 0 6 3.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
76319891 85160 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)c(F)c1 10.1007/s00044-012-0118-7
CHEMBL2281970 85160 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)c(F)c1 10.1007/s00044-012-0118-7
44570268 187847 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 8 0 6 5.4 CCCCC1C(=O)N(C[C@H]2CC[C@H](OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL502432 187847 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 8 0 6 5.4 CCCCC1C(=O)N(C[C@H]2CC[C@H](OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
11421221 63417 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180155 63417 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
18442936 70697 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 10 0 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951905 70697 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 10 0 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44590230 178262 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 409 7 1 5 4.0 Cc1nnc(C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL469542 178262 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 409 7 1 5 4.0 Cc1nnc(C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44392143 64483 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 495 7 1 2 7.1 CN(C(=O)Nc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181967 64483 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 495 7 1 2 7.1 CN(C(=O)Nc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392106 122260 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.4 CN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360524 122260 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.4 CN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
53325385 58135 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683061 58135 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
57396951 70700 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 640 11 0 7 2.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951909 70700 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 640 11 0 7 2.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16728627 146985 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1F 10.1016/j.bmcl.2006.09.052
CHEMBL393069 146985 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1F 10.1016/j.bmcl.2006.09.052
155513284 169148 0 None - 1 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 343 3 2 5 2.9 Nc1nc2[nH]c(C3CCCC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4438407 169148 0 None - 1 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 343 3 2 5 2.9 Nc1nc2[nH]c(C3CCCC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
44392167 63132 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 519 10 1 4 4.4 CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179877 63132 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 519 10 1 4 4.4 CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
46880847 7453 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 477 7 1 5 4.7 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.01.080
CHEMBL1087533 7453 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 477 7 1 5 4.7 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.01.080
491773 12704 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188399 12704 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL536288 12704 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
56647076 92226 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 92226 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
474150 11911 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
CHEMBL1183377 11911 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
CHEMBL293882 11911 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
483355 109882 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 14 0 7 6.8 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL324284 109882 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 14 0 7 6.8 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
54583462 60559 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)nc1 10.1016/j.bmcl.2011.02.058
CHEMBL1762331 60559 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)nc1 10.1016/j.bmcl.2011.02.058
44455034 94723 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL255855 94723 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
44590865 176152 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 457 8 2 4 5.1 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2[nH]ncc2-c2ccncc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460217 176152 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 457 8 2 4 5.1 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2[nH]ncc2-c2ccncc2)CC1 10.1016/j.bmcl.2009.01.009
162656188 180323 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 429 5 3 5 1.4 CN[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)n3)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
CHEMBL4757857 180323 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 429 5 3 5 1.4 CN[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)n3)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
44431949 148483 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL394256 148483 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
57400372 70688 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 604 11 0 7 2.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951896 70688 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 604 11 0 7 2.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44447733 94644 0 None - 0 Crab-eating macaque 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255431 94644 0 None - 0 Crab-eating macaque 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
72713858 92255 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 92255 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
44415821 161144 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1C1CC2COCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL413501 161144 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1C1CC2COCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
72712371 92216 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 92216 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
11626984 83100 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203621 83100 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
76316242 85177 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 521 10 0 5 4.7 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282510 85177 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 521 10 0 5 4.7 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-012-0138-3
44461581 204185 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL84029 204185 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44431949 148483 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL394256 148483 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
489833 110950 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.1 Cc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL327540 110950 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.1 Cc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
474149 11180 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL1179247 11180 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL66301 11180 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
16728620 90291 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1016/j.bmcl.2006.09.052
CHEMBL239153 90291 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1016/j.bmcl.2006.09.052
16728620 90291 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1007/s00044-012-0118-7
CHEMBL239153 90291 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1007/s00044-012-0118-7
54584052 62523 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 518 6 0 4 6.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2cnc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784395 62523 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 518 6 0 4 6.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2cnc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
25131902 186696 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 6 1 5 5.7 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL492897 186696 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 6 1 5 5.7 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccccc2)CC1 10.1021/jm800598a
10371054 192213 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 7 1 6 4.8 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL522158 192213 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 7 1 6 4.8 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
76311990 84827 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 8 0 4 4.4 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL2259883 84827 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 8 0 4 4.4 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
16728644 85150 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 408 6 3 3 4.3 CC/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281961 85150 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 408 6 3 3 4.3 CC/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44431951 87849 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234843 87849 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
5481705 162917 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL420057 162917 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481704 163856 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL421356 163856 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478399 204151 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83818 204151 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489307 110373 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 603 13 1 6 6.5 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
CHEMBL326111 110373 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 603 13 1 6 6.5 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
483340 5243 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL106803 5243 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
489339 5266 2 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 635 12 2 5 6.1 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL106907 5266 2 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 635 12 2 5 6.1 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
46888479 8708 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 523 7 1 3 5.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096765 8708 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 523 7 1 3 5.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
5481742 106569 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 527 8 0 3 6.8 [O-][S+]1CC2(CCN(CC[C@H](COCc3ccccc3)c3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(00)00637-5
CHEMBL315707 106569 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 527 8 0 3 6.8 [O-][S+]1CC2(CCN(CC[C@H](COCc3ccccc3)c3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(00)00637-5
5481743 204763 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 541 7 0 4 6.5 O=C(OC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL88319 204763 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 541 7 0 4 6.5 O=C(OC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
44573338 188168 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 598 8 1 5 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(F)c2)CCN(C(C(=O)O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL505443 188168 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 598 8 1 5 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(F)c2)CCN(C(C(=O)O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2009.02.014
44573254 192680 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 513 6 1 4 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL524050 192680 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 513 6 1 4 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)C)CC1 10.1016/j.bmcl.2009.02.014
501049 4253 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100958 4253 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501057 4667 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL103782 4667 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44455069 94987 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
CHEMBL257081 94987 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
44454977 97516 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccc(Cl)cc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272716 97516 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccc(Cl)cc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
44555481 5625 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1078231 5625 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2010.02.004
501049 4253 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100958 4253 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501057 4667 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103782 4667 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
486602 105505 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 611 13 0 5 6.6 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL313216 105505 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 611 13 0 5 6.6 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
478444 170557 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL445836 170557 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461689 203930 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81926 203930 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461823 204220 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84309 204220 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
516351 59961 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 578 8 2 4 6.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL174303 59961 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 578 8 2 4 6.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
44325542 111801 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 575 8 0 4 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329140 111801 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 575 8 0 4 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490016 111845 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 531 8 0 4 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329417 111845 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 531 8 0 4 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
516326 60720 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL176392 60720 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516326 60720 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL176392 60720 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
10280445 94684 0 None - 0 Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255645 94684 0 None - 0 Crab-eating macaque 8.4 pIC50 = 8.4 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
516326 60720 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL176392 60720 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
68764898 664 1 None - 3 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
9430 664 1 None - 3 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
CHEMBL3577945 664 1 None - 3 Human 8.4 pIC50 = 8.4 Binding
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
44384642 59508 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 566 9 2 4 6.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C3(c4ccccc4)CC3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL172845 59508 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 566 9 2 4 6.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C3(c4ccccc4)CC3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
10117348 13799 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL1196455 13799 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL557015 13799 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
474162 11162 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179157 11162 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL62598 11162 1 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
53319838 58489 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688242 58489 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
516327 129197 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL367421 129197 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
5275760 76696 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207301 76696 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
11585625 76716 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207447 76716 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516327 129197 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367421 129197 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516327 129197 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL367421 129197 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
11527691 103059 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085313 103059 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CCC)cc1 10.1021/jm0509703
516334 119911 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL353827 119911 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274042 162577 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL417825 162577 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274042 162577 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL417825 162577 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
516334 119911 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL353827 119911 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274042 162577 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL417825 162577 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516334 119911 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL353827 119911 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516329 129647 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 622 10 1 5 7.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC(F)(F)F)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL367863 129647 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 622 10 1 5 7.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC(F)(F)F)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
44590799 176207 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 479 9 1 3 5.2 CCN(C(=O)c1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460628 176207 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 479 9 1 3 5.2 CCN(C(=O)c1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44564982 192574 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 499 8 1 6 4.1 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC[S+]([O-])CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL523267 192574 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 499 8 1 6 4.1 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC[S+]([O-])CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
5481746 112272 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL330570 112272 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(00)00637-5
478503 204456 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL86419 204456 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1016/s0960-894x(00)00637-5
478500 205117 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL90620 205117 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/s0960-894x(00)00637-5
44412984 139574 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL380083 139574 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
44573302 188022 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 580 6 0 6 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL502909 188022 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 580 6 0 6 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
54580467 60547 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 591 7 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Cc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762314 60547 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 591 7 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Cc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
11365412 60554 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 597 9 1 4 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(F)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762324 60554 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 597 9 1 4 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(F)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11261876 60563 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762335 60563 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
11478988 60631 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 605 9 1 6 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762467 60631 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 605 9 1 6 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
5479787 116086 3 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL336672 116086 3 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1016/j.bmcl.2011.02.058
44461513 104246 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 487 10 0 5 4.0 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL310645 104246 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 487 10 0 5 4.0 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461581 204185 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84029 204185 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44439314 91521 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 438 7 3 4 4.3 CC/C(=N\NC(=N)N)c1cc(Br)cc(OC)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241476 91521 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 438 7 3 4 4.3 CC/C(=N\NC(=N)N)c1cc(Br)cc(OC)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44431951 87849 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234843 87849 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
486595 204198 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL84120 204198 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
479876 111503 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328888 111503 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44324386 111023 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 303 6 0 2 3.5 CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL327880 111023 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 303 6 0 2 3.5 CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00639-9
11234566 178299 15 None - 0 Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 386 5 1 3 5.3 CC(C)=CCC[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@@H]12 10.1021/np049974l
CHEMBL469855 178299 15 None - 0 Human 4.4 pIC50 = 4.4 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 386 5 1 3 5.3 CC(C)=CCC[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@@H]12 10.1021/np049974l
489313 5362 2 None - 0 Human 7.4 pIC50 = 7.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 601 10 1 6 6.1 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL107425 5362 2 None - 0 Human 7.4 pIC50 = 7.4 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 601 10 1 6 6.1 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
44590739 189000 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2C3CCC2CN(C(c2ccccc2)c2ccccc2)C3)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL514749 189000 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2C3CCC2CN(C(c2ccccc2)c2ccccc2)C3)CC1 10.1016/j.bmcl.2009.01.012
44383760 167988 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 2 5 5.6 O=C(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL435724 167988 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 2 5 5.6 O=C(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
72712159 92212 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 92212 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
44392126 65750 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 467 6 0 3 5.4 CN(C(=O)N1Cc2ccccc2C1=O)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183885 65750 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 467 6 0 3 5.4 CN(C(=O)N1Cc2ccccc2C1=O)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
52944231 17945 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 618 7 0 7 3.8 CS(=O)(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)S(=O)(=O)c4ccc(C#N)cc4Cl)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
CHEMBL1269387 17945 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 618 7 0 7 3.8 CS(=O)(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)S(=O)(=O)c4ccc(C#N)cc4Cl)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
16728645 149029 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
CHEMBL394684 149029 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
44392253 64913 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 1 3 5.9 CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182780 64913 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 1 3 5.9 CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
505876 27657 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 485 8 0 3 6.0 C=CCN(c1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137154 27657 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 485 8 0 3 6.0 C=CCN(c1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
59458245 92211 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 92211 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16728645 149029 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL394684 149029 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
44374017 119482 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL350027 119482 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
25205764 6577 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 554 8 0 6 4.3 CCCCC1CN(CC2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1083437 6577 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 554 8 0 6 4.3 CCCCC1CN(CC2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
46880775 6142 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081477 6142 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
474158 11154 2 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179117 11154 2 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL61267 11154 2 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
72712161 92215 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 92215 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
474148 11175 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
CHEMBL1179235 11175 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
CHEMBL65681 11175 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
72712159 92212 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 92212 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
46888546 8757 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 1 4 3.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097170 8757 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 1 4 3.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46882080 5523 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 609 9 0 7 5.6 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077362 5523 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 609 9 0 7 5.6 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
72713858 92255 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 92255 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
73346388 92223 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 92223 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
456615 102260 1 None - 1 Human 6.4 pIC50 = 6.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL305026 102260 1 None - 1 Human 6.4 pIC50 = 6.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
483353 14501 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120584 14501 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
25133271 188440 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 7 1 4 6.4 O=C(c1ccccc1)N1CCCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL509298 188440 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 7 1 4 6.4 O=C(c1ccccc1)N1CCCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
76330768 85148 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 658 8 3 3 8.9 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1007/s00044-012-0118-7
CHEMBL2281959 85148 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 658 8 3 3 8.9 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1007/s00044-012-0118-7
11166533 148297 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL394115 148297 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
5481745 204753 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1007/s00044-011-9863-2
CHEMBL88261 204753 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1007/s00044-011-9863-2
46882075 5518 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 595 5 0 6 5.1 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077355 5518 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 595 5 0 6 5.1 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
5481715 103916 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL310305 103916 1 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44431975 87502 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 659 8 3 4 7.8 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1016/j.bmcl.2007.01.050
CHEMBL234017 87502 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 659 8 3 4 7.8 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1016/j.bmcl.2007.01.050
11166533 148297 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL394115 148297 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
479835 204782 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 8 0 4 5.6 CN(CC(CCN1CCC2(CC1)CSc1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL88455 204782 1 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 8 0 4 5.6 CN(CC(CCN1CCC2(CC1)CSc1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
25133620 186595 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 5 1 5 4.8 CC(C)(C)OC(=O)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL492292 186595 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 5 1 5 4.8 CC(C)(C)OC(=O)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
44374136 51420 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL158438 51420 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
44392088 63127 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 0 4 4.6 CN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179858 63127 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 0 4 4.6 CN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073661 139464 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(F)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL380005 139464 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(F)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
44374136 51420 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL158438 51420 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
490006 111026 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 489 8 0 4 5.6 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327898 111026 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 489 8 0 4 5.6 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
489822 205707 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 3 5.5 O=C(c1cccs1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL94182 205707 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 3 5.5 O=C(c1cccs1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44374136 51420 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL158438 51420 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
76330770 85156 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 584 8 3 3 7.6 Cc1cccc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281967 85156 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 584 8 3 3 7.6 Cc1cccc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
24794583 180501 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 464 5 3 6 2.3 CN[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
CHEMBL4760098 180501 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 464 5 3 6 2.3 CN[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
46888498 8634 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 383 6 1 3 2.8 CC(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096101 8634 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 383 6 1 3 2.8 CC(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44431979 87390 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 585 8 3 4 6.4 Cc1cccc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL233846 87390 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 585 8 3 4 6.4 Cc1cccc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44392114 65721 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 442 8 1 3 5.1 CN(C(=O)Cc1ccc(O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183709 65721 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 442 8 1 3 5.1 CN(C(=O)Cc1ccc(O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11154101 87660 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 408 5 1 3 4.6 NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234673 87660 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 408 5 1 3 4.6 NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
10008490 191994 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 584 7 1 5 5.1 O=C(C1CCCC1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL521529 191994 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 584 7 1 5 5.1 O=C(C1CCCC1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728613 91123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL240636 91123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
44590584 176209 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 463 10 2 4 3.9 COc1ccc(CC(=O)NC2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.01.009
CHEMBL460630 176209 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 463 10 2 4 3.9 COc1ccc(CC(=O)NC2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.01.009
483342 107671 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL319622 107671 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44454972 97365 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272064 97365 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
489817 205539 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 502 5 0 2 6.2 O=C(c1ccccc1Br)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93168 205539 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 502 5 0 2 6.2 O=C(c1ccccc1Br)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489826 205582 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 402 5 0 2 4.9 O=C(C1CCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93457 205582 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 402 5 0 2 4.9 O=C(C1CCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
11189082 146468 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL392659 146468 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
16728613 91123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240636 91123 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
473081 205315 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.3 CC(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL91697 205315 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.3 CC(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
11249997 87905 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 563 6 1 3 6.9 OC1(c2ccc(Br)cc2)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234894 87905 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 563 6 1 3 6.9 OC1(c2ccc(Br)cc2)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
489595 167306 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
CHEMBL431111 167306 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
44392176 64733 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 1 4 5.3 CCN(C(=O)NCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182380 64733 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 1 4 5.3 CCN(C(=O)NCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11189082 146468 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL392659 146468 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44565081 186492 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN([C@@H](C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491320 186492 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN([C@@H](C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44392104 165396 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 452 7 1 3 5.7 CN(C(=O)Nc1cccc(C#N)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL425168 165396 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 452 7 1 3 5.7 CN(C(=O)Nc1cccc(C#N)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
4080740 165611 6 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 464 10 1 6 3.7 O=C(CSc1nc2ccccc2c(=O)n1CCCN1CCCCC1)NCCc1ccccc1 10.1021/jm061389p
CHEMBL426385 165611 6 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 464 10 1 6 3.7 O=C(CSc1nc2ccccc2c(=O)n1CCCN1CCCCC1)NCCc1ccccc1 10.1021/jm061389p
24794624 179026 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 492 6 3 6 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4742683 179026 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 492 6 3 6 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
44373852 54322 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL161093 54322 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
44373721 164756 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL423427 164756 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
44590585 190513 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518794 190513 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489343 4847 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 647 13 2 5 6.3 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL104698 4847 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 647 13 2 5 6.3 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
505879 28420 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137728 28420 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
496974 4145 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL100336 4145 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
3011729 70685 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 602 11 0 6 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951893 70685 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 602 11 0 6 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
57395179 70702 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 633 12 0 7 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(OC)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951911 70702 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 633 12 0 7 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(OC)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
10348408 168860 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C)c1C(C(=O)O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL442619 168860 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C)c1C(C(=O)O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573340 188226 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 576 8 0 6 6.9 COC(=O)C(c1ccccc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506273 188226 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 576 8 0 6 6.9 COC(=O)C(c1ccccc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573336 188360 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 565 5 0 6 5.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)N2CCOCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL508250 188360 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 565 5 0 6 5.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)N2CCOCC2)CC1 10.1016/j.bmcl.2009.02.014
11605997 58487 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688240 58487 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
496974 4145 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL100336 4145 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
501050 4191 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100596 4191 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
505879 28420 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137728 28420 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
46880887 7402 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.3 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087153 7402 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.3 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
46880849 7455 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087535 7455 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
501050 4191 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100596 4191 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461476 103675 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309619 103675 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478414 104271 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL310780 104271 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461677 167452 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 14 0 5 6.4 CCCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL432182 167452 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 14 0 5 6.4 CCCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481713 204046 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481713 204046 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL82880 204046 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL82880 204046 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44415847 79483 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 457 9 1 5 4.6 O=C(N[C@@H](CCN1CCC(n2cnc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
CHEMBL212437 79483 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 457 9 1 5 4.6 O=C(N[C@@H](CCN1CCC(n2cnc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
516180 130026 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368098 130026 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
490013 205488 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 525 8 0 4 5.7 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL92803 205488 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 525 8 0 4 5.7 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44461476 103675 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309619 103675 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
54584059 62539 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(Cl)c2)CC1 10.1021/jm200279v
CHEMBL1784481 62539 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(Cl)c2)CC1 10.1021/jm200279v
25132254 102796 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084492 102796 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
25132604 102804 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 5 0 5 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084500 102804 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 5 0 5 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
10278617 94726 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 94726 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008902 200984 1 None - 0 Crab-eating macaque 8.3 pIC50 = 8.3 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61536 200984 1 None - 0 Crab-eating macaque 8.3 pIC50 = 8.3 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
5275763 96330 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL264832 96330 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
3002977 2416 70 None - 2 Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
803 2416 70 None - 2 Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
806 2416 70 None - 2 Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
CHEMBL1201187 2416 70 None - 2 Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
CHEMBL256907 2416 70 None - 2 Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
CHEMBL584744 2416 70 None - 2 Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
DB04835 2416 70 None - 2 Mouse 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
25133963 102800 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084496 102800 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
50992246 58148 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 58148 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
5275842 63490 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 604 11 0 6 5.1 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL180274 63490 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 604 11 0 6 5.1 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
57396843 70236 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 12 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1949696 70236 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 12 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
516368 130681 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL368637 130681 1 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
72711958 92209 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 92209 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3001322 439 19 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 439 19 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 439 19 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 439 19 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
44404640 72175 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 13 1 5 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199118 72175 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 13 1 5 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
72711955 92206 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435861 92206 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
501054 4507 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102674 4507 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496984 162889 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL419895 162889 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496973 167509 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL432596 167509 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
478414 104271 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL310780 104271 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481744 204812 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1007/s00044-011-9863-2
CHEMBL88644 204812 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1007/s00044-011-9863-2
11376667 60549 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 579 9 1 4 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762316 60549 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 579 9 1 4 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11215601 60551 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762318 60551 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11238728 60562 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1ccnc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
CHEMBL1762334 60562 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1ccnc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
5481712 105411 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL312808 105411 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44415784 79397 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 395 7 1 5 3.6 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL212087 79397 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 395 7 1 5 3.6 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
482148 162756 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL418954 162756 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
15950679 92213 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 92213 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
72712374 92219 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 92219 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
16073671 170799 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 652 11 0 6 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL446187 170799 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 652 11 0 6 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
16728621 90299 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL239154 90299 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
479860 205258 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91413 205258 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
16728621 90299 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL239154 90299 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
478496 204579 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1007/s00044-011-9863-2
CHEMBL87167 204579 1 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1007/s00044-011-9863-2
25133617 102793 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 536 7 0 5 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccco2)CC1 10.1021/jm800598a
CHEMBL3084489 102793 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 536 7 0 5 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccco2)CC1 10.1021/jm800598a
12425 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
44273850 99133 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 554 12 2 4 5.6 O=C(O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL284010 99133 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 554 12 2 4 5.6 O=C(O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
44392137 64504 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182074 64504 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
46883507 6017 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 523 7 0 4 6.3 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1080794 6017 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 523 7 0 4 6.3 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392168 122757 4 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 457 8 0 4 5.4 CN(C(=O)c1cccc([N+](=O)[O-])c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL361414 122757 4 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 457 8 0 4 5.4 CN(C(=O)c1cccc([N+](=O)[O-])c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
53389710 171705 0 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 331 5 2 5 2.6 CCCCc1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4474757 171705 0 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 331 5 2 5 2.6 CCCCc1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
489808 111937 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccccc1Cl)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329813 111937 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccccc1Cl)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
73347894 92208 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 92208 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44564885 178723 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 10 1 6 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)COCC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473353 178723 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 10 1 6 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)COCC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
25130903 187114 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 8 1 5 5.9 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CCN(Cc3ccco3)C1)CC2 10.1021/jm800598a
CHEMBL495297 187114 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 8 1 5 5.9 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CCN(Cc3ccco3)C1)CC2 10.1021/jm800598a
16728786 13841 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 13841 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL558043 13841 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44455033 94722 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
CHEMBL255854 94722 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
12425 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None - 0 Human 4.3 pIC50 = 4.3 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
44454975 154932 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1c(Cl)cccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL404056 154932 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1c(Cl)cccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
44590943 175813 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 439 9 1 6 3.7 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2nnc(CN(C)C)o2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459598 175813 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 439 9 1 6 3.7 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2nnc(CN(C)C)o2)CC1 10.1016/j.bmcl.2009.01.009
44392258 65726 3 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.5 CCN(C(=O)NC(C)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183746 65726 3 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.5 CCN(C(=O)NC(C)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
53324140 58139 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683065 58139 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
72712371 92216 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 92216 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
483345 4889 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104867 4889 1 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
489821 111107 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccco1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL328373 111107 2 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccco1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392109 165737 4 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 406 7 0 2 5.6 CN(C(=O)CC(C)(C)C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL427137 165737 4 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 406 7 0 2 5.6 CN(C(=O)CC(C)(C)C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44590850 176127 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 441 8 1 3 5.4 Cc1ccnc(C)c1C(=O)NCCN1CCCC(CC(c2ccccc2)c2ccccc2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL459986 176127 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 441 8 1 3 5.4 Cc1ccnc(C)c1C(=O)NCCN1CCCC(CC(c2ccccc2)c2ccccc2)C1 10.1016/j.bmcl.2009.01.012
16073673 77443 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 7 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C#N)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL209278 77443 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 7 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C#N)c2)CC1 10.1016/j.bmcl.2006.03.089
72712158 92210 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435865 92210 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711506 92247 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435902 92247 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
72711049 92239 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 92239 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
44392204 65281 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 472 9 0 3 6.1 CSc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL183409 65281 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 472 9 0 3 6.1 CSc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
16073668 79359 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2c(F)cccc2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211903 79359 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2c(F)cccc2F)CC1 10.1016/j.bmcl.2006.03.089
10159218 13807 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1196504 13807 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL557199 13807 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
54585383 60540 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 544 9 0 5 4.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCN(C)C(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762306 60540 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 544 9 0 5 4.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCN(C)C(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
44431972 88721 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 625 8 3 4 7.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1016/j.bmcl.2007.01.050
CHEMBL236622 88721 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 625 8 3 4 7.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1016/j.bmcl.2007.01.050
73346389 92224 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 92224 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
489827 111772 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 418 7 0 2 5.5 CCC(CC)C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329107 111772 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 418 7 0 2 5.5 CCC(CC)C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
76312666 85153 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 3 3 8.3 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1007/s00044-012-0118-7
CHEMBL2281964 85153 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 3 3 8.3 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1007/s00044-012-0118-7
479870 105918 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 498 9 0 3 5.6 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc(F)c(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL313950 105918 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 498 9 0 3 5.6 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc(F)c(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5481871 204856 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 4.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(F)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL88927 204856 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 4.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(F)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
6475311 11176 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
CHEMBL1179236 11176 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
CHEMBL65696 11176 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
16728617 91130 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1016/j.bmcl.2006.09.052
CHEMBL240655 91130 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1016/j.bmcl.2006.09.052
16728617 91130 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1007/s00044-012-0118-7
CHEMBL240655 91130 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1007/s00044-012-0118-7
53318854 58146 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683072 58146 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
53389845 172382 0 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 315 3 2 5 2.1 Nc1nc2[nH]c(C3CC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4517518 172382 0 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 315 3 2 5 2.1 Nc1nc2[nH]c(C3CC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
44431962 87906 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234896 87906 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44431959 146890 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL393004 146890 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44404692 71786 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197907 71786 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
46882948 5687 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.4 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078659 5687 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.4 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392110 63554 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL180498 63554 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44392166 63607 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 504 8 0 2 6.1 CN(C(=O)Cc1ccc(Br)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180685 63607 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 504 8 0 2 6.1 CN(C(=O)Cc1ccc(Br)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431962 87906 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234896 87906 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431959 146890 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL393004 146890 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44590441 178437 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 445 6 0 3 4.0 Cc1cccc(C)c1C(=O)N1CCC(N2CC(N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471218 178437 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 445 6 0 3 4.0 Cc1cccc(C)c1C(=O)N1CCC(N2CC(N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
16726107 83062 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
CHEMBL220199 83062 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
5481754 204732 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL88159 204732 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
44392135 64776 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 3 5.0 CN(C(=O)C(=O)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182403 64776 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 3 5.0 CN(C(=O)C(=O)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392115 65722 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 7 1 2 6.1 Cc1cccc(NC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
CHEMBL183710 65722 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 7 1 2 6.1 Cc1cccc(NC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
5481749 84975 1 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 8 0 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2c(c1)CCC2 10.1007/s00044-011-9863-2
CHEMBL2263647 84975 1 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 8 0 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2c(c1)CCC2 10.1007/s00044-011-9863-2
76308345 84828 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 5.5 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL2259884 84828 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 5.5 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
76327119 85151 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 339 4 0 2 4.7 CN(C)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281962 85151 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 339 4 0 2 4.7 CN(C)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11210440 87587 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL234461 87587 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
16728635 91321 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL241057 91321 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728609 166849 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL429641 166849 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
5481859 203637 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79716 203637 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5482457 204163 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83882 204163 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44373926 51804 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL158754 51804 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
183790 3673 8 None 3 2 Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
783 3673 8 None 3 2 Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL1178786 3673 8 None 3 2 Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
25205923 7020 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 6 5.6 CCO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085223 7020 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 6 5.6 CCO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888453 8662 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 473 7 1 3 4.7 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096445 8662 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 473 7 1 3 4.7 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888525 8827 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 491 7 1 3 4.9 Cc1cc(F)cc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097815 8827 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 491 7 1 3 4.9 Cc1cc(F)cc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
5479844 109947 1 None 1 2 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1016/j.bmcl.2010.03.095
CHEMBL324643 109947 1 None 1 2 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1016/j.bmcl.2010.03.095
505869 28040 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137419 28040 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
11503459 83095 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1beta from human CCR5 expressed in HEK293 cellsDisplacement of MIP-1beta from human CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1021/acs.jmedchem.8b00180
CHEMBL2203615 83095 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of MIP-1beta from human CCR5 expressed in HEK293 cellsDisplacement of MIP-1beta from human CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1021/acs.jmedchem.8b00180
496973 167509 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
CHEMBL432596 167509 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
496984 162889 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL419895 162889 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
44573256 178430 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 553 6 1 4 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC2CCCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL471149 178430 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 553 6 1 4 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC2CCCCC2)CC1 10.1016/j.bmcl.2009.02.014
11503459 83096 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203616 83096 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
501054 4507 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102674 4507 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496984 162889 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL419895 162889 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496973 167509 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL432596 167509 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
46880774 6141 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081476 6141 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
46880774 6286 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082191 6286 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
501054 4507 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102674 4507 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461274 104377 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 645 13 0 5 7.0 CCCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311052 104377 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 645 13 0 5 7.0 CCCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478446 203641 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79770 203641 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461713 203680 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL80043 203680 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415820 79842 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 468 7 1 4 5.6 Cc1nc2ccccc2n1C1CC12CC1CCC2N1CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL213914 79842 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 468 7 1 4 5.6 Cc1nc2ccccc2n1C1CC12CC1CCC2N1CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
9827221 109201 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against C-C chemokine receptor type 5Inhibitory activity against C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322817 109201 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against C-C chemokine receptor type 5Inhibitory activity against C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
44461713 203680 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL80043 203680 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
10280945 12716 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188557 12716 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536743 12716 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10280945 12716 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188557 12716 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL536743 12716 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
44564983 186465 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 515 8 1 7 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCS(=O)(=O)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491153 186465 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 515 8 1 7 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCS(=O)(=O)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010259 188570 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511154 188570 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010259 188570 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511154 188570 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010259 188570 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511154 188570 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44404719 133711 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 548 11 0 5 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL371691 133711 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 548 11 0 5 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401765 67598 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 514 8 1 5 5.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(Cn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL191139 67598 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 514 8 1 5 5.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(Cn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
72711507 92248 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 92248 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
5275839 165553 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 4.8 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL426048 165553 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 4.8 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
489316 108543 2 None - 0 Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 458 9 0 2 7.0 c1ccc(CCCC2CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00652-7
CHEMBL321267 108543 2 None - 0 Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 458 9 0 2 7.0 c1ccc(CCCC2CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00652-7
489305 164049 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 526 12 1 5 5.4 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL421598 164049 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 526 12 1 5 5.4 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
49871007 58490 9 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58490 9 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
44447733 94644 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255431 94644 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
505880 27499 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137038 27499 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505880 27499 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137038 27499 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
16041224 92195 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 556 8 1 6 5.2 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435850 92195 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 556 8 1 6 5.2 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
505880 27499 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137038 27499 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
11700429 103057 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 103057 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
478352 11916 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183391 11916 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL294501 11916 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
516358 177799 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL465416 177799 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44384705 120292 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 10 1 5 7.2 CCn1ncc(C(C)(C)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL355749 120292 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 10 1 5 7.2 CCn1ncc(C(C)(C)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516358 177799 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL465416 177799 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496983 109354 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL323370 109354 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010266 178514 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471765 178514 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
489314 5321 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 585 10 0 5 6.9 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL107170 5321 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 585 10 0 5 6.9 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
25206204 187779 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 610 7 0 7 4.7 CCCCC1C(=O)N(CC2CCN(C(=O)OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL501383 187779 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 610 7 0 7 4.7 CCCCC1C(=O)N(CC2CCN(C(=O)OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230897 190832 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 548 7 0 6 3.5 CCCCC1CN(S(=O)(=O)N(C)C)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL519298 190832 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 548 7 0 6 3.5 CCCCC1CN(S(=O)(=O)N(C)C)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
478502 105485 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(00)00637-5
CHEMBL313071 105485 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(00)00637-5
5481748 111049 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL328024 111049 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00637-5
478387 204916 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
CHEMBL89279 204916 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
44392161 63589 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 451 8 0 3 5.2 CN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180656 63589 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 451 8 0 3 5.2 CN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11157818 60553 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762320 60553 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11204141 60561 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccnc1OC(c1ccc(C(F)(F)F)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762333 60561 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccnc1OC(c1ccc(C(F)(F)F)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
479871 106649 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1C 10.1016/s0960-894x(00)00639-9
CHEMBL316189 106649 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1C 10.1016/s0960-894x(00)00639-9
11210440 87587 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL234461 87587 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728612 90924 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 424 5 3 3 3.6 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Br)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240260 90924 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 424 5 3 3 3.6 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Br)cc1 10.1016/j.bmcl.2006.09.052
16728629 91126 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240639 91126 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728635 91321 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL241057 91321 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
11210440 87587 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL234461 87587 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
3010251 14379 1 None - 0 Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 571 14 0 7 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)CC)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120419 14379 1 None - 0 Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 571 14 0 7 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)CC)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
3010250 113623 1 None - 0 Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 557 13 0 7 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(C)(=O)=O)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL332908 113623 1 None - 0 Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 557 13 0 7 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(C)(=O)=O)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44559501 172041 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 523 3 2 7 2.4 CC(=O)O[C@@H]1[C@@H]2O[C@H]2[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]123 10.1021/np049974l
CHEMBL449278 172041 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 523 3 2 7 2.4 CC(=O)O[C@@H]1[C@@H]2O[C@H]2[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]123 10.1021/np049974l
16728629 91126 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL240639 91126 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
489325 162785 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 541 7 1 4 5.7 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](c4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
CHEMBL419172 162785 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 541 7 1 4 5.7 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](c4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
46883025 5721 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.2 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078936 5721 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.2 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882079 5522 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 605 7 0 7 5.3 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077361 5522 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 605 7 0 7 5.3 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
11598797 12802 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 12802 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL538084 12802 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
489805 205611 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 439 5 1 2 5.8 O=C(Nc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93644 205611 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 439 5 1 2 5.8 O=C(Nc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
9909684 64590 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 413 7 0 3 4.8 CN(C(=O)c1ccncc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182266 64590 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 413 7 0 3 4.8 CN(C(=O)c1ccncc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44565037 192372 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489324 192372 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL522259 192372 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
46890341 7019 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 602 7 0 6 5.2 CO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085222 7019 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 602 7 0 6 5.2 CO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
44392244 63439 3 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 9 1 2 5.9 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180184 63439 3 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 9 1 2 5.9 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
72711048 92238 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 92238 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
72712597 92221 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 92221 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
44401593 70709 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195199 70709 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10840677 11160 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
CHEMBL1179151 11160 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
CHEMBL62454 11160 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
44401593 70709 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195199 70709 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44401593 70709 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195199 70709 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44439155 91528 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 12 4 6 5.2 COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
CHEMBL241497 91528 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 12 4 6 5.2 COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
52947044 18071 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 559 8 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270401 18071 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 559 8 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25132253 102795 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 528 5 0 5 6.9 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084491 102795 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 528 5 0 5 6.9 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
25133961 102797 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 7 0 5 7.3 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084493 102797 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 7 0 5 7.3 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm800598a
44392103 64902 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 484 9 0 4 5.2 COC(=O)c1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182731 64902 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 484 9 0 4 5.2 COC(=O)c1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
11606411 84870 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of MIP1alpha from CCR5 receptorDisplacement of MIP1alpha from CCR5 receptor
ChEMBL 550 4 1 2 7.2 C[C@H]1CN([C@@H]2CC[C@](C)(C(=O)NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)CC[C@@]12C=Cc1ccccc12 10.1021/jm070166b
CHEMBL226066 84870 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of MIP1alpha from CCR5 receptorDisplacement of MIP1alpha from CCR5 receptor
ChEMBL 550 4 1 2 7.2 C[C@H]1CN([C@@H]2CC[C@](C)(C(=O)NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)CC[C@@]12C=Cc1ccccc12 10.1021/jm070166b
93149 106704 78 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106704 78 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
25231041 188268 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 7 3.6 CCCCC1CN(S(=O)(=O)C2CCN(C=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL506958 188268 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 7 3.6 CCCCC1CN(S(=O)(=O)C2CCN(C=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44590862 190167 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.1 CCN(C(=O)c1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518326 190167 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.1 CCN(C(=O)c1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
5481736 106187 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL314342 106187 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(01)00654-0
5481736 106187 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314342 106187 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
44590751 176313 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 9 1 3 5.5 CCN(C(=O)N(C)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461688 176313 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 9 1 3 5.5 CCN(C(=O)N(C)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
25205600 7135 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 564 7 0 6 4.5 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085723 7135 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 564 7 0 6 4.5 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
20664160 180318 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL475777 180318 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
20664160 180318 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475777 180318 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
5482457 204163 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83882 204163 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
20664160 180318 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475777 180318 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
72713859 92256 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 92256 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
44392124 64890 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1OC 10.1016/j.bmcl.2004.10.044
CHEMBL182682 64890 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1OC 10.1016/j.bmcl.2004.10.044
58282592 139418 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assayInhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assay
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.5b00497
CHEMBL3799799 139418 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assayInhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assay
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.5b00497
478413 203661 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79958 203661 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44392153 64599 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 465 9 0 3 5.6 CCN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182279 64599 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 465 9 0 3 5.6 CCN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
505874 28342 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137650 28342 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505874 28342 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137650 28342 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
5275761 76750 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207633 76750 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
505874 28342 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137650 28342 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44392169 63516 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180334 63516 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
474156 11169 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
CHEMBL1179200 11169 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
CHEMBL64591 11169 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
93149 106704 78 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106704 78 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
489806 111013 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL327846 111013 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
11520510 103052 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 724 17 1 7 9.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085305 103052 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 724 17 1 7 9.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CC(C)C)cc1 10.1021/jm0509703
489806 111013 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327846 111013 2 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
478296 157366 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00232-3
CHEMBL408438 157366 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00232-3
10208679 12718 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 12718 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536751 12718 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
11342750 5603 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.4 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078013 5603 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.4 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392148 64937 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 483 9 1 3 5.3 CC(=O)Nc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182878 64937 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 483 9 1 3 5.3 CC(=O)Nc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44392203 65728 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1cccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
CHEMBL183769 65728 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1cccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
44392160 123157 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 2 5.9 CC(C(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1)c1ccccc1 10.1016/j.bmcl.2004.10.044
CHEMBL362168 123157 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 2 5.9 CC(C(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1)c1ccccc1 10.1016/j.bmcl.2004.10.044
483354 11691 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 12 0 5 6.7 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118196 11691 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 12 0 5 6.7 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44373767 168064 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL436245 168064 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
44392084 64595 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 462 8 0 2 5.7 CN(C(=O)Cc1ccc(F)c(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182274 64595 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 462 8 0 2 5.7 CN(C(=O)Cc1ccc(F)c(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728623 89857 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL238545 89857 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
478502 105485 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1007/s00044-011-9863-2
CHEMBL313071 105485 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1007/s00044-011-9863-2
5481727 203633 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79697 203633 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481702 204099 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83338 204099 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
76315544 84829 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 6.1 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL2259885 84829 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 6.1 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
489341 4869 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
489341 4869 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104793 4869 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL104793 4869 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
46888456 8710 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 459 7 1 3 4.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096768 8710 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 459 7 1 3 4.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888545 8756 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 474 7 1 4 4.1 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097169 8756 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 474 7 1 4 4.1 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
20664141 78581 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 533 8 1 6 5.0 Cc1cc(C)n2ncc(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)c2n1 10.1016/j.bmcl.2005.02.030
CHEMBL2113084 78581 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 533 8 1 6 5.0 Cc1cc(C)n2ncc(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)c2n1 10.1016/j.bmcl.2005.02.030
496983 109354 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL323370 109354 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
10461319 168909 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 606 8 1 7 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc3c(c2)OCO3)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443106 168909 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 606 8 1 7 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc3c(c2)OCO3)CC1 10.1016/j.bmcl.2009.02.014
44573255 169975 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 5 1 4 6.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL445003 169975 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 5 1 4 6.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)(C)C)CC1 10.1016/j.bmcl.2009.02.014
44573337 187615 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 592 9 1 6 6.8 COc1ccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.02.014
CHEMBL499109 187615 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 592 9 1 6 6.8 COc1ccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.02.014
10325578 188255 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 564 6 0 6 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506795 188255 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 564 6 0 6 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
496983 109354 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL323370 109354 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010266 178514 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471765 178514 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
46882947 5591 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.5 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077912 5591 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.5 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46880848 7454 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087534 7454 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
3010266 178514 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471765 178514 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
5275829 204299 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL85086 204299 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44404709 71709 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 576 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(=O)OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197680 71709 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 576 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(=O)OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
10008425 102801 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 5 0 4 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084497 102801 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 5 0 4 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
44590557 175778 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 8 1 5 5.4 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459571 175778 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 8 1 5 5.4 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
516348 127281 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 576 8 2 4 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4cccc5ccccc45)[nH]n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL366439 127281 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 576 8 2 4 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4cccc5ccccc45)[nH]n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516347 129205 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 551 8 2 5 5.9 N#Cc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4ccccc4)CC3)n[nH]2)cc1 10.1016/j.bmcl.2003.12.004
CHEMBL367446 129205 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 551 8 2 5 5.9 N#Cc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4ccccc4)CC3)n[nH]2)cc1 10.1016/j.bmcl.2003.12.004
72711741 92204 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 92204 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44404657 132993 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 593 11 1 5 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(C)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370826 132993 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 593 11 1 5 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(C)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
25231038 171858 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 9 0 6 5.2 CCCCC1C(=O)N(CC2CCN(CC(F)F)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL447808 171858 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 9 0 6 5.2 CCCCC1C(=O)N(CC2CCN(CC(F)F)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
478499 204766 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL88344 204766 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1016/s0960-894x(00)00637-5
44322729 205073 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 629 8 1 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2[nH]ccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL90385 205073 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 629 8 1 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2[nH]ccc2c1 10.1016/s0960-894x(00)00637-5
11250534 60565 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cc(Cl)ccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762337 60565 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cc(Cl)ccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478412 167396 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL431795 167396 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
44415783 79639 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 382 7 1 5 3.6 Cc1nc(C2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)no1 10.1016/j.bmcl.2006.06.012
CHEMBL213009 79639 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 382 7 1 5 3.6 Cc1nc(C2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)no1 10.1016/j.bmcl.2006.06.012
16728623 89857 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL238545 89857 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
5481727 203633 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79697 203633 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
56754672 122470 6 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)
ChEMBL 363 6 1 5 3.2 COc1ncc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)cn1 10.1021/acsmedchemlett.5b00036
CHEMBL3608771 122470 6 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)
ChEMBL 363 6 1 5 3.2 COc1ncc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)cn1 10.1021/acsmedchemlett.5b00036
12093170 857 27 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
9431 857 27 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
CHEMBL4519152 857 27 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
25133270 169907 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 594 7 0 5 5.9 CN1CN(c2ccccc2)C2(CCN(CCCC3(c4ccc(Cl)c(Cl)c4)CCN(C(=O)c4ccco4)C3)CC2)C1=O 10.1021/jm800598a
CHEMBL444915 169907 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 594 7 0 5 5.9 CN1CN(c2ccccc2)C2(CCN(CCCC3(c4ccc(Cl)c(Cl)c4)CCN(C(=O)c4ccco4)C3)CC2)C1=O 10.1021/jm800598a
50992246 58148 2 None - 0 Mouse 7.2 pIC50 = 7.2 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 58148 2 None - 0 Mouse 7.2 pIC50 = 7.2 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
9873546 77668 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
CHEMBL209899 77668 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
23285265 111808 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 512 9 0 3 6.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc2ccccc2c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL329190 111808 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 512 9 0 3 6.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc2ccccc2c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392154 65754 3 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 430 7 0 2 5.6 CN(C(=O)c1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183907 65754 3 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 430 7 0 2 5.6 CN(C(=O)c1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483351 112839 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 15 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(CC)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL331754 112839 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 15 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(CC)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44590863 176134 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 461 9 1 3 5.0 CCN(C(=O)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460008 176134 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 461 9 1 3 5.0 CCN(C(=O)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
11578088 77758 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 612 9 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NC(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL210327 77758 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 612 9 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NC(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57335017 69980 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 595 8 4 6 2.8 N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
CHEMBL1944776 69980 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 595 8 4 6 2.8 N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
44573127 186633 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 1 5 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncc[nH]2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492503 186633 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 1 5 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncc[nH]2)CC1 10.1016/j.bmcl.2009.02.014
44404645 72103 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 673 13 1 6 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198884 72103 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 673 13 1 6 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
44392218 64213 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 390 7 0 2 4.9 CN(C(=O)C1CCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181502 64213 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 390 7 0 2 4.9 CN(C(=O)C1CCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
52942078 18145 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 505 6 0 6 3.8 COC(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)c4c(C)ncnc4C)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
CHEMBL1270900 18145 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 505 6 0 6 3.8 COC(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)c4c(C)ncnc4C)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
16728647 149031 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1007/s00044-012-0118-7
CHEMBL394685 149031 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1007/s00044-012-0118-7
478447 204069 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83113 204069 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
16728647 149031 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL394685 149031 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1016/j.bmcl.2006.09.052
489810 106624 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccc(Cl)cc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL316073 106624 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccc(Cl)cc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44570270 169731 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 567 7 1 6 4.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL444667 169731 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 567 7 1 6 4.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44392096 131250 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL369311 131250 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11787124 5605 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.2 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078015 5605 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.2 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
516315 129653 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1Cc1ccccc1 10.1016/j.bmcl.2003.12.004
CHEMBL367894 129653 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1Cc1ccccc1 10.1016/j.bmcl.2003.12.004
44404601 134953 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372852 134953 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
489340 107339 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 669 12 2 5 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL319233 107339 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 669 12 2 5 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
72713859 92256 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 92256 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
53318853 58133 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683059 58133 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@H]2C)C1 10.1016/j.bmcl.2011.01.015
44392123 129393 4 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL367586 129393 4 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
25130901 102805 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 5 0 5 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)C1 10.1021/jm800598a
CHEMBL3084501 102805 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 5 0 5 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)C1 10.1021/jm800598a
25231105 173518 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 7 0 7 4.0 CCCCC1CN(S(=O)(=O)C2CCN(C(C)=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL454493 173518 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 7 0 7 4.0 CCCCC1CN(S(=O)(=O)C2CCN(C(C)=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44404697 134235 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL371865 134235 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
44455180 97472 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 478 8 1 5 5.4 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272556 97472 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 478 8 1 5 5.4 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
516319 59707 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human Chemokine receptor 5 when co-administered with compound 8fInhibitory activity against human Chemokine receptor 5 when co-administered with compound 8f
ChEMBL 568 10 1 5 6.4 CCc1cc(Cc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL173609 59707 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human Chemokine receptor 5 when co-administered with compound 8fInhibitory activity against human Chemokine receptor 5 when co-administered with compound 8f
ChEMBL 568 10 1 5 6.4 CCc1cc(Cc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
11598 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
23725177 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL4442783 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
11598 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
23725177 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
CHEMBL4442783 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
5481737 106054 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 570 7 0 4 6.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Oc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314124 106054 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 570 7 0 4 6.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Oc1ccccc1 10.1016/s0960-894x(00)00637-5
44392116 121989 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360120 121989 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073659 72184 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199147 72184 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
16073659 72184 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL199147 72184 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2006.03.089
72711277 92242 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 92242 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44392095 123285 4 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 402 7 0 3 5.0 CN(C(=O)c1ccco1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL362388 123285 4 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 402 7 0 3 5.0 CN(C(=O)c1ccco1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
77281926 187194 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@@](C)(O)C(=O)O)C1=O 10.1021/np060121y
CHEMBL495854 187194 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@@](C)(O)C(=O)O)C1=O 10.1021/np060121y
57400375 70701 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 681 12 0 8 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(S(C)(=O)=O)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951910 70701 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 681 12 0 8 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(S(C)(=O)=O)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44461804 204224 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL84351 204224 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
3209888 137060 4 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 452 6 0 6 4.0 Fc1ccc(Cn2nnnc2C(c2ccccc2F)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm061389p
CHEMBL375591 137060 4 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 452 6 0 6 4.0 Fc1ccc(Cn2nnnc2C(c2ccccc2F)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm061389p
667748 83358 78 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83358 78 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
25133618 186686 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 586 6 1 5 7.0 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
CHEMBL492854 186686 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 586 6 1 5 7.0 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
1474 153853 133 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153853 133 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
478501 105486 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL313072 105486 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
16728611 152158 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
CHEMBL397296 152158 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
44374016 52101 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL159018 52101 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
46890343 7023 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 7 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CCC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085226 7023 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 7 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CCC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888480 8709 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 481 7 1 3 4.9 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccccc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096766 8709 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 481 7 1 3 4.9 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccccc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
72711956 92207 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 92207 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
25256857 169224 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 562 8 1 5 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443936 169224 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 562 8 1 5 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11641131 83093 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 458 7 1 4 5.8 Cc1nc2ccccc2n1[C@H]1C[C@H](C)N(CC[C@H](NC(=O)C2CCC2)c2ccccc2)[C@H](C)C1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203613 83093 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 458 7 1 4 5.8 Cc1nc2ccccc2n1[C@H]1C[C@H](C)N(CC[C@H](NC(=O)C2CCC2)c2ccccc2)[C@H](C)C1 10.1111/j.1747-0285.2006.00376.x
23650547 178491 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cellsDisplacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cells
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471623 178491 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cellsDisplacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cells
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
46866599 6291 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.0 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082202 6291 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.0 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
52946506 18166 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 7 0 6 3.1 Cc1cc(=O)oc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271108 18166 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 7 0 6 3.1 Cc1cc(=O)oc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
10278617 94726 2 None - 0 Crab-eating macaque 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 94726 2 None - 0 Crab-eating macaque 8.1 pIC50 = 8.1 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
20664159 71076 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3nnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL196087 71076 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3nnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
491775 12753 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 12753 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL537424 12753 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
53325460 58171 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683190 58171 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
44404596 71921 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198277 71921 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
59458159 92253 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435908 92253 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
57391720 70691 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 672 12 0 7 3.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951899 70691 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 672 12 0 7 3.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
3011723 70696 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951904 70696 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
5275762 76725 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207485 76725 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
54585964 62532 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 546 7 0 4 7.0 CCc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784404 62532 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 546 7 0 4 7.0 CCc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
505866 28197 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137524 28197 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
25230971 176992 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 7 0 7 3.2 CCCOC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL464055 176992 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 7 0 7 3.2 CCCOC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
489331 5171 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL106381 5171 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
5481745 204753 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1016/s0960-894x(00)00637-5
CHEMBL88261 204753 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1016/s0960-894x(00)00637-5
46883026 5693 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 570 7 0 6 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078710 5693 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 570 7 0 6 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
5481867 111506 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 582 8 0 7 4.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328898 111506 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 582 8 0 7 4.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479883 204740 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL88197 204740 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
44392105 65254 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccc(Cl)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183293 65254 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccc(Cl)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728611 152158 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL397296 152158 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
44461804 204224 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL84351 204224 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
10445499 178300 1 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np030146m
CHEMBL469856 178300 1 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np030146m
24794585 178934 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 478 5 2 6 2.6 CC(=O)N[C@@H]1C[C@H](N(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4741305 178934 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 478 5 2 6 2.6 CC(=O)N[C@@H]1C[C@H](N(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
10585 1058 1 None - 1 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None - 1 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None - 1 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
44392123 129393 4 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL367586 129393 4 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
57391591 69982 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 637 10 4 6 3.8 CC(C)N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
CHEMBL1944778 69982 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 637 10 4 6 3.8 CC(C)N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
489829 205681 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 444 6 0 2 6.4 Clc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL94032 205681 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 444 6 0 2 6.4 Clc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
667748 83358 78 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83358 78 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
11597 666 3 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
23725180 666 3 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
CHEMBL4781426 666 3 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
3011721 70694 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951902 70694 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
491775 12753 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188807 12753 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL537424 12753 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
76327118 85146 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(Cl)c1 10.1007/s00044-012-0118-7
CHEMBL2281957 85146 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(Cl)c1 10.1007/s00044-012-0118-7
25205601 6355 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 540 7 0 6 4.0 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1082487 6355 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 540 7 0 6 4.0 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
16728609 166849 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL429641 166849 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
474152 11904 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL1183357 11904 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL292345 11904 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
483364 154683 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL402701 154683 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
10585 1058 1 None - 1 Human 4.1 pIC50 = 4.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1058 1 None - 1 Human 4.1 pIC50 = 4.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1058 1 None - 1 Human 4.1 pIC50 = 4.1 Binding
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
1474 153853 133 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153853 133 None - 0 Human 4.1 pIC50 = 4.1 Binding
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
5481750 204893 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1007/s00044-011-9863-2
CHEMBL89167 204893 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1007/s00044-011-9863-2
44404720 134683 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 594 11 0 4 6.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(-c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372297 134683 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 594 11 0 4 6.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(-c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
72712597 92221 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 92221 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
44564884 178722 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 4.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473352 178722 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 4.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
478494 204903 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1016/s0960-894x(00)00637-5
CHEMBL89221 204903 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1016/s0960-894x(00)00637-5
16728642 90766 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N/NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240018 90766 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N/NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11259200 87672 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 6 1 3 5.0 O=C(O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234676 87672 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 6 1 3 5.0 O=C(O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
25133619 192698 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 1 5 5.2 CC(C)(C)OC(=O)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL524159 192698 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 1 5 5.2 CC(C)(C)OC(=O)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
44373748 54648 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL161480 54648 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
10281316 73359 0 None - 0 Mouse 7.1 pIC50 = 7.1 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 565 13 6 5 3.6 CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NCC 10.1016/j.bmcl.2012.03.007
CHEMBL2018386 73359 0 None - 0 Mouse 7.1 pIC50 = 7.1 Binding
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 565 13 6 5 3.6 CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NCC 10.1016/j.bmcl.2012.03.007
44373748 54648 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL161480 54648 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
44373748 54648 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL161480 54648 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
11634966 12754 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 12754 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL537425 12754 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
483348 15107 2 None - 0 Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.5 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL121321 15107 2 None - 0 Human 5.1 pIC50 = 5.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.5 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44392078 64011 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 418 7 0 3 5.5 CN(C(=O)c1cccs1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181260 64011 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 418 7 0 3 5.5 CN(C(=O)c1cccs1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728628 89874 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1016/j.bmcl.2006.09.052
CHEMBL238549 89874 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1016/j.bmcl.2006.09.052
16728628 89874 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1007/s00044-012-0118-7
CHEMBL238549 89874 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1007/s00044-012-0118-7
483350 14454 2 None - 0 Human 4.1 pIC50 = 4.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 13 0 5 6.9 CCC(CC(CCN1CCC(N(CC)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.03.112
CHEMBL120513 14454 2 None - 0 Human 4.1 pIC50 = 4.1 Binding
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 13 0 5 6.9 CCC(CC(CCN1CCC(N(CC)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.03.112
10290194 78601 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 11 1 6 6.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(=O)OC(C)(C)C)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL2113131 78601 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 11 1 6 6.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(=O)OC(C)(C)C)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
11215950 5604 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 5 5.4 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078014 5604 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 5 5.4 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
489816 205380 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 500 6 0 2 7.1 O=C(c1ccccc1-c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL92133 205380 2 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 500 6 0 2 7.1 O=C(c1ccccc1-c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44564835 178721 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 397 7 1 5 4.0 CC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
CHEMBL473348 178721 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 397 7 1 5 4.0 CC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
16728615 150161 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1007/s00044-012-0118-7
CHEMBL395607 150161 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1007/s00044-012-0118-7
5481711 204227 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL84374 204227 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
46888584 8540 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 529 8 1 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095191 8540 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 529 8 1 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888499 8635 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 493 7 1 3 5.1 Cc1cccc(Cl)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096102 8635 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 493 7 1 3 5.1 Cc1cccc(Cl)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
505870 27405 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL136977 27405 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
505866 28197 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137524 28197 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
72711742 92205 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 92205 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
11626984 83092 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203612 83092 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
505866 28197 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137524 28197 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516350 59022 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 612 8 2 4 7.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4Cl)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL170717 59022 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 612 8 2 4 7.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4Cl)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
516341 131006 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL369189 131006 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
516330 130350 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 626 12 1 7 6.0 CCOC(=O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368517 130350 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 626 12 1 7 6.0 CCOC(=O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
5275837 63167 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 575 10 0 5 5.4 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL180013 63167 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 575 10 0 5 5.4 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
490012 111003 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 511 9 0 4 6.0 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327801 111003 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 511 9 0 4 6.0 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44404658 135542 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 629 12 1 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NS(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL373214 135542 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 629 12 1 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NS(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
73347894 92208 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 92208 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
73346388 92223 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 92223 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
72714079 92231 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 92231 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44447731 94643 0 None - 0 Crab-eating macaque 8.0 pIC50 = 8.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255430 94643 0 None - 0 Crab-eating macaque 8.0 pIC50 = 8.0 Binding
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
456319 202368 1 None - 1 Human 7.1 pIC50 = 7.1 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.7 Cc1ccccc1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL70124 202368 1 None - 1 Human 7.1 pIC50 = 7.1 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.7 Cc1ccccc1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
25206069 7015 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 560 5 0 6 4.2 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085218 7015 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 560 5 0 6 4.2 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
5481751 106477 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1016/s0960-894x(00)00637-5
CHEMBL315084 106477 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1016/s0960-894x(00)00637-5
479846 205383 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL92147 205383 1 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
16728615 150161 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2006.09.052
CHEMBL395607 150161 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2006.09.052
6480205 190845 3 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 368 2 0 2 5.8 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)CC(=O)[C@H]4/C(C=O)=C\C[C@H]3[C@H]12 10.1021/np049844c
CHEMBL519317 190845 3 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 368 2 0 2 5.8 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)CC(=O)[C@H]4/C(C=O)=C\C[C@H]3[C@H]12 10.1021/np049844c
72713861 92227 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435882 92227 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
72711280 92245 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
CHEMBL2435900 92245 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
44392074 64418 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 505 9 1 4 4.0 CN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181913 64418 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 505 9 1 4 4.0 CN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
10008921 187758 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 612 8 1 5 5.1 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
CHEMBL501077 187758 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 612 8 1 5 5.1 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
46882073 5516 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 571 5 0 6 4.7 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077353 5516 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 571 5 0 6 4.7 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
73352463 92191 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
CHEMBL2435846 92191 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
16655051 85149 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 385 5 3 4 3.1 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(C#N)cc1 10.1007/s00044-012-0118-7
CHEMBL2281960 85149 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 385 5 3 4 3.1 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(C#N)cc1 10.1007/s00044-012-0118-7
44439313 91520 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 415 6 3 5 3.1 COc1cc(Br)cc(/C(C)=N/NC(=N)N)c1OCc1ccc(C#N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241475 91520 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 415 6 3 5 3.1 COc1cc(Br)cc(/C(C)=N/NC(=N)N)c1OCc1ccc(C#N)cc1 10.1016/j.bmcl.2006.09.052
52947748 18022 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 525 8 0 6 2.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270101 18022 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 525 8 0 6 2.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25132946 187113 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 576 7 1 4 5.5 O=C1CC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL495291 187113 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 576 7 1 4 5.5 O=C1CC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
25130571 187115 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 498 6 1 5 3.9 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)C1 10.1021/jm800598a
CHEMBL495298 187115 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 498 6 1 5 3.9 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)C1 10.1021/jm800598a
489809 205665 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1cccc(Cl)c1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93949 205665 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1cccc(Cl)c1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44590946 175819 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 424 8 1 5 4.8 CC(C)c1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
CHEMBL459600 175819 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 424 8 1 5 4.8 CC(C)c1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
44455143 154700 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 8 1 5 4.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC(C)C)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL402776 154700 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 8 1 5 4.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC(C)C)c1ccccc1 10.1016/j.bmcl.2007.12.058
489815 205031 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 442 5 0 2 5.6 O=C(c1ccccc1F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL90129 205031 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 442 5 0 2 5.6 O=C(c1ccccc1F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
46883030 5696 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 623 7 0 7 5.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078713 5696 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 623 7 0 7 5.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
489814 205610 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 5 0 2 6.4 O=C(c1ccccc1C(F)(F)F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93625 205610 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 5 0 2 6.4 O=C(c1ccccc1C(F)(F)F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44455313 94664 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 463 7 0 5 5.5 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL255535 94664 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 463 7 0 5 5.5 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
54584427 60556 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccnc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762327 60556 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccnc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
46882074 5517 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 570 5 0 5 5.3 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077354 5517 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 570 5 0 5 5.3 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
457845 161239 1 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 320 4 1 2 3.9 c1ccc(C2CCN(C[C@H]3CNC[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL414222 161239 1 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 320 4 1 2 3.9 c1ccc(C2CCN(C[C@H]3CNC[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00545-5
52943283 18155 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 553 8 0 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(=O)(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271000 18155 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 553 8 0 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(=O)(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
1638 2673 33 None -6 17 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1676 2673 33 None -6 17 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1878 2673 33 None -6 17 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
5284596 2673 33 None -6 17 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
CHEMBL80 2673 33 None -6 17 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
DB01183 2673 33 None -6 17 Mouse 8.0 pKd = 8.0 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
2984051 55014 5 None - 1 Human 5.0 pKd = 5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 333 6 1 2 4.5 CC(C)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
CHEMBL1618631 55014 5 None - 1 Human 5.0 pKd = 5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 333 6 1 2 4.5 CC(C)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
10287138 72764 0 None - 1 Human 5.0 pKd = 5.0 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011440 72764 0 None - 1 Human 5.0 pKd = 5.0 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
10287138 72764 0 None - 1 Human 4.8 pKd = 4.8 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011440 72764 0 None - 1 Human 4.8 pKd = 4.8 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
2964123 67310 11 None - 1 Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 375 7 1 3 4.3 Brc1ccc(OCc2ccccc2)c(CNCC2CCCO2)c1 10.1021/ml2000017
CHEMBL1907216 67310 11 None - 1 Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 375 7 1 3 4.3 Brc1ccc(OCc2ccccc2)c(CNCC2CCCO2)c1 10.1021/ml2000017
1638 2673 33 None -6 17 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1676 2673 33 None -6 17 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1878 2673 33 None -6 17 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
5284596 2673 33 None -6 17 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
CHEMBL80 2673 33 None -6 17 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
DB01183 2673 33 None -6 17 Mouse 7.7 pKd = 7.7 Binding
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
10215932 72765 1 None - 1 Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011441 72765 1 None - 1 Human 4.7 pKd = 4.7 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
11598 665 6 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
23725177 665 6 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL4442783 665 6 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
3002977 2416 70 None -3 2 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
803 2416 70 None -3 2 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
806 2416 70 None -3 2 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
CHEMBL1201187 2416 70 None -3 2 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
CHEMBL256907 2416 70 None -3 2 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
CHEMBL584744 2416 70 None -3 2 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
DB04835 2416 70 None -3 2 Human 7.6 pKd = 7.6 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
1017290 55553 13 None - 1 Human 4.6 pKd = 4.6 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 363 7 2 3 3.9 CC(C)(CO)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
CHEMBL1623307 55553 13 None - 1 Human 4.6 pKd = 4.6 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 363 7 2 3 3.9 CC(C)(CO)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
10215932 72765 1 None - 1 Human 4.5 pKd = 4.5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011441 72765 1 None - 1 Human 4.5 pKd = 4.5 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
3001322 439 19 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
805 439 19 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
CHEMBL1255794 439 19 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
DB06497 439 19 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
49871007 58490 9 None - 1 Human 8.5 pKd = 8.5 Binding
Activation of CCR5 in human PBMC cellsActivation of CCR5 in human PBMC cells
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58490 9 None - 1 Human 8.5 pKd = 8.5 Binding
Activation of CCR5 in human PBMC cellsActivation of CCR5 in human PBMC cells
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3373405 55388 11 None - 1 Human 4.3 pKd = 4.3 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 394 4 0 3 3.7 COc1ccc(Br)cc1CN1CCCC(C(=O)N2CCCCC2)C1 10.1021/ml2000017
CHEMBL1621896 55388 11 None - 1 Human 4.3 pKd = 4.3 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 394 4 0 3 3.7 COc1ccc(Br)cc1CN1CCCC(C(=O)N2CCCCC2)C1 10.1021/ml2000017
1017997 72763 9 None - 1 Human 5.1 pKd = 5.1 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 382 7 1 3 4.7 Brc1ccc(OCc2ccccc2)c(CNCc2ccccn2)c1 10.1021/ml2000017
CHEMBL2011439 72763 9 None - 1 Human 5.1 pKd = 5.1 Binding
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 382 7 1 3 4.7 Brc1ccc(OCc2ccccc2)c(CNCc2ccccn2)c1 10.1021/ml2000017
6532436 31415 1 None - 1 Human 10.0 pKi = 10 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 616 7 0 5 7.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(-c4ccncc4)cc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140484 31415 1 None - 1 Human 10.0 pKi = 10 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 616 7 0 5 7.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(-c4ccncc4)cc3C)CC2)CC1 10.1021/jm030265z
3002977 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
803 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
806 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL1201187 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL256907 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL584744 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
DB04835 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
3002977 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
803 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
806 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL1201187 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL256907 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL584744 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
DB04835 2416 70 None 3 2 Rhesus macaque 9.6 pKi = 9.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
483407 165476 18 None - 1 Human 9.6 pKi = 9.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
CHEMBL425618 165476 18 None - 1 Human 9.6 pKi = 9.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
6532435 115147 1 None - 1 Human 9.5 pKi = 9.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 668 6 0 5 6.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1021/jm030265z
CHEMBL335365 115147 1 None - 1 Human 9.5 pKi = 9.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 668 6 0 5 6.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1021/jm030265z
5482301 119364 1 None - 1 Human 9.5 pKi = 9.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 668 6 0 5 6.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL349008 119364 1 None - 1 Human 9.5 pKi = 9.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 668 6 0 5 6.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
6532434 115636 1 None - 1 Human 9.4 pKi = 9.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 6 0 5 6.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL335794 115636 1 None - 1 Human 9.4 pKi = 9.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 6 0 5 6.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1021/jm030265z
5482300 119537 1 None - 1 Human 9.4 pKi = 9.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 580 6 0 5 6.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL350563 119537 1 None - 1 Human 9.4 pKi = 9.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 580 6 0 5 6.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
463616 31819 1 None 2884 2 Human 9.2 pKi = 9.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
CHEMBL140827 31819 1 None 2884 2 Human 9.2 pKi = 9.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
463616 31819 1 None 2884 2 Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL140827 31819 1 None 2884 2 Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
5495582 116277 1 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 684 6 0 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1021/jm030265z
CHEMBL337776 116277 1 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 684 6 0 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1021/jm030265z
9579116 55969 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 684 6 0 5 5.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL162880 55969 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 684 6 0 5 5.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
71462570 82140 0 None 1 3 Human 9.0 pKi = 9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 518 5 2 5 5.6 CC1(C)CN(CC/C=C2/c3cc(C(=O)O)ccc3OCc3ncccc32)C[C@H](c2ccc(Cl)cc2)[C@H]1O 10.1021/jm300682j
CHEMBL2178569 82140 0 None 1 3 Human 9.0 pKi = 9 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 518 5 2 5 5.6 CC1(C)CN(CC/C=C2/c3cc(C(=O)O)ccc3OCc3ncccc32)C[C@H](c2ccc(Cl)cc2)[C@H]1O 10.1021/jm300682j
44337326 7871 0 None 1 3 Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm015526o
CHEMBL109051 7871 0 None 1 3 Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm015526o
456375 9987 1 None - 1 Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL115487 9987 1 None - 1 Human 9.0 pKi = 9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
9575320 5067 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
CHEMBL105821 5067 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
9574357 109271 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
CHEMBL323172 109271 0 None 1 2 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
9575320 5067 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL105821 5067 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
9574357 109271 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL323172 109271 0 None -1 2 Mouse 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
5482298 29054 1 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL138285 29054 1 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
5479841 30520 1 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 0 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139559 30520 1 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 0 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
6533781 29467 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 596 6 0 5 5.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL138640 29467 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 596 6 0 5 5.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1021/jm030265z
5495581 56759 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 596 6 0 5 5.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL164484 56759 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 596 6 0 5 5.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
5495597 31358 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140418 31358 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1021/jm030265z
5495597 31358 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140418 31358 1 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
183790 3673 8 None 3 2 Human 8.9 pKi = 8.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
783 3673 8 None 3 2 Human 8.9 pKi = 8.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
CHEMBL1178786 3673 8 None 3 2 Human 8.9 pKi = 8.9 Binding
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
5479844 109947 1 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL324643 109947 1 None 1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
502259 116285 1 None 61 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL337820 116285 1 None 61 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462571 118277 1 None 97 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
CHEMBL342137 118277 1 None 97 2 Human 8.0 pKi = 8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
502259 116285 1 None 61 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL337820 116285 1 None 61 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
462571 118277 1 None 97 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
CHEMBL342137 118277 1 None 97 2 Human 8.0 pKi = 8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
44337326 7871 0 None -1000 3 Mouse 6.0 pKi = 6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm0200815
CHEMBL109051 7871 0 None -1000 3 Mouse 6.0 pKi = 6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm0200815
463892 31646 1 None 18 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
CHEMBL140706 31646 1 None 18 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
463209 120606 1 None 6 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 519 5 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL357557 120606 1 None 6 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 519 5 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
463210 164352 1 None 15 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 561 4 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL422326 164352 1 None 15 2 Human 8.0 pKi = 8.0 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 561 4 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
457874 78039 1 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CON=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL2111747 78039 1 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CON=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479846 109953 1 None - 1 Mouse 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324671 109953 1 None - 1 Mouse 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
463892 31646 1 None 18 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
CHEMBL140706 31646 1 None 18 2 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
5495587 118853 1 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL344435 118853 1 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495587 118853 1 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL344435 118853 1 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
511295 9153 1 None 1 2 Human 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL110786 9153 1 None 1 2 Human 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
511295 9153 1 None -1 2 Mouse 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL110786 9153 1 None -1 2 Mouse 7.0 pKi = 7.0 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
463319 118878 1 None 102 2 Human 7.9 pKi = 7.9 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL344607 118878 1 None 102 2 Human 7.9 pKi = 7.9 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462409 110189 1 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL326020 110189 1 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
44337251 5349 0 None - 1 Mouse 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 569 8 0 5 5.8 COCCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL107363 5349 0 None - 1 Mouse 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 569 8 0 5 5.8 COCCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
456323 9596 1 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
CHEMBL113154 9596 1 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
463319 118878 1 None 102 2 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL344607 118878 1 None 102 2 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
483746 31090 2 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 661 4 0 3 5.4 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3I)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
CHEMBL140183 31090 2 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 661 4 0 3 5.4 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3I)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
5495585 32277 1 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL141201 32277 1 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495585 32277 1 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL141201 32277 1 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
456339 9441 1 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL112299 9441 1 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456339 9441 1 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL112299 9441 1 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
90666578 108898 0 None - 1 Rhesus macaque 7.8 pKi = 7.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
CHEMBL3219780 108898 0 None - 1 Rhesus macaque 7.8 pKi = 7.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
112500049 131951 0 None - 1 Human 7.8 pKi = 7.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
CHEMBL3697626 131951 0 None - 1 Human 7.8 pKi = 7.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
71718930 87385 0 None -75 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 601 5 1 7 4.4 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(C(F)(F)F)nc(N3CCc4cc(C(F)(F)F)ccc4C3)c2C)CC1 10.1021/ml400055e
CHEMBL2338390 87385 0 None -75 2 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 601 5 1 7 4.4 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(C(F)(F)F)nc(N3CCc4cc(C(F)(F)F)ccc4C3)c2C)CC1 10.1021/ml400055e
90666577 108897 0 None - 1 Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219779 108897 0 None - 1 Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
101577042 182550 0 None - 1 Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4795179 182550 0 None - 1 Rhesus macaque 6.8 pKi = 6.8 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
112500047 123938 0 None - 1 Human 6.8 pKi = 6.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
CHEMBL3639964 123938 0 None - 1 Human 6.8 pKi = 6.8 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
511306 5170 1 None -1 2 Mouse 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL106369 5170 1 None -1 2 Mouse 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511306 5170 1 None 1 2 Human 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL106369 5170 1 None 1 2 Human 6.8 pKi = 6.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
9579325 106852 0 None - 1 Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 5 4.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm0200815
CHEMBL317644 106852 0 None - 1 Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 5 4.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm0200815
5496112 30550 1 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 5 4.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm030265z
CHEMBL139607 30550 1 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 5 4.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm030265z
462989 32870 1 None 14 2 Human 7.8 pKi = 7.8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL141699 32870 1 None 14 2 Human 7.8 pKi = 7.8 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
9574356 5115 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm015526o
CHEMBL106098 5115 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm015526o
9574359 5235 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm015526o
CHEMBL106767 5235 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm015526o
9574359 5235 0 None -1 2 Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm0200815
CHEMBL106767 5235 0 None -1 2 Mouse 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm0200815
5479851 30432 1 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 1 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm030265z
CHEMBL139459 30432 1 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 1 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm030265z
462989 32870 1 None 14 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL141699 32870 1 None 14 2 Human 7.8 pKi = 7.8 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
456292 96288 1 None 42 2 Human 7.8 pKi = 7.8 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 553 6 0 5 6.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL264442 96288 1 None 42 2 Human 7.8 pKi = 7.8 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 553 6 0 5 6.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
3117 206096 100 None -8 16 Human 4.7 pKi = 4.7 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 206096 100 None -8 16 Human 4.7 pKi = 4.7 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
9574356 5115 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106098 5115 0 None -1 2 Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5479840 28957 1 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 5 0 5 4.5 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138198 28957 1 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 5 0 5 4.5 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
511298 109428 1 None -1 2 Mouse 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL323454 109428 1 None -1 2 Mouse 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511298 109428 1 None 1 2 Human 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL323454 109428 1 None 1 2 Human 6.7 pKi = 6.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
464036 9639 4 None 1174 2 Human 8.7 pKi = 8.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL113436 9639 4 None 1174 2 Human 8.7 pKi = 8.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
10617034 206578 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 339 3 2 2 5.1 O=C(O)c1ccc(-c2ccc(-c3cc4c(F)ccc(F)c4o3)[nH]2)cc1 10.1021/jm300682j
CHEMBL99221 206578 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 339 3 2 2 5.1 O=C(O)c1ccc(-c2ccc(-c3cc4c(F)ccc(F)c4o3)[nH]2)cc1 10.1021/jm300682j
44341106 9527 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 511 5 0 4 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL112686 9527 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 511 5 0 4 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479844 109947 1 None -1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324643 109947 1 None -1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479846 109953 1 None - 1 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324671 109953 1 None - 1 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479845 9541 1 None 3 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL112760 9541 1 None 3 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495584 31318 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140390 31318 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
5479843 112544 1 None 4 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL331140 112544 1 None 4 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495584 31318 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140390 31318 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
802 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
804 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
9574343 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
CHEMBL78535 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
802 411 9 None 1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
804 411 9 None 1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
9574343 411 9 None 1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
CHEMBL78535 411 9 None 1 2 Mouse 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
802 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
804 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
9574343 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
CHEMBL78535 411 9 None -1 2 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
5495589 114979 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL335120 114979 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1021/jm030265z
3009355 3914 21 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
807 3914 21 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
CHEMBL82301 3914 21 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
DB06652 3914 21 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
5495589 114979 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL335120 114979 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
6532433 33257 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 541 6 0 6 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL142021 33257 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 541 6 0 6 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
5482299 119657 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 541 6 0 6 5.0 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL351625 119657 1 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 541 6 0 6 5.0 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
464036 9639 4 None 1174 2 Human 8.6 pKi = 8.6 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL113436 9639 4 None 1174 2 Human 8.6 pKi = 8.6 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
464036 9639 4 None 1174 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL113436 9639 4 None 1174 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
6533779 28644 1 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1021/jm030265z
CHEMBL137934 28644 1 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1021/jm030265z
CHEMBL5071060 212470 0 None 21 2 Rhesus macaque 8.6 pKi = 8.6 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL None None None Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1021/acs.jmedchem.1c00408
462395 114691 1 None 128 2 Human 8.6 pKi = 8.6 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
CHEMBL334470 114691 1 None 128 2 Human 8.6 pKi = 8.6 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
462395 114691 1 None 128 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL334470 114691 1 None 128 2 Human 8.6 pKi = 8.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
462902 119335 1 None 8 2 Human 7.7 pKi = 7.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 460 4 0 6 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL348667 119335 1 None 8 2 Human 7.7 pKi = 7.7 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 460 4 0 6 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
483744 9522 2 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL112659 9522 2 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579332 5199 0 None - 1 Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 7 0 7 3.5 CCO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106558 5199 0 None - 1 Mouse 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 7 0 7 3.5 CCO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
483744 9522 2 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL112659 9522 2 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496119 29032 1 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 7 0 7 3.5 CCO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138263 29032 1 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 7 0 7 3.5 CCO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
71718331 87386 0 None -208 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 663 8 2 8 5.7 Cc1c(NC[C@H]2CCC[C@@H](c3ccc(C(F)(F)F)cc3)O2)nc(C2CCOCC2)nc1C(=O)N1CCC(N[C@H]2CCOC[C@H]2F)CC1 10.1021/ml400055e
CHEMBL2338391 87386 0 None -208 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 663 8 2 8 5.7 Cc1c(NC[C@H]2CCC[C@@H](c3ccc(C(F)(F)F)cc3)O2)nc(C2CCOCC2)nc1C(=O)N1CCC(N[C@H]2CCOC[C@H]2F)CC1 10.1021/ml400055e
9827221 109201 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322817 109201 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
5495579 55973 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL162946 55973 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
461838 201944 1 None 1 2 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 611 6 0 7 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3F)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL67281 201944 1 None 1 2 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 611 6 0 7 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3F)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
89702731 108895 0 None -4 3 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
CHEMBL3219777 108895 0 None -4 3 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
162650661 179559 0 None -74 2 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4748891 179559 0 None -74 2 Rhesus macaque 6.6 pKi = 6.6 Binding
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
89702731 108895 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL3219777 108895 0 None -4 3 Human 6.6 pKi = 6.6 Binding
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
9579329 5116 0 None - 1 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 5 0 5 4.3 CO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106099 5116 0 None - 1 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 5 0 5 4.3 CO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496116 28898 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 5 0 5 4.3 CO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138143 28898 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 5 0 5 4.3 CO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5479845 9541 1 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL112760 9541 1 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
511304 5303 1 None -1 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL107092 5303 1 None -1 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
5479845 9541 1 None -3 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL112760 9541 1 None -3 2 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511304 5303 1 None 1 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL107092 5303 1 None 1 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
5479845 9541 1 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL112760 9541 1 None 3 2 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495595 30201 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139246 30201 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1021/jm030265z
5495595 30201 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL139246 30201 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
9579318 169266 0 None - 1 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 6 0 5 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL443999 169266 0 None - 1 Mouse 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 6 0 5 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm0200815
5496105 28744 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 6 0 5 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL138028 28744 1 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 6 0 5 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm030265z
11069824 110170 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 419 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccccc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL325957 110170 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 419 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccccc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456293 202351 1 None 17 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL70010 202351 1 None 17 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
11079978 9076 0 None - 1 Mouse 6.6 pKi = 6.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 404 4 0 2 5.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3)CC2)CC1 10.1021/jm0200815
CHEMBL110270 9076 0 None - 1 Mouse 6.6 pKi = 6.6 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 404 4 0 2 5.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3)CC2)CC1 10.1021/jm0200815
457672 7129 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL108569 7129 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
457672 7129 1 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL108569 7129 1 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457672 7129 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL108569 7129 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
483747 104917 2 None 177 4 Human 8.5 pKi = 8.5 Binding
Ability of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL311795 104917 2 None 177 4 Human 8.5 pKi = 8.5 Binding
Ability of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
484578 9585 2 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL113072 9585 2 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579312 108646 0 None - 1 Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 6 0 4 6.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm0200815
CHEMBL321413 108646 0 None - 1 Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 6 0 4 6.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm0200815
484578 9585 2 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL113072 9585 2 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
483747 104917 2 None 177 4 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL311795 104917 2 None 177 4 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496099 164691 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 6 0 4 6.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm030265z
CHEMBL423000 164691 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 6 0 4 6.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm030265z
5495590 31480 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140552 31480 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1021/jm030265z
5495590 31480 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140552 31480 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL5074744 212548 0 None 1 2 Rhesus macaque 8.5 pKi = 8.5 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
5495588 31928 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL140912 31928 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495588 31928 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140912 31928 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
9574358 5063 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm015526o
CHEMBL105784 5063 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm015526o
9574358 5063 0 None -1 2 Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm0200815
CHEMBL105784 5063 0 None -1 2 Mouse 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm0200815
5479842 116204 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 5 1 5 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL337340 116204 1 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 5 1 5 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm030265z
9579330 5195 0 None - 1 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 6 0 5 5.1 CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106533 5195 0 None - 1 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 6 0 5 5.1 CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496117 95954 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 6 0 5 5.1 CCO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL261950 95954 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 6 0 5 5.1 CCO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
456647 10104 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL116008 10104 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579334 5885 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 6 0 5 4.2 CCO/N=C(\c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL107999 5885 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 6 0 5 4.2 CCO/N=C(\c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
9579328 167518 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 7 3.1 CO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL432636 167518 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 7 3.1 CO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
456647 10104 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL116008 10104 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496115 29484 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 7 3.1 CO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138655 29484 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 7 3.1 CO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5496121 32464 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 6 0 5 4.2 CCO/N=C(/c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL141345 32464 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 6 0 5 4.2 CCO/N=C(/c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
73345281 88801 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL 942 8 10 19 -0.6 C[C@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)C5=C[C@H](O)C67C(=O)O[C@@](C)(C8CCC(C)(C)O8)[C@@]6(O)CC[C@@]7(C)C5CCC4C3(C)C)OC[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 10.1016/s0960-894x(02)00599-1
CHEMBL2367888 88801 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL 942 8 10 19 -0.6 C[C@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)C5=C[C@H](O)C67C(=O)O[C@@](C)(C8CCC(C)(C)O8)[C@@]6(O)CC[C@@]7(C)C5CCC4C3(C)C)OC[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 10.1016/s0960-894x(02)00599-1
455656 202303 1 None 3 2 Human 7.5 pKi = 7.5 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cellsAbility to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cells
ChEMBL 604 6 1 8 4.5 Cc1cccc(N)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL69670 202303 1 None 3 2 Human 7.5 pKi = 7.5 Binding
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cellsAbility to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cells
ChEMBL 604 6 1 8 4.5 Cc1cccc(N)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
71717723 87387 0 None -51 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 525 7 2 7 4.3 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(CF)nc(Nc3ccc(Cl)c(Cl)c3)c2C)CC1 10.1021/ml400055e
CHEMBL2338392 87387 0 None -51 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 525 7 2 7 4.3 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(CF)nc(Nc3ccc(Cl)c(Cl)c3)c2C)CC1 10.1021/ml400055e
5495593 118575 1 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL342706 118575 1 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1021/jm030265z
5495593 118575 1 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL342706 118575 1 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
455657 202298 1 None 3 2 Human 7.5 pKi = 7.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 624 6 1 8 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL69642 202298 1 None 3 2 Human 7.5 pKi = 7.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 624 6 1 8 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
9579315 5061 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL105779 5061 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511303 5174 1 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106406 5174 1 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0200815
9579316 5239 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL106790 5239 0 None - 1 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511307 5286 1 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106982 5286 1 None -1 2 Mouse 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm0200815
511303 5174 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106406 5174 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
511307 5286 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106982 5286 1 None 1 2 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm030265z
5496102 32994 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141802 32994 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5496103 118253 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL341928 118253 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
474465 201373 2 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 6 0 5 5.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL63757 201373 2 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 6 0 5 5.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
511297 5146 1 None 1 2 Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106264 5146 1 None 1 2 Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm030265z
511297 5146 1 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106264 5146 1 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm0200815
474188 31419 2 None 28 2 Human 7.4 pKi = 7.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL140490 31419 2 None 28 2 Human 7.4 pKi = 7.4 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
474188 31419 2 None 28 2 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL140490 31419 2 None 28 2 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
9579314 7792 0 None - 1 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL109008 7792 0 None - 1 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496101 29893 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL138975 29893 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
9579331 106956 0 None - 1 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 562 7 0 6 5.0 CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL318311 106956 0 None - 1 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 562 7 0 6 5.0 CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496118 29044 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 562 7 0 6 5.0 CCO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138274 29044 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 562 7 0 6 5.0 CCO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
9574360 8009 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm015526o
CHEMBL109158 8009 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm015526o
9574360 8009 0 None -1 2 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm0200815
CHEMBL109158 8009 0 None -1 2 Mouse 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm0200815
5479852 29951 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 1 5 5.1 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm030265z
CHEMBL139029 29951 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 1 5 5.1 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm030265z
5495583 32280 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 0 6 4.6 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141202 32280 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 0 6 4.6 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
9579117 54679 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 527 5 0 6 4.6 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL161587 54679 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 527 5 0 6 4.6 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL5094690 213725 0 None - 1 Rhesus macaque 7.4 pKi = 7.4 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells by competitive radioligand binding assay
ChEMBL None None None CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)NCCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
9579321 9141 0 None - 1 Mouse 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm0200815
CHEMBL110730 9141 0 None - 1 Mouse 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm0200815
5496108 29764 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm030265z
CHEMBL138879 29764 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm030265z
5495594 30616 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139701 30616 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1021/jm030265z
5495594 30616 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL139701 30616 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
456611 201851 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL66623 201851 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
461546 9375 1 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
CHEMBL111982 9375 1 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
461546 9375 1 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL111982 9375 1 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
463517 201998 1 None -436 2 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL67563 201998 1 None -436 2 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
461871 161208 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 543 6 0 3 6.9 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4cccc(Cl)c4)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL413972 161208 1 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 543 6 0 3 6.9 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4cccc(Cl)c4)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
503637 56038 1 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56038 1 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
5479843 112544 1 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL331140 112544 1 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479843 112544 1 None -4 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL331140 112544 1 None -4 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479843 112544 1 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL331140 112544 1 None 4 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
462772 101828 1 None 5 2 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 643 6 0 7 5.9 C[C@H]1CN(C2CCN(C(=O)c3c(Cl)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL303503 101828 1 None 5 2 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 643 6 0 7 5.9 C[C@H]1CN(C2CCN(C(=O)c3c(Cl)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
484577 9377 2 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL111998 9377 2 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
484579 9580 2 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm0155401
CHEMBL113042 9580 2 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm0155401
456323 9596 1 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm0155401
CHEMBL113154 9596 1 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm0155401
456372 10028 1 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL115716 10028 1 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
461327 110059 1 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm0155401
CHEMBL325276 110059 1 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm0155401
484577 9377 2 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL111998 9377 2 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
484579 9580 2 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm030265z
CHEMBL113042 9580 2 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm030265z
456372 10028 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL115716 10028 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
461327 110059 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL325276 110059 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
503637 56038 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56038 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
462573 29301 1 None 316 2 Human 8.3 pKi = 8.3 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL138502 29301 1 None 316 2 Human 8.3 pKi = 8.3 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462573 29301 1 None 316 2 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL138502 29301 1 None 316 2 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
9579326 108104 0 None - 1 Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 532 5 0 5 4.7 CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL320502 108104 0 None - 1 Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 532 5 0 5 4.7 CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496113 32416 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 0 5 4.7 CO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL141301 32416 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 0 5 4.7 CO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5495596 118725 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL343520 118725 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1021/jm030265z
5495596 118725 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL343520 118725 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
9579333 162864 0 None - 1 Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 512 6 0 5 4.7 CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL419735 162864 0 None - 1 Mouse 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 512 6 0 5 4.7 CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496120 118769 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 512 6 0 5 4.7 CCO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL343826 118769 1 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 512 6 0 5 4.7 CCO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL5089300 213417 0 None 1 2 Rhesus macaque 8.2 pKi = 8.2 Binding
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
5495591 32851 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141683 32851 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1021/jm030265z
5495591 32851 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL141683 32851 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
71719547 87388 0 None -50 2 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 660 8 2 9 5.8 Cc1cc(-c2nc(NC[C@H]3CCC[C@@H](c4ccc(C(F)(F)F)cc4)O3)c(C)c(C(=O)N3CCC(N[C@@H]4CCOC[C@@H]4F)CC3)n2)no1 10.1021/ml400055e
CHEMBL2338393 87388 0 None -50 2 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 660 8 2 9 5.8 Cc1cc(-c2nc(NC[C@H]3CCC[C@@H](c4ccc(C(F)(F)F)cc4)O3)c(C)c(C(=O)N3CCC(N[C@@H]4CCOC[C@@H]4F)CC3)n2)no1 10.1021/ml400055e
CHEMBL2367887 207831 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL None None None COC1[C@@H](O)C(OC2[C@@H](O)[C@H](O[C@@H]3[C@@H](C)O[C@@H](O[C@H]4[C@H](O[C@H]5CC[C@]6(C)C7=C[C@H](O)C89C(=O)O[C@@](C)(CCCC(C)C)C8CC[C@@]9(C)C7CCC6C5(C)C)OC[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](OC6O[C@H](CO)[C@@H](O)[C@H](OC)[C@H]6O)[C@H]5O)[C@@H]4O)[C@H](O)[C@H]3O)O[C@H](CO)[C@H]2O)O[C@H](CO)[C@H]1O 10.1016/s0960-894x(02)00599-1
457671 5132 1 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL106209 5132 1 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
457671 5132 1 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106209 5132 1 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457671 5132 1 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106209 5132 1 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
511305 106829 1 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL317476 106829 1 None -1 2 Mouse 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
511305 106829 1 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL317476 106829 1 None 1 2 Human 7.3 pKi = 7.3 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
457875 5143 1 None 1 3 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106247 5143 1 None 1 3 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457875 5143 1 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106247 5143 1 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
483741 33258 2 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 504 4 0 2 6.6 CC1(N2CCC(Cc3ccc(Br)cc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm030265z
CHEMBL142022 33258 2 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 504 4 0 2 6.6 CC1(N2CCC(Cc3ccc(Br)cc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm030265z
511308 7565 1 None -1 2 Mouse 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL108845 7565 1 None -1 2 Mouse 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511308 7565 1 None 1 2 Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL108845 7565 1 None 1 2 Human 6.2 pKi = 6.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
5495592 31115 1 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140201 31115 1 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1021/jm030265z
5495592 31115 1 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140201 31115 1 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
456298 9681 1 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
CHEMBL113648 9681 1 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
44337265 5188 0 None - 1 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 555 7 1 5 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OCCO)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106507 5188 0 None - 1 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 555 7 1 5 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OCCO)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511299 9175 1 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL110871 9175 1 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511299 9175 1 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL110871 9175 1 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
456298 9681 1 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL113648 9681 1 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
3497 1154 20 None -2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
5311123 1154 20 None -2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
CHEMBL1628706 1154 20 None -2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
457875 5143 1 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL106247 5143 1 None -1 3 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
10961907 9161 0 None - 1 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1 10.1021/jm0200815
CHEMBL110809 9161 0 None - 1 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1 10.1021/jm0200815
511294 5152 1 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106299 5152 1 None -1 2 Mouse 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm0200815
511294 5152 1 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106299 5152 1 None 1 2 Human 7.2 pKi = 7.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm030265z
511332 109127 4 None 35 3 Human 8.2 pKi = 8.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL322251 109127 4 None 35 3 Human 8.2 pKi = 8.2 Binding
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
511332 109127 4 None 35 3 Human 8.2 pKi = 8.2 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322251 109127 4 None 35 3 Human 8.2 pKi = 8.2 Binding
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456375 9987 1 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL115487 9987 1 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
457871 100243 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL292625 100243 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
9579320 9147 0 None - 1 Mouse 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm0200815
CHEMBL110757 9147 0 None - 1 Mouse 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm0200815
457871 100243 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL292625 100243 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
511332 109127 4 None 35 3 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL322251 109127 4 None 35 3 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
462409 110189 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL326020 110189 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496107 116023 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL336246 116023 1 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm030265z
9579327 5244 0 None - 1 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 548 6 0 6 4.6 CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106813 5244 0 None - 1 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 548 6 0 6 4.6 CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496114 118255 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 548 6 0 6 4.6 CO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL341945 118255 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 548 6 0 6 4.6 CO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
463502 202288 1 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL69581 202288 1 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
9579311 5180 0 None - 1 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106468 5180 0 None - 1 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496098 118463 1 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL342452 118463 1 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
484581 110097 2 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL325556 110097 2 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
511309 5315 1 None -1 2 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL107154 5315 1 None -1 2 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511309 5315 1 None 1 2 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL107154 5315 1 None 1 2 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
484581 110097 2 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL325556 110097 2 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5495586 118215 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL341758 118215 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495586 118215 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL341758 118215 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
6533780 28552 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1021/jm030265z
CHEMBL137856 28552 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1021/jm030265z
5495580 54770 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL161664 54770 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
2600 3708 73 None -5 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
2608 3708 73 None -5 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
5405 3708 73 None -5 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
CHEMBL17157 3708 73 None -5 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
DB00342 3708 73 None -5 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
511296 9103 1 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL110463 9103 1 None -1 2 Mouse 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511296 9103 1 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL110463 9103 1 None 1 2 Human 7.1 pKi = 7.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
9579313 162764 0 None - 1 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL418997 162764 0 None - 1 Mouse 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496100 116209 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL337364 116209 1 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
503637 56038 1 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56038 1 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
503637 56038 1 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56038 1 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
3002977 2416 70 None - 2 Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
803 2416 70 None - 2 Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
806 2416 70 None - 2 Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL1201187 2416 70 None - 2 Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL256907 2416 70 None - 2 Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL584744 2416 70 None - 2 Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
DB04835 2416 70 None - 2 Mouse 8.1 pIC50 = 8.1 Binding
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
11598 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
23725177 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
CHEMBL4442783 665 6 None - 1 Human 6.1 pIC50 = 6.1 Binding
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
11614352 544 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
7686 544 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
CHEMBL1951914 544 1 None - 0 Human 9.6 pIC50 = 9.6 Binding
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
10416 1841 23 None - 1 Human 5.2 pIC50 = 5.2 Binding
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
46861584 1841 23 None - 1 Human 5.2 pIC50 = 5.2 Binding
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
CHEMBL2018969 1841 23 None - 1 Human 5.2 pIC50 = 5.2 Binding
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
3002977 2416 70 None -3 2 Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
803 2416 70 None -3 2 Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
806 2416 70 None -3 2 Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL1201187 2416 70 None -3 2 Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL256907 2416 70 None -3 2 Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL584744 2416 70 None -3 2 Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
DB04835 2416 70 None -3 2 Human 8.1 pKd = 8.1 Binding
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
1638 2673 33 None -6 17 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
1676 2673 33 None -6 17 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
1878 2673 33 None -6 17 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
5284596 2673 33 None -6 17 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
CHEMBL80 2673 33 None -6 17 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
DB01183 2673 33 None -6 17 Mouse 8.1 pKd = 8.1 Binding
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
802 411 9 None -1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
804 411 9 None -1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
9574343 411 9 None -1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
CHEMBL78535 411 9 None -1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
3002977 2416 70 None -3 2 Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
803 2416 70 None -3 2 Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
806 2416 70 None -3 2 Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL1201187 2416 70 None -3 2 Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL256907 2416 70 None -3 2 Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL584744 2416 70 None -3 2 Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
DB04835 2416 70 None -3 2 Human 9.1 pKd None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
3117 206096 100 None -8 16 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
CHEMBL964 206096 100 None -8 16 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
2600 3708 73 None -5 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
2608 3708 73 None -5 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
5405 3708 73 None -5 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
CHEMBL17157 3708 73 None -5 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
DB00342 3708 73 None -5 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
3002977 2416 70 None 3 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
803 2416 70 None 3 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
806 2416 70 None 3 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL1201187 2416 70 None 3 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL256907 2416 70 None 3 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL584744 2416 70 None 3 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
DB04835 2416 70 None 3 2 Rhesus macaque 8.0 pKi = 8.0 Binding
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
753 814 0 None -1 2 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
771 823 0 None -1 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
759 851 0 None -25 4 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
183790 3673 8 None 3 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
783 3673 8 None 3 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
CHEMBL1178786 3673 8 None 3 2 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
802 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
802 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
802 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
804 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
804 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
804 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
9574343 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
9574343 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
9574343 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
CHEMBL78535 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
CHEMBL78535 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
CHEMBL78535 411 9 None -1 2 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
756 843 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
756 843 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
756 843 0 None -3 2 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
3001322 439 19 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
805 439 19 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
CHEMBL1255794 439 19 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
DB06497 439 19 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
3009355 3914 21 None - 1 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
807 3914 21 None - 1 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
CHEMBL82301 3914 21 None - 1 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
DB06652 3914 21 None - 1 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
772 855 0 None - 1 Human 9.3 pKi = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
758 850 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10318947
758 850 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
758 850 0 None 3 4 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
757 848 0 None 112 2 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
757 848 0 None 112 2 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
760 1617 0 None 3 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
752 701 0 None -12 2 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
770 813 0 None 79 2 Human 9.1 pKi None 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730